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“When a book is finished it looks so orderly, and it looks like it was always the way it is. 
But of course there were so many dead ends, and there’s so much on the cutting room floor.” 
 




Skin sonoporation refers to the creation of aqueous pathways in the stratum corneum 
with ultrasound. The mechanism responsible for the permeability increase that arises from 
sonoporation is inertial cavitation – the formation and collapse of gaseous cavities in the 
coupling fluid. In vitro skin sonoporation experiments are usually conducted in Franz diffusion 
cells – an apparatus designed for passive transdermal transport experiments. During skin 
sonoporation, the temperature of the coupling fluid often increases to a level which can cause 
burns. To mitigate temperature increases, previous studies have relied on duty cycles and 
replacement of the coupling fluid during ultrasound application. Reliance on these two 
methods has resulted in sonoporation protocols that are not clinically applicable: when using 
a duty cycle, 12 minutes of ultrasound can take up to 2 hours to administer; while coupling 
fluid replacement requires constant monitoring and disruptive manual intervention. This 
thesis introduces a circulation system which enables the coupling fluid to be set and 
maintained at a specified, safe temperature during continuous ultrasound application. With 
this new technology, duty cycles and fluid replacement are no longer required during in vitro, 
in vivo or clinical sonoporation. Using the temperature control system, a series of experiments 
were conducted to investigate the influence of coupling fluid temperature on post-
sonoporation transport. Although the inertial cavitation activity decreased, the post-
sonoporation transport increased as the specified coupling fluid temperature increased.  
  
In other therapeutic ultrasound systems, passive cavitation detectors (PCDs) are used to 
monitor inertial cavitation activity (the main mechanism of permeability increase) to ensure 
it remains at the desired level during ultrasound application. Passive cavitation detectors 
iv 
 
cannot be used to effectively monitor inertial cavitation activity in standard Franz diffusion 
cells as the donor chambers are too small to incorporate a transducer and hydrophone during 
sonoporation. Researchers have therefore had to assume that, for a given intensity, inertial 
cavitation activity always remains constant during ultrasound application. A modified 
diffusion cell setup that incorporates a transducer and PCD hydrophone during sonoporation 
is introduced. The PCD output was shown to increase with increasing ultrasound intensity (as 
inertial cavitation does) and decrease with increasing coupling fluid temperature (as inertial 
cavitation was shown to do). It can be concluded from these results that a PCD positioned in 
the coupling fluid can be used to monitor the inertial cavitation activity which occurs during 
skin sonoporation. Applying this system to clinical setups will be of great benefit as it will 
enable any changes in inertial cavitation activity to be detected and counteracted in real-time. 
 
Acoustic reflections have been shown to significantly influence the ultrasound fields in cell 
sonoporation setups. The influence of acoustic reflection on the ultrasound field during skin 
sonoporation has not been investigated. A modified Franz diffusion cell setup was 
manufactured which allowed for passive measurement of the inertial cavitation at the skin 
aperture during sonoporation (with and without the suppression of reflections). When 
acoustic reflection was suppressed, the inertial cavitation dose (ICD) was lower than when 
the reflection was not supressed. It can be concluded from this result that the acoustic 
reflections within a low-frequency sonoporation setup can influence the inertial cavitation 
activity which occurs during ultrasound application. Therefore, for a given set input 
parameters, the same inertial cavitation activity that was obtained in vitro is not guaranteed 




Chapter 1 contains the introduction which has two sections: Background, and Gaps in the 
Field and Thesis Objectives. Chapter 2 introduces a novel coupling fluid temperature control 
system developed specifically for sonoporation in Franz diffusion cells. The system enables 
the coupling fluid to be set and maintained at a specified temperature during continuous 
sonoporation. Chapter 3 introduces a passive cavitation detector (PCD) system capable of 
measuring the broadband noise emission that occurs during skin sonoporation in a Franz 
diffusion cell. Chapter 4 reports an investigation into the influence of acoustic reflection 
during ultrasound application in a Franz diffusion cell. Chapter 5 summarises the overall 
conclusions of the thesis and Chapter 6 suggests future work.  
 
Two significant appendices are included in this thesis. Appendix A reports an initial 
attempt to employ both coupling fluid temperature control and a PCD during skin 
sonoporation. This was the first known study in which skin permeability (quantified by 
measuring caffeine transport with HPLC) was increased with ultrasound while the coupling 
fluid was circulated and cooled, a significant contribution to the field. The time saved by not 
needing to use duty cycles or fluid replacement meant that a full 10 repetitions could be run 
for each of the transport datasets – more than most previous studies have found it feasible 
to run. The work reported in Appendix A was vital in the development of the improved 





Appendix B reports an investigation conducted to find a combination of experimental 
parameters appropriate for the coupling fluid temperature study in Chapter 2. Appendix B 
also contains a demonstration of the novel temperature control system’s ability to maintain 
a constant coupling fluid temperature during a long (30 minute) continuous application of 
ultrasound – another significant contribution to the field. The mean post-sonoporation 
calcein transport achieved with 30 minutes of sonoporation was almost twice that achieved 
with 10 minutes. Given this positive relationship between application time and transport, 
future researchers and clinicians will find it beneficial to use long application times. With the 
temperature control system, duty cycles and fluid replacement are no longer required. 
Therefore, it is now possible to apply long durations (≥30 minutes) of ultrasound in a 
reasonable, clinically practical time. 
 
A list of completed conference and journal publications is provided at the end of the 
thesis, along with a list of journal papers in preparation. A full length journal paper based on 
the findings of Chapter 4 has been published already (in the Journal of Ultrasound in Medicine 
and Biology). A full length journal paper based off of the findings of Chapter 2 is under review 
(by the Journal of Ultrasound in Medicine and Biology). Three additional full length journal 
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1Z    Acoustic impedance (material 1) 
2Z   Acoustic impedance (material 2) 
BLN   Baseline noise level 
   Mean value of the noise floor 
    Standard deviation of the noise floor  
CAFC   Caffeine concentration 











 Transdermal Drug Delivery 
In transdermal drug delivery (TDD), a topically applied drug permeant diffuses through the 
skin before being absorbed into the bloodstream. The outermost layer of the skin, the stratum 
corneum (SC), is the greatest contributor to the skin’s barrier function. Therefore, it is the 
permeability of the SC that dictates the rate at which topical permeants can diffuse through 
the skin (Becker, et al. 2014, Bommannan, et al. 1990, Marjukka Suhonen, et al. 1999, Tezel, 
et al. 2003b, Trommer and Neubert 2006). The SC is composed of flat Keratin fibre husks 
embedded in lipid layers which are arranged in lamellar sheets (Harding 2004, Menon, et al. 
2012, Mitragotri, et al. 1996). Most transdermal transport of lipophilic solutes occurs through 
the SC space occupied by the lipid structures (Barry 2001, Kirjavainen, et al. 1999, Ogiso, et 
al. 1998, Prausnitz, et al. 2004), however, these lipid bilayers are a formidable barrier to any 
substances with molecular weights above 500 Da (Paliwal, et al. 2006). Despite the barrier 
presented by the SC, transdermal drug delivery is an attractive delivery method as there are 
no significant first pass metabolism effects from the liver, there is no pain during delivery, no 
chance of disease transmission by needle sharing, patients can self-administer, and a slow 
release of drugs is easily achieved (Boucaud, et al. 2001, Prausnitz and Langer 2008). There 
has been success with a number of commercialised passive TDD products for substances such 
as Fentanyl (for pain management) and Nicotine (Prausnitz and Langer 2008). However, 
techniques to temporarily increase the SC permeability must be developed if TDD is to 
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become a realistic delivery method for substances that do not diffuse passively. Researchers 
have used a variety of techniques to actively increase the permeability of the SC to 
transdermal transport by diffusion. These techniques have employed electric fields (Kost, et 
al. 1996, Prausnitz 1999, Wong, et al. 2006, Zorec, et al. 2013), ultrasound (Boucaud, et al. 
2001, Cancel, et al. 2004, Johnson, et al. 1996, Park, et al. 2010, Tang, et al. 2001, Zorec, et al. 
2015), chemical enhancement (Benson 2005, Lee, et al. 2010, Pathan and Setty 2009, Seto, et 
al. 2010), and microneedles (Chen, et al. 2010, Henry, et al. 1998b, Lanke, et al. 2009, 
Prausnitz and Langer 2008). This thesis is concerned with the application of ultrasound to the 
skin.  
 
 Ultrasound Enhanced Transdermal Drug Delivery 
Under certain conditions, the application of ultrasound has been shown to enhance 
transdermal transport (Boucaud, et al. 2002, Cevc 1997, Kushner, et al. 2004, Lee, et al. 2004a, 
Lee, et al. 2004b, Mitragotri, et al. 1995a, Mitragotri and Kost 2004, Tachibana and Tachibana 
1991, Tezel, et al. 2005). Ultrasound enhanced TDD can be classified into two categories 
(Ogura, et al. 2008): sonophoresis and sonoporation. In a sonophoresis experiment the 
ultrasound field and the permeant are applied to the skin simultaneously (Lee, et al. 2010, 
Merino, et al. 2003, Mitragotri, et al. 1996, Morimoto, et al. 2005, Polat, et al. 2012). 
Sonophoresis is thought to not only increase the skin permeability (due to structural 
alterations in the SC), but also enhance the permeant diffusion by convection (Mitragotri and 
Kost 2004). This thesis focuses on low-frequency (20 kHz to 100 kHz) sonoporation (also 
referred to as pre-treatment sonophoresis), which Zorec, et al. (2015) described as “the 
creation of aqueous pathways in the SC as a result of ultrasound application.” In a 
sonoporation experiment, ultrasound is applied to the skin for a set period of time to increase 
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its permeability. The ultrasound transducer is then removed and a permeant solution is 
applied to the temporarily permeabilized skin.  
 
 The Mechanism Behind Ultrasound Enhancement 
Ultrasound intensity is defined as the ultrasonic power flowing through a unit area normal 
to the direction of propagation (O’Brien Jr 2007). When a threshold intensity is reached in an 
ultrasound field, cavitation nuclei in the coupling fluid (the medium between the transducer 
and skin) grow to form cavitation bubbles which then violently collapse upon compression 
(Helga, et al. 2015, Mitragotri and Kost 2004). This formation and violent collapse of bubbles 
is termed inertial cavitation (Chang, et al. 2001, Gaitan, et al. 1992, Lai, et al. 2006, Lawrie, et 
al. 2000, Miller 2007, Mitragotri and Kost 2004). The aggregate of all of the inertial cavitation 
collapses which occur in an ultrasound field is termed the inertial cavitation activity – the 
more collapse events that occur, the greater the inertial cavitation activity. Researchers have 
established that this inertial cavitation activity is the mechanism behind the skin permeability 
enhancement that occurs during ultrasound application (Alvarez‐Román, et al. 2003, Lee, et 
al. 2010, Mitragotri, et al. 1995b, Tang, et al. 2002a, Tezel and Mitragotri 2003a, Tezel, et al. 
2002, Tezel, et al. 2001, Ueda, et al. 2009, Ueda, et al. 1996, Wu, et al. 1998). When a 
cavitation bubble is far away from a solid boundary its collapse is symmetrical (Mitragotri and 
Kost 2004). When a bubble collapses near the skin surface, the movement of the portion of 
the bubble nearest to the skin is restricted, while the unrestricted portion of the bubble 
continues to collapse towards the skin. This results in an asymmetric collapse and the 
formation of a high-speed liquid jet (known as a micro jet) in the direction of the skin (Boyd 
and Becker 2018, Lauterborn and Ohl 1997, Tezel and Mitragotri 2003a, Wolloch and Kost 
2010). These micro jets are thought to disrupt the SC structure by removing some portion of 
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the lipids and introducing defects to the lipid lamellae (Dahlan, et al. 2009, Mitragotri and 
Kost 2004, Smith 2007). Disruption of these lipid bilayers is known to result in an increase in 
skin permeability (Francoeur, et al. 1990, Gay, et al. 1994, Golden, et al. 1986, Potts and 
Francoeur 1990, Potts, et al. 1991). Cavitation induced lipid disruption was demonstrated in 
the study by Alvarez‐Román, et al. (2003) which found, using infrared spectroscopy, that 
approximately 30 % of the intercellular lipids of the SC were removed during 20 kHz 
ultrasound application at an intensity of 15 W/cm2 (the transducer was 5 mm from the skin 
and ultrasound was applied for 2 hours using a 10 % duty cycle). Similarly, Lee, et al. (2010) 
used a postfixation method to show that discrete elongated defects appeared in the lipid 
lamellae during 5 minutes of continuous ultrasound application at 0.8 W/cm2 and 25 kHz. 
Lipid disruption was also demonstrated by Ueda, et al. (1996) who found that the leaching of 
lipids from the SC increased with increasing ultrasound application time (for a frequency of 
150 kHz and an intensity of 0.11 W/cm2).  
 
Cavitation induced increases in skin permeability can be visualised by applying red dye to 
the skin after ultrasound application. As the amount of dye absorbed by the skin is dependent 
on the permeability – the areas which appear redder are known to be more permeable. These 
areas of increased permeability are known as local transport regions (LTRs) (Kushner, et al. 
2008). By using this dye method, a number of studies have shown that post-ultrasound LTR 
formation is heterogeneous across the skin surface (Kushner, et al. 2008, Morimoto, et al. 
2005, Schoellhammer 2015). 
 
Tang, et al. (2002a) effectively demonstrated the importance of inertial cavitation to skin 
sonoporation by changing the coupling fluid from a low viscosity buffer solution to high 
5 
 
viscosity castor oil (thereby supressing cavitation). This suppression decreased permeability 
enhancement (the ratio of post-sonoporation skin permeability to pre-sonoporation skin 
permeability) by almost 100 %. In that study the frequency was 20 kHz, the intensity was 
1.6 W/cm2, the transducer was 8 mm from the skin and ultrasound was applied for 2 hours 
using a 10 % duty cycle.  
 
 In vitro Experimentation 
Experimental studies that investigate the effects of low-frequency ultrasound on skin 
permeability have nearly always used glass Franz diffusion cells (Baji, et al. 2018, Han and Das 
2013, Herwadkar, et al. 2012, Lavon, et al. 2005, Le, et al. 2000, Merino, et al. 2003, 
Mitragotri, et al. 2000a, Paliwal, et al. 2006, Rangsimawong, et al. 2018, Sarheed and Abdul 
Rasool 2011, Sarheed and Frum 2012, Smith, et al. 2003, Tang, et al. 2002a, Terahara, et al. 
2002a, Terahara, et al. 2002b, Tezel and Mitragotri 2003a, Tezel, et al. 2001, Yin, et al. 2016). 
These consist of a donor and receiver chamber, clamped together with a skin sample in 
between. A cross-section of a standard Franz diffusion cell is shown in Fig. 1-1. Images of 
standard Franz diffusion cells are shown in Fig. 1-2. An ultrasound transducer is inserted into 
the donor chamber with the active face a set distance from the skin surface and parallel to 
the skin surface. The donor chamber fluid acts as the coupling fluid. The ultrasound waves 




Fig. 1-1 Cross-section of a standard Franz diffusion cell 
 
 
Fig. 1-2 Images of standard glass Franz diffusion cells (a) without receiver chamber water 
jacket and (b) with receiver chamber water jacket 
 
Two methods are used to quantify the permeability increase achieved through ultrasound 
application in a diffusion cell: mass transport experiments, and electrical conductivity 
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experiments. In mass transport experiments a permeant molecule is added to the donor 
solution in some known concentration. The concentration of the permeant in the receiver 
solution is then measured to determine the amount that has diffused through the skin over a 
certain time period. The greater the concentration of the permeant in the receiver chamber 
after ultrasound application, relative to a control case without ultrasound, the greater the 
skin permeability increase achieved. Past studies have used permeants such as mannitol 
(Merino, et al. 2003, Mitragotri, et al. 2000a, Terahara, et al. 2002a, Terahara, et al. 2002b), 
glucose (Schoellhammer, et al. 2012), caffeine (Sarheed and Abdul Rasool 2011), ketoprofen 
(Herwadkar, et al. 2012), calcein (Lavon, et al. 2005), and bovine serum albumin (Han and Das 
2013). Receiver chamber concentrations have been measured with techniques such as 
scintillation counting (Merino, et al. 2003, Mitragotri, et al. 2000a, Schoellhammer, et al. 
2012, Terahara, et al. 2002a, Terahara, et al. 2002b), high-performance liquid 
chromatography (Han and Das 2013, Herwadkar, et al. 2012, Sarheed and Abdul Rasool 2011), 
and spectrophotometry (Lavon, et al. 2005).  
 
Electrical conductivity experiments require less time than mass transport experiments as 
the skin’s electrical properties may be immediately measured so that no lengthy transport 
diffusion times are required (Tezel, et al. 2001). Electrodes are placed into the donor and 
receiver chambers and an AC current is passed from one electrode, through the skin, to the 
other electrode. A conductivity value is then calculated from the measured current and the 
input voltage. Skin electrical conductivity can be used as a proxy for skin permeability as 
conductivity has been shown to increase with increasing permeability (Mitragotri, et al. 
2000a). As this conductivity increase can be measured instantaneously (without having to 
wait for drug diffusion), it is often used as the measured variable in empirical studies 
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(Mitragotri, et al. 2000a, Tang, et al. 2002b, Terahara, et al. 2002a, Tezel, et al. 2001). 
However, the frequent use of electrical conductivity instead of mass transport has resulted in 
a relative scarcity of actual permeability data (Sarheed and Abdul Rasool 2011), which can 
only be obtained with mass transport experiments.  
 
Previous sonoporation studies have used Franz diffusion cells to investigate the influences 
of five main experimental parameters on inertial cavitation activity and the permeability 
enhancement achieved. In their sonoporation study, Tezel, et al. (2002) investigated the 
influence of ultrasound frequency on skin conductivity enhancement (the ratio of post-
sonoporation conductivity to pre-sonoporation conductivity). The conductivity enhancement 
achieved at 19.6 kHz was 3 times that achieved at 36.9 kHz and 23 times that achieved at 
93.4 kHz. These results show that skin conductivity enhancement, an established proxy for 
permeability enhancement, increases with decreasing ultrasound frequency. Decreases in 
skin permeability enhancement with increasing ultrasound frequency were also shown by 
Tezel, et al. (2001), using electrical conductivity, and Merino, et al. (2003), using mass 
transport. 
 
In their skin sonoporation study, Terahara, et al. (2002a) investigated the influence of 
ultrasound pre-treatment time on skin conductivity enhancement and mannitol permeability 
enhancement. Relative to its pre-sonoporation value, the mean conductivity increased 3-fold 
after 3 minutes of ultrasound application and 25-fold after 12 minutes of application. 
Likewise, the mean mannitol permeability increased 8-fold after 3 minutes of sonoporation 
and 14-fold after 12 minutes. These results indicate that skin permeability enhancement 
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increases with increasing exposure time. A similar result was found in the study by Mitragotri, 
et al. (2000a). 
 
Herwadkar, et al. (2012) investigated the influence of duty cycle on the transdermal delivery 
of ketoprofen in their low-frequency study. They applied ultrasound at an intensity of 
6.9 W/cm2 with a duty cycle of either 100 % or 50 % (5 s on 5 s off). The total application time 
was the same for both duty cycles, meaning that the 100 % case took 2 minutes and the 50 % 
case took 4 minutes. There was a negligible difference in transdermal ketoprofen delivery 
between the two cases, meaning that duty cycle does not affect skin permeability increase. 
Similarly, Mitragotri, et al. (2000a) showed that, for a given total application time, the duty 
cycle does not affect the number of inertial cavitation events which occur at the skin aperture.   
Terahara, et al. (2002a) showed that increasing the axial distance from the active face of 
the transducer to the skin surface decreases the electrical conductivity enhancement 
achieved. The conductivity enhancement achieved when the transducer was 2.5 mm from the 
skin surface was 3.5 times that achieved when it was 10 mm from the skin surface. In their 
low-frequency study, Herwadkar, et al. (2012) measured the transdermal delivery of 
Ketoprofen following 2 minutes of ultrasound application. They found that the transdermal 
transport was over 5 times greater following sonoporation at 0.3 cm than it was following 
sonoporation at 0.6 cm. From these results in can be concluded that permeability 
enhancement decreases as the transducer to skin distance increases.  
 
In their low-frequency skin study, Tezel, et al. (2001) showed that the skin conductivity 
enhancement achieved with ultrasound increases with increasing ultrasound intensity if all 
other parameters remain constant. The skin conductivity was measured after insonation 
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(exposure to ultrasound) at five different frequencies. The conductivity enhancement 
increased as intensity increased, regardless of the frequency. Using a frequency of 58.9 kHz, 
the conductivity enhancement achieved at 1.3 W/cm2 was 2.5 times that achieved at 
0.8 W/cm2. Increases in skin permeability enhancement with increasing intensity were also 
reported in the sonoporation studies by Tang, et al. (2002a) and Mitragotri, et al. (2000a).  
 
Nearly all of the aforementioned sonoporation studies used off-the-shelf, glass Franz 
diffusion cells. These apparatus are regularly used because they are ready-made in standard 
sizes, easily obtainable, and are the established norm for transdermal experiments. However, 
in their sonoporation study, Zorec, et al. (2015) noted that, although Franz diffusion cells are 
considered the gold standard in passive diffusion studies, they are not ideal for studies which 
employ enhancement methods such as electroporation or sonoporation. Due to their glass 
construction, the geometry of standard Franz diffusion cells are difficult to customise without 
expensive glassblowing techniques and equipment. The difficulties associated with 
customising the geometry of standard glass Franz diffusion cells have made it impractical for 
sonoporation studies to incorporate custom systems for temperature control, cavitation 
monitoring, or the suppression of acoustic reflection – useful features which have been 
effectively incorporated into cell sonoporation and ultrasound ablation setups (Farny, et al. 
2010, Hallow, et al. 2006, Hockham, et al. 2010, Kinoshita and Hynynen 2007, Montes and 
Hynynen 1995). The motivations behind incorporating systems for temperature control, 
passive cavitation monitoring, and the suppression of acoustic reflection in a sonoporation 
setup are discussed next.  
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 Gaps in the Field and Thesis Objectives 
 
 The Problem of Coupling Fluid Temperature Increase During Sonoporation 
When skin is sonoporated in a Franz diffusion cell, the donor chamber fluid acts as the 
coupling fluid. When the ultrasound waves travel through the coupling fluid a fraction of their 
energy is absorbed and converted to heat (Bacon and Carstensen 1990, O’Brien Jr 2007). At 
sufficiently high transducer induced pressure amplitudes, this heating may result in a 
significant, unwanted increase in the coupling fluid temperature (Tang, et al. 2002a, Terahara, 
et al. 2002a). Increases in coupling fluid temperature must be mitigated to maintain clinically 
relevant in vitro conditions: significant discomfort and blistering can occur when the skin is 
exposed to temperatures above 43 °C (Hao, et al. 2016, Lindeque, et al. 2013), while 
prolonged exposure to 44 °C has been shown to cause irreversible damage to epidermal cells 
(Moritz and Henriques 1947). Furthermore, second degree burns can occur within 4 minutes 
of the skin temperature reaching 51 °C (Williamson and Scholtz 1949). 
 
In addition to causing burns and discomfort, increases in the temperature of the SC have 
also been shown to cause lipid phase transitions in the SC. Differential scanning calorimetry 
studies have shown that the SC lipids undergo multiple phase transitions between 10 °C and 
50 °C (Akomeah, et al. 2004, Clarys, et al. 1998, Gay, et al. 1994, Golden, et al. 1986, Golden, 
et al. 1987, Silva, et al. 2006, Tang, et al. 2002a, Van Duzee 1975). These lipid phase transitions 
are known to result in increases in the skin’s permeability to mass transfer (Gay, et al. 1994, 
Potts and Francoeur 1990). Therefore, the coupling fluid temperature increases which occur 
during sonoporation can affect the permeability of the SC. 
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Past studies have avoided excessive temperature increases by employing duty cycles and 
coupling fluid replacement (Baji, et al. 2018, Lavon, et al. 2005, Paliwal, et al. 2006, Polat, et 
al. 2011a, Rich, et al. 2014, Sarheed and Abdul Rasool 2011, Tang, et al. 2002a, Terahara, et 
al. 2002a, Tezel, et al. 2004, Tezel, et al. 2001). In their study concerning the role of cavitation 
in sonoporation, Tang, et al. (2002a) used a duty cycle (0.1 s on 0.9 s off) to reduce the heating 
rate. Despite this, the coupling fluid temperature still exceeded 37 °C after 10 minutes of 
ultrasound application. The authors of that study also periodically replaced the coupling fluid 
with new, room temperature solution to maintain the skin temperature below 40 °C. A duty 
cycle and periodic replacement were also employed in the study by Lavon, et al. (2005) which 
found that, with a 50 % duty cycle (0.5 s on 0.5 s off), the temperature of the coupling fluid 
increased by 3-5 °C every 5 minutes. To limit the temperature rise, the authors of that study 
replaced the coupling fluid every 5 minutes. Although these two methods are an effective 
way to mitigate increases in the coupling fluid temperature, they are impractical. Duty cycles 
increase the time required to run an experiment (by up to 10-fold in the case of a 10 % duty 
cycle), while fluid replacement requires constant monitoring and tedious manual 
intervention. Furthermore, these methods are not able to maintain the coupling fluid 
temperature at a specified constant value, they simply avoid excessive temperature 
increases. A novel system capable of maintaining a constant coupling fluid temperature 
during skin sonoporation would be of great benefit to the field: it would remove the need for 
duty cycles or fluid replacement and enable previously impossible investigations into the 
influence of coupling fluid temperature.  
 
The first thesis objective is to devise an experimental setup that is able to maintain a 
constant coupling fluid temperature during sonoporation in a Franz diffusion cell. The system 
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used to maintain the temperature must not impact the inertial cavitation activity at the skin 
aperture. The system must also be easy to remove from one diffusion cell and apply to 
another so that multiple diffusion cells can be used within one set of diffusion experiments. 
 
 The Unknown Influence of Coupling Fluid Temperature on Inertial 
Cavitation in a Franz Diffusion Cell 
Researchers have established that inertial cavitation is the primary mechanism behind skin 
sonoporation. Coupling fluid temperature is known to affect inertial cavitation activity in 
other ultrasound setups. In their high-intensity focussed ultrasound (HIFU) study, Hockham, 
et al. (2010) indicated that inertial cavitation activity can decrease with increasing coupling 
fluid temperature due to an associated increase in vapour pressure. In their low-frequency 
study involving a pressurised resonator, Bader, et al. (2012) showed that the inertial 
cavitation threshold (the pressure required to stimulate inertial cavitation) decreases with 
increasing temperature. A decrease in the cavitation threshold with temperature was also 
shown in the high frequency diagnostic ultrasound study by (Brabec and Mornstein 2007). 
The pressure required to achieve cavitation at 39 °C was 67 % less than the pressure required 
to achieve cavitation at 25 °C. From the studies of Hockham, et al. (2010), Bader, et al. (2012), 
and Brabec and Mornstein (2007), it is unclear how the coupling fluid temperature affects the 
inertial cavitation activity which impacts the skin in a low-frequency Franz diffusion cell setup. 
An experimental investigation is needed. This has not previously been investigated because 
the existing experimental systems are unable to set the coupling fluid at a variety of specific 
temperatures during ultrasound application. When objective one is met, and a desired 
coupling fluid temperature can be maintained, it will be helpful for researchers to know which 
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temperature will provide them with the greatest amount of inertial cavitation activity for a 
given set of input parameters. Therefore, the second thesis objective is to investigate the 
influence of coupling fluid temperature on the inertial cavitation activity that impacts the skin 
in a Franz diffusion cell. Meeting this objective will provide valuable knowledge to help 
researchers select the most effective coupling fluid temperature.  
 
In their low-frequency sonoporation study, Terahara, et al. (2002a) used aluminium foil as 
a physical dosimeter.  The number of pits in the foil were counted after ultrasound application 
at a variety of ultrasound intensities and transducer distances. Pitting was shown to increase 
with increasing intensity and decrease with increasing transducer distance. From these results 
the authors concluded that inertial cavitation activity at the skin surface increases with 
increasing intensity and decreases with increasing transducer distance. A foil pitting 
technique will be used to meet the second thesis objective.  
  
 The Unknown Influence of Coupling Fluid Temperature on Post-
sonoporation Transport 
Without a means to maintain the coupling fluid temperature at a set value during 
sonoporation, researchers have been unable to investigate the influence of coupling fluid 
temperature on post-sonoporation transport. The skin permeability increase achieved with 
sonoporation is known to be dependent on experimental parameters such as ultrasound 
frequency, ultrasound intensity, the distance between the transducer and the skin, and the 
ultrasound application time. Investigating the influences of these parameters was motivated 
by the desire to optimize ultrasound enhancement (Herwadkar, et al. 2012, Terahara, et al. 
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2002a, Tezel, et al. 2001). If such optimization is to be achieved then an understanding of all 
of the experimental parameters that affect post-sonoporation transport must be obtained. 
Therefore, an investigation into the influence of coupling fluid temperature (during 
sonoporation) on the post-sonoporation transport is needed. 
 
The third thesis objective is to investigate the influence of coupling fluid temperature on 
the transdermal transport that follows sonoporation in a low-frequency Franz diffusion cell 
setup. This investigation will implement a version of the temperature control system 
developed in objective one in order to maintain three different coupling fluid temperatures 
over the duration of ultrasound application. The transdermal transport following 
sonoporation at each of these temperatures will then be compared to illustrate the influence 
of coupling fluid temperature. The results of this study could have important implications for 
future experimental and clinical sonoporation applications: if a higher coupling fluid is shown 
to increase the post-sonoporation transport, future researchers could use the temperature 
control system developed for objective one to further increase the post-sonoporation 
transport obtained with a given set of ultrasound input parameters.  
 
 The Need for Passive Cavitation Detection During Skin Sonoporation 
In skin sonoporation studies, the ultrasound input parameters (frequency, intensity, 
application time, and transducer distance) are used to dictate the inertial cavitation activity 
to which the skin is exposed. Because these parameters are generally held constant during 
the experiments, researchers might assume that the inertial cavitation activity also remains 
constant during sonoporation. However, inertial cavitation activity is transient in nature (Rich 
2017) and can change during the course of ultrasound application due to bubble dissolution, 
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the depletion of cavitation nuclei, interactions between bubbles, increased vapour pressure 
caused by heating, and shielding caused by pre-focal bubble activity (Hockham, et al. 2010). 
For example, in the HIFU study by Hockham, et al. (2010), repeated insonation of the same 
phantom resulted in a marked decrease in inertial cavitation activity due to depletion of 
cavitation nucleation sites.  
 
Outside of skin sonoporation, experimental setups that use inertial cavitation often include 
passive cavitation detector (PCD) systems to monitor inertial cavitation activity during 
ultrasound application (Bian, et al. 2017, Bull, et al. 2013, Cleveland, et al. 2000, Farny, et al. 
2010, Gateau, et al. 2011, Gyöngy and Coussios 2010, Hallow, et al. 2006, Helga, et al. 2015, 
Hockham, et al. 2010, King, et al. 2010, Liu, et al. 1998, Salgaonkar, et al. 2009). Monitoring 
the inertial cavitation activity with a PCD allows any changes in the inertial cavitation activity 
to be detected in real-time. The experimental inputs to the ultrasound field can then be 
adjusted to counteract these changes and ensure that the inertial cavitation activity remains 
at the required level throughout ultrasound application. The PCD output can also be used to 
detect and avoid potentially harmful exposure levels when applying therapeutic ultrasound 
(Rich 2017).  
 
In a PCD system, a hydrophone, placed directly into the coupling fluid and aligned with 
the ultrasound beam, measures the ultrasound pressure fluctuations that are radiated by the 
cavitation bubbles during ultrasound application. The voltage vs. time data that this 
hydrophone records during ultrasound application is then filtered to isolate the broadband 
noise. The RMS value of the broadband noise is indicative of the magnitude of the inertial 
cavitation within the ultrasound field (Farny, et al. 2010, Hallow, et al. 2006, Helga, et al. 2015, 
17 
 
Liu, et al. 1998, Sundaram, et al. 2003). The broadband noise level can be seen at all 
frequencies within the spectrum that do not contain a subharmonic, ultraharmonic, or 
harmonic peak. Cell sonoporation studies, such as those conducted by Chen, et al. (2003) and 
Hallow, et al. (2006), have shown that it is the inertial cavitation dose (ICD), the time integral 
of broadband noise, as opposed to the magnitude of broadband noise emission at any one 
time, that best correlates with cavitation-induced enhancement of a bioeffect such as 
hemolysis or intracellular uptake. This is because the ICD includes a temporal component, 
therefore, any changes in inertial cavitation activity over the course of ultrasound exposure 
will be reflected by the ICD value. 
 
While PCDs have been frequently employed in studies involving the insonation of media 
other than skin (Coussios and Roy 2008, Farny, et al. 2010, Liu, et al. 1998, McDannold, et al. 
2006, Qiu, et al. 2010, Yao-Sheng, et al. 2010, Zhou, et al. 2008), they have rarely been used 
in low-frequency in vitro skin studies. This is due to the geometric constraints within the 
traditional Franz diffusion cell which makes it difficult to fit both a transducer and a 
hydrophone in the coupling fluid. In the study by Tang, et al. (2002a) a hydrophone was fixed 
to the outer surface of the bottom of a receiver chamber with epoxy. This allowed for the PCD 
data to be recorded during ultrasound application but did not directly capture the acoustic 
signal within the coupling fluid – where the important inertial cavitation activity is known is 
known to occur (Tang, et al. 2002a). Tezel and Mitragotri (2003a) were able to directly 
monitor the ultrasound field in the coupling fluid, but could not take measurements during 
skin insonation as the hydrophone was positioned where the skin sample would usually be 
positioned. In the high-frequency sonoporation study by Rich (2017), a PCD hydrophone was 
embedded in the receiver chamber of a diffusion cell. This setup enabled PCD data to be 
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recorded during sonoporation but limited the study to one diffusion cell as the hydrophone 
was fixed in place. This limitation was acceptable for that study as conductivity was used to 
quantify the permeability increase. However, a permanently embedded hydrophone would 
be impractical for mass transport studies which require the concurrent use of multiple 
diffusion cells. Placement of the hydrophone below the skin is also clinically impractical. A 
diffusion cell setup that allows for a PCD hydrophone to be positioned in the coupling fluid 
during sonoporation must be developed. Such a setup could enable real-time monitoring and 
control of the inertial cavitation activity that occurs in the coupling fluid during skin 
sonoporation.   
 
The fourth thesis objective is to design and manufacture a diffusion cell setup that enables 
a PCD hydrophone to be positioned in the coupling fluid during sonoporation. In this setup it 
must be quick and easy to remove the PCD hydrophone from one diffusion cell and apply it 
to another so that multiple diffusion cells can be used within one set of diffusion experiments. 
The positioning of the PCD hydrophone, relative to both the skin aperture and the transducer, 
must be consistent from one repetition to the next. The fifth thesis objective is to assess the 
ability of the diffusion cell PCD setup (from objective four) to monitor the inertial cavitation 
activity that occurs during skin sonoporation. This will be achieved by varying experimental 
parameters (that are known to affect the inertial cavitation activity) to see if the PCD output 
responds accordingly.  
 
In in vitro experiments the post-sonoporation transport is quantified by measuring the 
concentration of the permeant in the receiver chamber after a period of diffusion. However, 
measurement of post-sonoporation transport cannot easily be made in an in vivo or clinical 
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setting. Such a measurement would require either an invasive subcutaneous extraction, 
which would defeat the purpose of using non-invasive transdermal delivery, or a 
measurement of a bodily fluid such as urine (Mitragotri and Kost 2000), which cannot be 
collected on demand. If sonoporation is to become a clinically practical technique, clinicians 
must have some indication of the likely range of post-sonoporation transport during the 
application of ultrasound. In their cell sonoporation study, Hallow, et al. (2006) proposed that 
ICD has the potential to be a unifying parameter that correlates with ultrasound enhancement 
over a broad range of experimental conditions – meaning that monitoring it during ultrasound 
application can enable real-time feedback about the permeability increases that are 
occurring. As part of objective five, the correlation between the PCD output and the post-
sonoporation transport will be assessed to investigate the potential of using PCD output, not 
just to monitor inertial cavitation activity, but also as an indicator of the post-sonoporation 
transport.  
 
 The Unknown Influence of Acoustic Reflection in a Franz Diffusion Cell 
In vitro studies have investigated the influence of several parameters (frequency, intensity 
etc.) on skin permeability increase. However, little attention has been paid to the potential 
influence of acoustic reflection in skin sonoporation studies. This was noted by Smith (2007), 
who stressed the importance of reporting the echoic conditions of a transdermal insonation 
apparatus.  
 
In vitro skin sonoporation and sonophoresis experiments in Franz diffusion cells involve 
ultrasound waves propagating within a finite volume of liquid. Therefore, there will always be 
acoustically reflective interfaces present in the experimental setup. An acoustically reflective 
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interface is an interface between two materials that have different acoustic impedances. For 
example, the interface where the coupling fluid meets the donor chamber wall or the 
interfaces where the receiver chamber wall meets the fluid surrounding the diffusion cell. 
Acoustic reflections occurring within in vitro insonation setups will always cause constructive 
and destructive interference. Zorec, et al. (2015) suggested that this interference may lead to 
a non-uniform sound field with parameters that are different from the field emitted by the 
transducer. Due to the reflection and interference that occurs within in vitro ultrasound 
setups, it is also possible for standing waves to occur (Barati, et al. 2007, Kinoshita and 
Hynynen 2007, Liu, et al. 1998).  
 
While, to the author’s knowledge, there are no published studies that explicitly investigate 
the influence of reflection in in vitro skin sonoporation or sonophoresis setups, some 
researchers have employed experimental methods intended to suppress these reflections. 
For example, in their low-frequency transdermal transport study, Merino, et al. (2003) placed 
a Teflon sheet at the bottom of the diffusion cell receiver chamber to “absorb ultrasound and 
thereby reduce multiple reflections in the diffusion cell”. The same Teflon sheet placement 
was used in the low-frequency study by Alvarez‐Román, et al. (2003) to absorb ultrasound 
and reduce multiple reflections. In their high-frequency in vivo study on transdermal 
transport through rat skin, Park, et al. (2012)  avoided “strong reflection” by positioning their 
thermocouple outside of the direct beam of their transducer. Mitragotri, et al. (1995b) 
inserted a 1 mm thick Teflon sheet opposite the transducer in a high-frequency horizontal 
diffusion cell setup in an attempt to reduce multiple ultrasound reflections. Zorec, et al. 
(2013) sonoporated their skin samples on a rubber block to “avoid sound wave reflections.” 
In their HIFU, in vitro study on transdermal transport through pig skin, Helga, et al. (2015) 
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inserted a polyurethane absorber opposite the transducer to “avoid reflections of the HIFU 
beam.”  
 
Previous studies of the insonation of cells in cell culture plates have shown that acoustic 
reflection from the walls of the cell culture plates may strongly influence the inertial cavitation 
activity. For example, Kinoshita and Hynynen (2007) found that sonoporation could be 
doubled by facilitating the presence of a standing wave. Similarly, Jelenc, et al. (2012) showed 
that by suppressing the acoustic reflection with an acoustically absorbent lining, the 
maximum reflected pressure (at the cell suspension) was reduced by 81 %. These results 
motivate an important question: at ultrasound intensities relevant to skin sonoporation, do 
the acoustic reflections that occur within a skin sonoporation setup significantly influence the 
inertial cavitation activity? This is an important consideration for researchers looking to 
translate the results of in vitro studies (conducted in highly reflective diffusion cells) to in vivo 
or clinical setups that have different echoic conditions: if the echoic conditions affect the 
inertial cavitation activity, then different input parameters may be required in a clinical setup 
to achieve the same inertial cavitation activity that was obtained in vitro.  
 
The sixth thesis objective is to devise an experimental setup that facilitates an 
investigation of the influence of acoustic reflection in a Franz diffusion cell. A modified Franz 
diffusion cell setup will be designed and manufactured to facilitate the measurement of 
inertial cavitation activity in the coupling fluid during ultrasound application. The echoic 
properties of this setup will then be altered to vary the acoustic reflections that occur. The 
seventh thesis objective is to investigate the influence of acoustic reflections on the inertial 





The identified gaps in the field are mostly due to the limitations of standard glass Franz 
diffusion cells. Franz diffusion cells were initially designed for passive transport experiments 
and are therefore poorly suited to sonoporation experiments. The donor chambers are too 
small to facilitate a PCD hydrophone, the glass construction makes it difficult to customise the 
geometry so that a coupling fluid cooling system can be incorporated, and the highly reflective 
acoustic boundaries likely cause unwanted interference in the ultrasound field. A key 
contribution of this thesis is the introduction of equipment made specifically for sonoporation 
experiments out of easily customisable, non-glass materials. This equipment enables 













Ultrasound induced heating during skin sonoporation can result in coupling fluid 
temperatures capable of causing burns. This study used a modified Franz diffusion cell along 
with a novel temperature regulation system to maintain the coupling fluid temperature at 
one of three set values (13 °C, 33 °C, or 46 °C) during the sonoporation of porcine skin. 
Following 10 minutes of sonoporation, a buffer solution containing calcein was applied to the 
skin and left to diffuse at room temperature for five hours. Periodic samples of the receiver 
fluid were taken at one hour intervals. The mean and median post-sonoporation transport of 
calcein increased with increasing coupling fluid temperature. The median transport achieved 
with a coupling fluid temperature of 46 °C was 2.3 times that achieved with a coupling fluid 
temperature of 33 °C which was 2.2 times that achieved with a coupling fluid temperature of 
13 °C. Past studies have used duty cycles and fluid replacement to keep the coupling fluid 
below 37-40 °C during sonoporation. However, this study showed that temperature 
dependent increases in post-sonoporation transport can occur below 37-40 °C. Foil pitting 
experiments were used to investigate the influence of coupling fluid temperature on the 
inertial cavitation activity that occurred at the skin aperture. The mean number of pits after 
1 s of ultrasound application at 10 °C was 2.0 times the mean number at 40 °C (p<0.05). It is 
then reasonable to conclude that, while the inertial cavitation activity decreased, the post-
sonoporation transport increased with increasing coupling fluid temperature. This increase 
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was attributed to temperature dependent structural changes in the SC, which increased the 
SC permeability.   
 
 Introduction 
Most published in vitro skin sonoporation experiments are conducted in Franz diffusion 
cells (Han and Das 2013, Herwadkar, et al. 2012, Lavon, et al. 2005, Mitragotri, et al. 2000a, 
Paliwal, et al. 2006, Tang, et al. 2002a, Terahara, et al. 2002a, Terahara, et al. 2002b). A 
transducer, inserted into the donor chamber, emits an ultrasound field which propagates 
through the coupling fluid towards the skin. When the ultrasound waves travel through the 
coupling fluid a fraction of their energy is absorbed and converted to heat (O’Brien Jr 2007). 
When the transducer amplitude is high enough, this heating may result in a significant, 
unwanted increase in the coupling fluid temperature (Tang, et al. 2002a, Terahara, et al. 
2002a). Increases in coupling fluid temperature must be mitigated due to the discomfort, 
burns, and damage to epidermal cells which occur when the skin temperature exceeds 40 °C 
(Hao, et al. 2016, Lindeque, et al. 2013, Moritz and Henriques 1947, Williamson and Scholtz 
1949).  
 
The donor chambers of standard glass Franz diffusion cells do not have any inbuilt fluid 
cooling capability. Therefore, past sonoporation studies have avoided excessive temperature 
increases by employing duty cycles and coupling fluid replacement (Lavon, et al. 2005, Paliwal, 
et al. 2006, Polat, et al. 2011a, Tang, et al. 2002a, Terahara, et al. 2002a, Tezel, et al. 2004, 
Tezel, et al. 2001). In their study concerning the role of cavitation in sonoporation, Tang, et 
al. (2002a) used a duty cycle (0.1 s on 0.9 s off) to reduce the heating rate. Despite this, the 
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coupling fluid temperature still exceeded 37 °C after 10 minutes of ultrasound application. 
The authors of that study also periodically replaced the coupling fluid with new, room 
temperature solution to maintain the skin temperature below 40 °C. A duty cycle and periodic 
replacement were also employed in the study by Lavon, et al. (2005) which found that, with 
a 50 % duty cycle (0.5 s on 0.5 s off), the temperature of the coupling fluid increased by 3-5 °C 
every 5 minutes. To limit the temperature rise, the authors of that study replaced the coupling 
fluid every 5 minutes. Although these two methods are an effective way to mitigate increases 
in the coupling fluid temperature, they are impractical.  
 
Duty cycles increase the time required to run an experiment – by up to 10-fold in the case 
of a 10 % duty cycle. In the study by Tang, et al. (2002a), more than 60 sonoporation 
experiments were conducted. In each of these experiments the ultrasound transducer was 
positioned in the donor chamber for 2 hours. However, because a duty cycle of 10 % was used 
to minimise thermal effects, only 12 minutes of ultrasound was applied during this time. 
Therefore, 60 experiments worth of ultrasound application took a total of 120 hours. If 
continuous ultrasound had been used, these same 60 experiments would have only taken 12 
hours. A similar issue occurs with clinical sonoporation setups. Two pilot clinical studies with 
human subjects used duty cycles of 17 % to 38 % to minimise thermal effects during 
sonoporation (Maruani, et al. 2010, Maruani, et al. 2012). If these studies had been able to 
safely use continuous ultrasound, patient contact time could have been reduced by up to 
83 % – resulting in a more clinically practical application protocol.  
 
The method of fluid replacement requires constant monitoring and tedious manual 
intervention. In the study by Tezel, et al. (2004), a 13 °C increase in coupling fluid temperature 
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occurred after 2 minutes of sonoporation – even with a 50 % duty cycle. Every 2 minutes the 
transducer was turned off so that the coupling fluid could be replaced. Each sonoporation 
experiment lasted for 10 minutes. Therefore, the coupling fluid had to be replaced 4 times in 
each experiment. Approximately 25 experiments were conducted meaning that the coupling 
fluid had to be replaced around 100 times in total – a lot of work for the authors of the study.  
 
Aside from being time-consuming and labour intensive, duty cycles and fluid replacement 
do not allow the coupling fluid temperature to be maintained at a specified level during 
ultrasound application. This is problematic as inertial cavitation activity can change with 
changes to the coupling fluid temperature (Bader, et al. 2012, Hockham, et al. 2010). 
Temperature variations of up to 20 °C have been reported in previous sonoporation studies 
(Tang, et al. 2002a, Terahara, et al. 2002a). Such changes in coupling fluid temperature during 
sonoporation can introduce a source of variability in both inertial cavitation activity and in the 
skin’s lipid thermal behaviour. This variability makes comparison between studies difficult: 
while two studies may use the same ultrasound inputs, if their thermal variations are not the 
same, the permeability changes may differ. 
 
The current study introduces a modified polypropylene Franz diffusion cell setup that can 
maintain a specified coupling fluid temperature during the continuous application of 
ultrasound. This setup is used to investigate the influence of coupling fluid on post-
sonoporation transport – an investigation that was impossible with previous coupling fluid 
temperature control methods. Porcine skin is exposed to a continuous ultrasound field at an 
intensity of 55 W/cm2 for 10 minutes. During ultrasound application, the coupling fluid is set 
and maintained at one of three temperatures (13 °C, 33 °C, or 46 °C) using a modified Franz 
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diffusion cell setup similar to that presented in my published study (Robertson and Becker 
2018). Following ultrasound application, a buffer solution containing calcein is applied to the 
skin and left to passively diffuse for five hours. The transport of calcein is measured by taking 
periodic samples of the receiver fluid. The current study also contains an investigation into 
the influence of coupling fluid temperature on inertial cavitation activity in a Franz diffusion 
cell.   
 
 Materials and Methods 
 Modified Diffusion Cell 
Modified Franz diffusion cells were used for this study. Unlike the standard glass diffusion 
cells used in previous studies, the custom geometry of these diffusion cells enabled the 
coupling fluid to be circulated and cooled during sonoporation. Each donor chamber had an 
outer diameter of 65 mm, an inner diameter of 61 mm, an aperture diameter of 9 mm, and a 
total volume of 96 mL. Each receiver chamber had a volume of 3.2 mL and an aperture 
diameter of 9 mm. A representative depiction of an assembled diffusion cell is shown in Fig. 
2-1. Dimensions of the donor and receiver chambers are shown in Fig. 2-2. 
 
The donor and receiver chambers were turned from solid polypropylene rods (Polystone, 
Dotmar EPP Pty Ltd., Christchurch, New Zealand) on a CNC lathe (Top-Turn CNC 406, Jashco 
Machine Manufacture Co. Ltd., Taichung, Taiwan). The receiver chamber sampling arms and 
donor chamber ports were then retrofitted by gluing (Loctite 401, Henkel AG, 
Düsseldorf, Germany) sections of carbon fibre tube (Carbon Fibre Tube Pultruded, 
MAKERshop, Auckland, New Zealand) into holes that were drilled into the polypropylene. The 
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tubing used for the sampling arms had an inner diameter of 3.5 mm and an outer diameter 
of 6 mm. The tubing used for the ports had an inner diameter of 2 mm and an outer diameter 
of 4 mm. The clamps that held the donor and receiver chambers together were 3-D printed 
from acrylonitrile butadiene styrene (ABS P430, Stratasys, Eden Prairie, MN, USA). A 
representative depiction of a clamp is shown in Fig. 2-3.  
 
 






Fig. 2-2 Dimensions of the polypropylene donor and receiver chambers (a) donor chamber 
plan view, (b) donor chamber front view, (c) receiver chamber plan view, and (d) receiver 
chamber right view  
 
 





The permeant solution that was applied to the skin consisted of calcein (Calcein C0875, 
Sigma-Aldrich, St. Louis, MO, USA) dissolved in phosphate buffered saline (PBS) (Gibco PBS 
pH 7.4, Thermo Fisher Scientific, Waltham, MA, USA) at a concentration of 0.1 % w/v (1 g/L). 
This solution was made and stored at room temperature. Calcein is an easy to measure 
permeant which is commonly used in transdermal transport studies (Henry, et al. 1998a, Oh, 
et al. 2008, Prausnitz, et al. 1993, Vanbever and Preat 1999, Xie, et al. 2005). Deionised water 
was taken from a Labwater L991008 Deioniser (Suez Ltd, Thame, UK). 
 
 Porcine Skin 
The in vitro skin models used in this study consisted of porcine ear skin. Porcine skin is 
commonly used in sonoporation and sonophoresis experiments (Lee and Zhou 2015, Merino, 
et al. 2003, Mitragotri, et al. 2000a, Paliwal, et al. 2006, Polat, et al. 2012, Sarheed and Abdul 
Rasool 2011, Schoellhammer, et al. 2012, Souza, et al. 2013, Tang, et al. 2002a, Terahara, et 
al. 2002a, Terahara, et al. 2002b, Tezel and Mitragotri 2003a, Tezel, et al. 2002, Tezel, et al. 
2001, Zorec, et al. 2015) due to the established histological and physiological similarities 
between porcine and human skin (Dick and Scott 1992, Jacobi, et al. 2007). In some cases 
human skin itself has been used (Kushner, et al. 2008, Mitragotri, et al. 1995b, Smith, et al. 
2003), however the complications associated with using cadaver skin makes it an impractical 
model for most studies.  
 
Porcine ears were obtained from an abattoir (Ashburton Meat Processors Ltd, Ashburton, 
New Zealand) immediately after slaughter. These ears were not scalded or exposed to 
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detergent at the abattoir. Upon arrival at the laboratory, the ears were cleaned with cold tap 
water to remove the blood and soil. The skin was then removed from the ears using a 
dermatome (Dermatome 50 mm, Nouvag AG, Goldach, Switzerland) set to a thickness of 
1 mm. This dermatome process, similar to that used in previous ultrasound studies (Boucaud, 
et al. 2001, Zorec, et al. 2015), achieved a consistent skin thickness close to full thickness. Full 
thickness skin, which is commonly used in sonoporation experiments (Merino, et al. 2003, 
Mitragotri, et al. 2000a, Terahara, et al. 2002a, Tezel, et al. 2002), is approximately 1-2 mm 
thick (Weimann and Wu 2002). Following the dermatome process, the pieces of skin were 
individually wrapped in Parafilm (PARAFILM, Sigma-Aldrich, St. Louis, MO, USA), placed in 
airtight plastic containers, and then transferred to a -20 °C freezer until use. The total time 
from slaughter to freezer was approximately 4 hours. All of the skin samples used for 
transport experiments were stored in the freezer no longer than 18 days. 
 
 Ultrasound Generation and Intensity Measurement 
A continuous low-frequency (20 kHz) ultrasound field was generated with an ultrasonic 
processor (VC 505 Ultrasonic Processor, Sonics and Materials Inc., Newtown, CT, USA). This 
processor was fitted with a 13 mm replaceable tip. A replaceable tip was necessary as 
extended use resulted in cavitation damage (Fig. 2-4) which affected the flatness of the tip 
surface (a flat tip surface is necessary for the formation of a uniform ultrasound field). 
Following the manufacturer’s instruction, compressed air was circulated through the 




Fig. 2-4 New transducer tip (left) and used transducer tip displaying cavitation induced 
damage from extended use in sonoporation experiments (right) 
 
The VC 505 ultrasonic processor allows the user to select the transducer tip displacement 
– quantified as a percentage of the maximum tip displacement (which is equal to 76 μm). For 
this study, the tip displacement was either 20 % or 60 %. The intensity of the ultrasound field 
with each of these tip displacements was determined using a common calorimetric approach 
(Merino, et al. 2003, Mitragotri, et al. 2000a, Mitragotri, et al. 2000b, Morimoto, et al. 2005, 
Mutoh, et al. 2003, Terahara, et al. 2002a) that was described in Section 2.4 of Robertson and 
Becker (2018). Briefly, the ultrasound transducer was positioned in a beaker of water 
embedded in a thermally insulating block of polystyrene. The transducer tip was 22 mm 
below the waterline of the beaker (the same depth used during sonoporation). The 
transducer was then operated at a variety of tip displacement amplitudes to vary the resulting 
ultrasound intensity. The intensity resulting from operation at each of the tip displacement 













where m  is the mass of water in the beaker (0.2 kg), PC  is the specific heat of water 
(4.187 kJ/kgK), A  is the active transducer face area (1.3 cm2), and T  is the measured 
change in temperature that occurred during the 3 minutes ( t ) of ultrasound exposure. Each 
of these intensity measurements was run in triplicate. The intensities calculated for tip 
displacements of 20 % and 60 % were 13 W/cm2 and 55 W/cm2 respectively. These were 
spatial average, temporal average intensities as in the study by (Mitragotri, et al. 2000a). Note 
that Appendix B reports the series of transdermal transport experiments which were used to 
determine a tip displacement (60 %), application time (10 minutes), and transducer to skin 
distance (3 mm) capable of producing a significant increase in Calcein transport in the present 
setup.       
 
The sonoporation intensity used in the present study (55 W/cm2) was higher than other 
intensities used in the literature. However, variations in the calorimetry protocols between 
different studies makes comparison of intensity values difficult. A broad range of ultrasound 
intensities have been used by past sonoporation studies. Although most studies use Eq. 2.1 
to determine intensity, each study uses different parameters (liquid, volume, vessel, 
application time, transducer depth, etc.) for their calorimetry experiments. In their low 
frequency sonoporation study, Sarheed and Abdul Rasool (2011) used an intensity of 
3.7 W/cm2. This value was calculated by measuring the temperature of 500 mL of distilled 
water before and after 15 minutes of ultrasound application. The water was contained in an 
insulated thermoflask. The depth of the transducer and transducer tip diameter were 
unspecified. Alternatively, in the study by Terahara, et al. (2002a), the intensities were 
between 2.4 W/cm2 and 33 W/cm2. These intensities were calculated by measuring the 
temperature of 150 mL of water before and after an unspecified duration of ultrasound 
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application. The water was contained in an uninsulated beaker. The transducer depth was 
varied between 0.5 cm and 8.5 cm. Note that transducer depth has a significant effect on the 
measured temperature increase (and the calculated intensity): because the entire transducer 
vibrates, not just the tip, more energy is transferred to the fluid when a greater portion of the 
transducer is submerged. An additional set of calorimetry experiments with the present setup 
showed that increasing the transducer depth from 5 mm to 40 mm increased the calculated 
intensity by 23 % (p=0.1). Yet another set of calorimetry protocols were used in the 
sonoporation study by Herwadkar, et al. (2012), which used an intensity of 6.9 W/cm2. 
Calorimetry was performed with 50 mL of water in an insulated beaker. The application time 
and transducer depth were both unspecified. The important consideration for any 
sonoporation study is not so much the intensity value but the inertial cavitation activity which 
occurs at the skin surface. From the foil pitting experiments presented later in this chapter, 
and those shown in Appendix B, it is clear that an intensity of 55 W/cm2 produces a significant 
amount of inertial cavitation activity in the present setup. Therefore, the intensity of 
55 W/cm2 was appropriate.  
 
An alternative method for quantifying the strength of an ultrasound field is to measure its 
pressure with a hydrophone (Mitragotri, et al. 1996, Park, et al. 2007, Smith, et al. 2003, Tezel, 
et al. 2001). This method was not used in this thesis as the driving pressure is difficult to 
determine with a hydrophone when inertial cavitation is present in the ultrasound field: 
cavitation shifts the acoustic energy to frequencies other than the 20 kHz driving pressure 
(Liu, et al. 1998). A full set of hydrophone experiments were conducted to demonstrate this 




Any ultrasound field emitted from a planar piezoelectric transducer can be conceptually 
split into two parts: the near field, and the far field. The near field has its origin at the active 








   (2.2) 
 
where D is the diameter of the active face of the transducer and  is the wavelength. Due to 
the significant spatial intensity fluctuations that occur in the near field, it is important to 
always ensure that the target medium is positioned far enough from the transducer face so 
as to be in the far more uniformly fluctuating and predictable far field during ultrasound 
application. For the 13 mm diameter transducer used in this thesis, the near field had a length 
of 0.58 mm. In the experiments described in this chapter the bottom of the tip was always 
positioned 3 mm from the surface of the skin. Therefore, the skin was well outside the near-
field – which is common practice in low-frequency skin sonoporation (Herwadkar, et al. 2012, 
Mitragotri, et al. 2000a, Polat, et al. 2011a). 
 
 Measurement and Regulation of Coupling Fluid Temperature 
The temperature of the coupling fluid was measured during each experiment using a wire 
type K thermocouple (Jaycar Electronics Pty. Ltd., Auckland, New Zealand). The location of 
the thermocouple (qualitatively depicted in Fig. 2-5) was chosen so that it was outside of the 
transducer beam and did not interfere with the ultrasound field near the skin. This position 
(8 mm above the bottom donor chamber wall and 7 mm from the transducer) was also chosen 
so that the thermocouple tip would not be damaged by cavitation. Preliminary temperature 
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measurements were conducted to assess the influence of the thermocouple position on the 
measured temperature. In these experiments, a second thermocouple was positioned 
directly over the skin (as shown in Fig. 2-6). The steady state temperatures measured by these 
thermocouples were compared under all of the experimental conditions used in this study. 
 
 
Fig. 2-5 Cross-section of the diffusion cell showing the positioning of the transducer and 
thermocouple during sonoporation 
 
Fig. 2-6 Cross-section of the diffusion cell showing the thermocouple positioned directly 




In this study, a temperature control system was used to set and maintain the coupling fluid 
temperature during sonoporation. This system was similar to the one I used in the published 
study (Robertson and Becker 2018), which forms the basis of Chapter 4. The coupling fluid 
(deionised water) was circulated out of the donor chamber via one of the two ports, through 
a heat exchanger, and back into the donor chamber via the other port (as shown in Fig. 2-7).  
 
 
Fig. 2-7 System schematic. The solid lines represent the coupling fluid circuit. The dashed 
lines represent the signal inputs to the transducer and the signal outputs from the 
thermocouple. 
 
A peristaltic pump (6-V Peristaltic Pump, Amazon, Seattle, WA, USA), driven by a power 
supply (MP3090, Powertech, Taiwan) maintained a constant flow rate of 0.14 L/min around 
this circuit. A peristaltic pump works by displacing fluid contained within a tube around a 
circular pump casing (Fig. 2-8). The only component that comes in contact with the fluid is the 
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inside of the tubing. This was a beneficial feature for the present study as it meant that the 
coupling fluid could not be contaminated by contact with other pump components. The heat 
exchanger consisted of an aluminium block submerged in a water bath (FP-50 
Refrigerated/Heating Circulator, Julabo GmbH., Selbach, Germany). When the coupling fluid 
passed through channels milled within this block (shown in Fig. 2-9), the coupling fluid 
temperature tended towards the temperature of the water bath (which could be set to any 
temperature between 1 °C and 99 °C). The aluminium block was designed so that it could be 
easily taken apart for cleaning/sterilisation if required. The positioning of the aluminium block 
in the water bath is shown in Fig. 2-10. 
 
 
Fig. 2-8 Inner working of the 6 V peristaltic pump. The rotating wheels applied pressure to 
the pump tube which displaced the coupling fluid. The fluid flowed through the pump at 




Fig. 2-9 Schematic of the heat exchanger that was positioned in water bath. The silicone 
tubing was inserted into the coupling fluid in and out holes. The two sections were bolted 
together with an O-ring in between to prevent leakage and to ensure that the coupling fluid 




Fig. 2-10 Images of the heat exchanger positioned in the water bath of the 
refrigerated/heating circulator (a) with the lid off and (b) with the lid on 
 
The temperature of the coupling fluid during ultrasound application was set by adjusting 
the water bath temperature. The components in the temperature regulation system were 
linked by silicone tubing (Silicone Tubing Clear Grade Inner Diameter 2.6 mm, Rubbermark 
Industries, Auckland, New Zealand) that could easily be removed from the donor chamber 
ports, allowing each of the seven diffusion cells to be integrated into and removed from the 
system. The coupling fluid circuit could easily be cleaned by pumping fresh deionised water 
through the heat exchanger, pump tubing, and linking tube. The custom built support 
structure that held the transducer, thermocouple and diffusion cells in place is described and 
shown in detail in Appendix Section A.2.7. The circulation of coupling fluid in the donor 
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chamber was shown to have a negligible effect on the inertial cavitation activity occurring at 
the skin aperture (this effect is quantified in Section 2.4.5). 
 
The heat exchanger setup used in the present study was an improvement over an earlier 
iteration that was used in both Chapter 4 and Appendix A. That earlier iteration, described in 
detail in Section 4.3.2, provided sufficient cooling power for ultrasound intensities of 
24 W/cm2 and below, but was unable to maintain a constant coupling fluid temperature at 
higher intensities. The coupling fluid temperature increases which occurred during 
sonoporation at intensities above 24 W/cm2 are shown in Section A.3.4 and discussed in 
Section A.4. The earlier heat exchanger iteration is mentioned here as researchers who intend 
to use low-intensity (<30 W/cm2) sonoporation would find it to be an affordable and compact 
alternative to the present version, which requires a laboratory water cooler. Furthermore, as 
this earlier iteration used thermoelectric Peltier plates to cool the fluid, the cooling power 
could be quickly adjusted during sonoporation, which may be a helpful feature for some 
researchers.  
 
An external, bidirectional heat pump could provide the coupling fluid temperature control 
required for continuous sonoporation or sonophoresis. However, this approach is not 
recommended as it would make it far more difficult to thoroughly clean the system, especially 
following a sonophoresis treatment (in which the circulating fluid contains a permeant 
substance). As the present heat exchanger can be separated from the other components, and 




 Transdermal Transport Experiments 
In the present study, experiments were conducted to investigate the influence of coupling 
fluid temperature on the post-sonoporation transdermal transport of Calcein. These 
experiments began with filling one of the receiver chambers with room temperature 
(19 °C ± 1 °C) PBS (Fig. 2-11). A skin sample was then taken from the freezer and visually 
checked for any holes or areas of non-uniform thickness through which the calcein solution 
could easily diffuse. Any samples that displayed such imperfections were disposed of. Once 
an appropriate skin sample was selected, it was clamped between the filled receiver chamber 
and the donor chamber.  
 
 
Fig. 2-11 Assembly of each diffusion cell involved (a) filling the receiver with PBS, (b) 





After ensuring that no air bubbles were present in the receiver chamber, the diffusion cell 
was mounted into the temperature regulation setup, which involved attaching the silicone 
tubing to the donor ports (shown in Fig. 2-12) and moving the thermocouple into position 
(note that full schematics of the support structure for the transducer, thermocouple, and 
diffusion cell are presented in Appendix A).  
 
 
Fig. 2-12 Image of the silicone tubing attached to the donor chamber ports 
 
Deionised water at room temperature was then added to the donor chamber and allowed 
to sit for three minutes to thaw the skin. The pump was then switched on in order to circulate 
the coupling fluid around the circuit (Fig. 2-7), thereby initiating temperature control. The 
water bath temperature required to achieve each of the coupling fluid target temperatures 
(13 °C, 33 °C or 46 °C) during sonoporation is shown in Table 2-1. Note that the present setup 
was capable of maintaining any coupling fluid temperature in the range of 10 °C to 70 °C 
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during continuous sonoporation. For each of the coupling fluid target temperatures, an 
additional set of experiments were run with coupling fluid circulation but without ultrasound. 
These three sets of experiments are termed ‘controls’. Note that these are positive controls 
as opposed to true negative controls as some temperature effect may be expected. However, 
readers should note that the term ‘control’ is used for the sake of simplicity. The water bath 
temperatures required to achieve each of the coupling fluid target temperatures (13 °C, 33 °C 
or 46 °C) during the control experiments are also shown in Table 2-1. 
 
Table 2-1 Water bath temperatures required to achieve the coupling fluid target 
temperatures for the control and sonoporation protocols. 
Protocol Control Sonoporation at 55 W/cm2 
Target temperature ( °C) 13 33 46 13 33 46 
Water bath temperature ( °C) 13 35 50 1 25 40 
 
With the temperature control system running, the coupling fluid was circulated for 
10 minutes with continuous ultrasound application at 55 W/cm2, or without ultrasound in the 
control case. The temperature of the coupling fluid was constantly monitored with the 
thermocouple during this time to ensure it remained at the desired target temperature. 
Following this 10 minute period, the coupling fluid was removed from the donor chamber and 
the diffusion cell was moved to a holding rack. A 0.5 mL volume of the calcein solution was 
then applied to the top of the skin so that its entire surface was submerged. This solution was 
left to diffuse for five hours at room temperature (19 °C ± 1 °C). During this time, 0.2 mL 
samples were taken from the receiver chamber every hour with a pipette (Calibra Digital 832 
Macro Pipette, Socorex, Ecublens, Switzerland). The sampled volume was then replaced with 
an identical volume of fresh PBS. This dilution was later accounted for when calculating the 
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concentration of calcein in the receiver chamber. The adjusted concentration, C , was found 













    
  (2.3) 
 
where RAWC  is the measured concentration value (in mg/L), sampleV  is the volume of the sample 
taken from the receiver chamber (0.2 mL), receiverV  is the volume of the receiver chamber 
(3.2 mL), and s  is the sample number (taken after 1, 2, 3, 4, or 5 hours). Note that each 
diffusion cell was washed with a surfactant cleaner (Jif, Unilever, France) in between each use 
to remove the calcein which had a tendency to adhere to the polypropylene. 
 
 Spectrofluorometry 
The concentration of calcein in the receiver fluid was measured using a spectrofluorometer 
(Fluorolog-3, Horiba Ltd., Kyoto, Japan). A spectrofluorometer was used for this study as it 
provided a relatively quick way to measure calcein concentration, compared to the more 
time-consuming high-performance liquid chromatography (HPLC) method used in the earlier 
sonoporation study reported in Appendix A. The spectrofluorometer excitation and emission 
wavelengths were 488 nm and 513 nm respectively. These wavelengths are similar to those 
used to measure calcein in the literature (Alvarez‐Román, et al. 2003, El Jastimi and Lafleur 
1999, Morimoto, et al. 2005, Mueller, et al. 2004, Petronilli, et al. 1999). The software package 
FluorEssence (FluorEssence V3.5, Horiba Ltd., Kyoto, Japan) was used to control the 
spectrofluorometer and analyse its output. Each 0.2 mL sample was pipetted into a 1.2 mL 
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quartz crystal cuvette (Starna Ltd, Essex, UK). The remaining 1 mL of the cuvette was then 
filled with PBS. This dilution was accounted for by multiplying the measured 
spectrofluorometer intensity by six. The emission intensity values measured by the 
spectrofluorometer (at 513 nm) were converted to calcein concentrations, RAWC , using the 
calibration curve described in Appendix B, which had the equation 
 
 
10 58.21 10 (I ) 4.04 10RAW SC
       (2.4) 
 
where SI  is the measured spectrofluorometer emission intensity (CPS). A total of 210 
individual spectrofluorometer measurements were required for this study. Between each 
measurement, the cuvette was cleaned with deionised water and dried with Kimwipes 
(Kimtech, Kimberly-Clarke, Irving, TX, USA) to ensure that all of the calcein was removed. 
 
 Measurement of the Receiver Fluid Temperature 
Temperature increases during sonoporation are a result of absorption: as the ultrasound 
propagates through a fluid medium, a portion of the acoustic energy is absorbed by the fluid 
and converted to heat. This absorption can occur in both the donor and receiver fluids due to 
the propagation of the ultrasound field throughout the diffusion cell. To measure the heat 
transfer to or from the receiver fluid, a hole was drilled in the bottom of a spare receiver 
chamber which was not required for the transport experiments. A thermocouple was then 
inserted through this hole so that its tip was positioned 2 mm below the skin surface (Fig. 
2-13). The hole in the bottom of the receiver chamber was then glued (Loctite 401, Henkel 
AG, Düsseldorf, Germany) to prevent any leakage and to ensure that the thermocouple 
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remained in position. Due to the use of polypropylene, this thermocouple position was easy 
to achieve with a standard drilling technique. With a glass receiver chamber this 
thermocouple position would have required specialist glass machining equipment – an 
illustration of the benefits of using polypropylene instead of glass. The thermocouple 
measured the temperature under each of the control and ultrasound experimental 
conditions. The thermocouple recorded data for a total of 30 minutes. The first 10 minutes of 
this corresponded to the 10 minutes of coupling fluid temperature regulation (for the control 
protocols) or the ten minutes of ultrasound application with coupling fluid temperature 
regulation (for the sonoporation protocols). An additional twenty minutes was also recorded 




Fig. 2-13 Cross-section of the diffusion cell showing the positioning of the thermocouple 
used to measure the receiver fluid temperature. The tip of the thermocouple was 2 mm from 




 Measurement of the Permeant Solution Temperature 
Following the 10 minutes of coupling fluid circulation (with or without ultrasound), the 
coupling fluid was removed from the donor chamber. The calcein-buffer solution was then 
added to the donor chamber so that diffusion could begin. During the first 15 minutes of this 
diffusion, the temperature of the calcein-buffer solution was measured with a thermocouple 
which was positioned 1 mm above the skin surface (Fig. 2-14). 
 
 
Fig. 2-14 Cross-section of the diffusion cell showing the positioning of the thermocouple 
used to measure the temperature of the 0.5 mL of calcein-buffer solution 
 
 Foil Pitting Experiments 
The pitting of aluminium foil has previously been used to quantify the influence of different 
experimental parameters on the inertial cavitation activity that occurs during sonoporation 
(Mitragotri, et al. 2000a). This technique was used to investigate the influence of coupling 
fluid temperature on the inertial cavitation activity in the present setup. Ten pieces of foil 
were placed in a diffusion cell and exposed to 1 s of ultrasound (at an intensity of 55 W/cm2) 
with the coupling fluid at 10 °C. This was repeated for another 10 foil samples that were 
exposed to ultrasound (at an intensity of 55 W/cm2) with the coupling fluid at 40 °C. A third 
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set of 10 foil samples were exposed to ultrasound (at an intensity of 13.3 W/cm2) with the 
coupling fluid at 10 °C. Finally, a fourth set of 10 foil samples were exposed to ultrasound (at 
an intensity of 13.3 W/cm2) with the coupling fluid at 10 °C. 
 
Foil pitting experiments were also used to investigate the influence of coupling fluid 
circulation on the inertial cavitation activity at the skin aperture. Ten pieces of 0.016 mm thick 
aluminium foil (Homebrand, Manukau, New Zealand) were exposed to ultrasound (at an 
intensity of 55 W/cm2) for 2 s with and without coupling fluid circulation. The number of pits 
in each of the 20 pieces of foil were then counted to quantify the influence of circulation. In 
these experiments, the coupling fluid in the donor chamber was deionized water at 
10 °C ± 1 °C. This temperature was achieved using the circulation system.  
 
The length of time that a piece of foil is submerged in water prior to ultrasound application 
can affect the prevalence of air bubbles (nucleation sites) on the surface of the foil. Prior to 
each ultrasound application, the foil was submerged in the coupling fluid while the circulation 
system brought the coupling fluid to the specified temperature. The time required to achieve 
this temperature was consistent across each foil pitting dataset. Therefore, the effect of the 
submergence, on the prevalence of nucleation sites on the foil surface, was also consistent. 
 
When counting the foil pits, any circular indent was counted as one pit. Two partially 
overlapping circular indents were counted as two pits. The duration of ultrasound exposure 
(either 1 s or 2 s) was short enough to avoid complete perforation of the foil, which would 





 Coupling Fluid Temperature 
This study employed a temperature regulation system to set and maintain the coupling fluid 
at one of three target temperatures (13 °C, 33 °C, and 46 °C) during 10 minutes of continuous 
ultrasound application. Temperature profiles are shown in Fig. 2-15 for regulated and 
unregulated continuous ultrasound application, application with a 50 % duty cycle, and 
application with a 10 % duty cycle. Unregulated continuous application resulted in the 
coupling fluid temperature exceeding 45 °C in just over 4 minutes. A 50 % duty cycle also 
resulted in the temperature increasing to above 40 °C. A 10 % duty cycle ensured that the 
temperature remained below 20 °C but an equivalent duration of only 1 minute of ultrasound 
was applied. When continuous application was used along with the novel temperature 
control system, the coupling fluid temperature increased to the target temperature of 13 °C 
and remained there for the duration. The temperature profiles for each of the three target 






Fig. 2-15 Coupling fluid temperature as a function of time for continuous ultrasound 




Fig. 2-16 Coupling fluid temperature profiles for the control and sonoporation protocols at 
target temperatures of 13 °C, 33 °C, and 46 °C 
 
In the present study, the coupling fluid temperature was measured with a thermocouple 
that was positioned outside of the transducer beam. Preliminary temperature measurements 
were conducted to determine the difference in coupling fluid temperature by position. The 
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temperature measured outside of the beam was compared to the temperature measured 
directly over the skin surface. At steady state during sonoporation, the temperature over the 
skin surface was no more than 2 °C higher than the temperature outside of the beam (Fig. 
2-17). This small difference had a negligible effect on the outcomes of the study. There was a 
negligible difference in the temperatures during the control protocols (in the absence of 
ultrasound).  
 
Fig. 2-17 The influence of thermocouple position on the thermocouple reading during 
sonoporation at an intensity of 55 W/cm2 and steady state target temperatures of 13 °C, 
33 °C, and 46 °C. The solid lines represent the temperatures recorded with the thermocouple 
outside of the transducer beam. The dashed lines represent the temperatures recorded with 
the thermocouple directly over the skin.  
 
 Transdermal Transport 
Using the modified Franz diffusion cell, the coupling fluid temperature was maintained at 
13 °C, 33 °C, or 46 °C for 10 minutes. During this period of temperature control, the skin was 
either exposed to continuous ultrasound at 55 W/cm2 (the sonoporation protocol), or not 
(the control protocol). Following this 10 minutes, the coupling fluid was removed and buffer 
solution containing calcein at 0.1 w/v % was placed in the donor chamber for 5 hours. At the 
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end of each hour, a sample was taken from the receiver chamber. The protocol with 
ultrasound is termed sonoporation not sonophoresis as the calcein-buffer solution was not 
present during ultrasound application.    
 
Seven repetitions of the control and sonoporation protocols were conducted for each 
coupling fluid target temperature to account for experimental variability. The receiver 
chamber concentrations for all seven repetitions are shown as a function of sampling time for 
each of the three control protocols (Fig. 2-18a, c, and e) and each of the three sonoporation 
protocols (Fig. 2-18b, d, and f). Most studies have presented sonoporation data using plots of 
the mean and standard deviation (Herwadkar, et al. 2012, Sarheed and Abdul Rasool 2011, 
Terahara, et al. 2002a). However, the variability within sonoporation datasets is often not 
normally distributed, therefore, presenting only the mean and standard deviation can be 
misleading. Consider the sonoporation study by Terahara, et al. (2002a) which presents an 
n=3 skin conductivity enhancement dataset with 100 % relative standard deviation. That 
dataset could have been normally distributed, but it is more likely that two data points were 
close together while the third was significantly different (making the mean value misleading). 
With this in mind, the variability of the datasets in Fig. 2-18 (which ranged from 49 % to 132 % 
relative standard deviation) is presented with boxplots. The crosses within each box represent 
the mean values, while the horizontal lines through the centre of each box represent the 
median values. Any data point that exceeded the upper quartile value by more than 1.5 times 
the interquartile range is shown as an outlier (represented by the “+” symbol). Note that 1.5 
times the interquartile range is the common convention for outlier identification when using 
boxplots (Hubert and Vandervieren 2008, Krzywinski and Altman 2014, Spitzer, et al. 2014, 
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Whyte, et al. 2013). These outlier values were still considered when calculating each mean 
and median.  
 
Following the control protocol, the mean and median receiver concentrations increased 
with time, regardless of the coupling fluid temperature. The mean concentrations after 5 
hours were 30-60 times the mean concentrations after 1 hour. Similar increases in mean and 
median concentration occurred with time following the sonoporation protocols. The 
variability of these datasets (Fig. 2-18) was high, but similar to the variability shown in 
previous, well cited sonoporation studies. In the study by Terahara, et al. (2002a), 20 kHz 
ultrasound was applied to porcine skin at an intensity of 7.44 W/cm2 for 12 minutes. A 
solution containing mannitol was then added to the donor chamber and left to diffuse for 
24 hours. This protocol resulted in a 15-fold mean transport enhancement relative to a 
control case with no ultrasound. After only three repetitions (n=3), the relative standard 
deviation in the mannitol transport dataset was 93 % – similar to the variability in the present 
study (49 % to 132 %). Likewise, in the study by Terahara, et al. (2002b), 20 kHz ultrasound 
was applied to porcine skin at an intensity of 2.39 W/cm2 for 12 minutes. This protocol 
resulted in an 8-fold mean mannitol transport enhancement after 24 hours of diffusion. That 
dataset, which contained five repetitions (n=5), had a relative standard deviation of 100 % – 







Fig. 2-18 Receiver chamber calcein concentration as a function of transport time following 
(a) control at 13 °C, (b) sonoporation at 13 °C, (c) control at 33 °C, (d) sonoporation at 33 °C, 
(e) control at 46 °C, and (f) sonoporation at 46 °C. The crosses within the boxes represent the 
mean values (n=7). The “+” symbols outside of the boxes represent outliers.  
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One of the key objectives of this study was to investigate the influence of coupling fluid 
temperature on post-sonoporation transport. To better illustrate this influence, the datasets 
from Fig. 2-18 were plotted as a function of coupling fluid temperature (Fig. 2-19). The first 
five subplots in Fig. 2-19 (a-e) present the receiver chamber concentration following the 
control (C) and sonoporation (S) protocols at each of the three coupling fluid temperatures 
(13 °C, 33 °C and 46 °C). The post-control receiver concentrations after five hours of transport 
are shown on their own (in Fig. 2-19f) so that the increase in mean post-control concentration 
with increasing coupling fluid temperature is visible.  
 
Regardless of the diffusion time, an increase in coupling fluid temperature resulted in an 
increase in post-sonoporation transport. After five hours, an increase in coupling fluid 
temperature (from 13 °C to 33 °C) resulted in a 3.4-fold increase in the mean post-
sonoporation calcein transport (p=0.07). A further 1.5-fold increase in mean post-
sonoporation transport was found when the coupling fluid temperature was increased from 
33 °C to 46 °C (p=0.7). An increase in transport with temperature also occurred post-control 
(Fig. 2-19f). After five hours, an increase in coupling fluid temperature (from 13 °C to 33 °C) 
resulted in a 1.8-fold increase in the mean post-control calcein transport (p=0.6). A further 
1.8-fold increase in mean post-control transport was found when the coupling fluid 
temperature was increased from 33 °C to 46 °C (p=0.8). Note that these p-values were found 
using a Wilcoxon rank sum test. The non-parametric Wilcoxon rank sum test was deemed 
appropriate for the datasets in Fig. 2-19 due to their abnormal distributions (a Kolmogorov-





Fig. 2-19 Receiver chamber calcein concentration as a function of coupling fluid 
temperature after (a) 1 hour, (b) 2 hours, (c) 3 hours, (d) 4 hours, and (e) 5 hours of 
transport. Panel (f) is the concentration of the control case at 5 hours. The letters C and S 
denote control and sonoporation protocols. The crosses within the boxes represent the mean 





 Receiver Fluid Temperature 
In a separate set of experiments, the receiver temperature was measured (for each of the 
three sonoporation and control protocols), to quantify its dependence on the coupling fluid 
temperature and the ultrasound field. A thermocouple, inserted through the bottom of the 
receiver chamber so that its tip was 2 mm below the skin, recorded data for 30 minutes. The 
first 10 minutes corresponded to the period of coupling fluid circulation. The following 
20 minutes corresponded to the period immediately after calcein application when the 
diffusion cell was left at room temperature (19 °C ± 1 °C). Two important results are apparent 
from this receiver fluid temperature data: the receiver fluid temperature during and 
immediately following the 10 minutes of coupling fluid circulation increased with increasing 
coupling fluid temperature; and at each of the three coupling fluid target temperatures, the 
receiver fluid temperature was always higher for the sonoporation protocol than it was for 







Fig. 2-20 Receiver chamber temperature as a function of time for each of the three 
coupling fluid target temperatures (a) without ultrasound and (b) with ultrasound. The 
temperature regulation system was run for the first ten minutes. The receiver fluid was then 
left to return back towards room temperature (19 °C ± 1 °C) for the remaining twenty 
minutes. The vertical lines depict the time at which the temperature regulation system was 
turned off.  
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 Permeant Solution Temperature 
The temperature of the calcein-buffer solution was measured during the first 15 minutes of 
diffusion to quantify its dependence on the coupling fluid temperature and the ultrasound 
field. Following the 10 minutes of sonoporation (or control), the coupling fluid was removed 
from the donor chamber and the calcein-buffer was applied to the skin. The room 
temperature during diffusion was always 19 °C ± 1 °C. In the first 15 minutes of diffusion, the 
maximum permeant temperature increased with increasing coupling fluid temperature, 
regardless of the protocol. It is also important to note that, for each of the three coupling fluid 
target temperatures, the permeant temperature was always higher following the 






Fig. 2-21 Donor chamber fluid temperature following ten minutes of temperature control 
(a) without ultrasound and (b) with ultrasound. The 15 minutes shown corresponds to the 





 Foil Pitting 
Foil pitting experiments were used to determine the influence of coupling fluid temperature 
on the inertial cavitation activity in the present setup. When the coupling fluid temperature 
was 10 °C, the mean number of pits after 1 s of ultrasound application (at an intensity of 
55 W/cm2) was 25.5 (Fig. 2-22). When the coupling fluid temperature was increased to 40 °C, 
the mean number of pits was 12.8 – representing a 50 % decrease (p<0.05). The same foil 
pitting experiment was repeated at an ultrasound intensity of 13 W/cm2. When the coupling 
fluid temperature was 10 °C, the mean number of pits after 1 s of ultrasound application was 
15.8 (Fig. 2-22). When the coupling fluid temperature was increased to 40 °C, the mean 
number of pits was 9.8 – representing a 38 % decrease (p<0.05).  
 
A similar foil pitting experiment is reported in Appendix A. That study used a transducer to 
skin distance of 5 mm and an intensity of 34 W/cm2 (compared to 3 mm and 55 W/cm2 in the 
present study). In Appendix A, the mean number of pits following ultrasound application at 
40 °C was 57 % less than the mean number at 25 °C (p<0.05), which was 65 % less than the 
mean number at 10 °C (Fig. A-13). These results are mentioned here to reinforce that an 
increase in coupling fluid temperature results in a decrease in pitting.  
 
In the present study, foil pitting experiments were also used to determine the influence of 
coupling fluid circulation on the inertial cavitation activity at the skin aperture. Ten pieces of 
aluminium foil were exposed to ultrasound (at an intensity of 55 W/cm2 and a transducer 
distance of 3 mm) for 2 s with and without coupling fluid circulation. The coupling fluid 
temperature was 10 °C ± 1 °C. Without coupling fluid circulation, the mean number of pits 
after ultrasound application was 36.6 and the median was 36.0 (Fig. 2-23). With coupling fluid 
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circulation, the mean number of pits was 35.7 and the median was 36.5. Therefore, circulation 
caused a 2 % decrease in the mean number of pits (p=0.85) and a 1 % increase in the median.  
 
 
Fig. 2-22 Number of pits in aluminium foil after 1 s of ultrasound application for coupling 
fluid temperatures of 10 °C and 40 °C, and ultrasound intensities of 13 W/cm2 and 
55 W/cm2. The transducer to skin distance was 3 mm. The crosses within the boxes represent 
the mean values (n=10). 
 
 
Fig. 2-23 The influence of coupling fluid circulation on the pitting of aluminium foil. 
Ultrasound was applied for 2 s at an intensity 55 W/cm2. The transducer to skin distance was 





This study introduced a modified diffusion cell setup with an active temperature control 
system that circulated the coupling fluid through a heat exchanger. Foil pitting experiments 
showed that the circulation of the coupling fluid had a negligible influence on the inertial 
cavitation activity at the skin aperture. During 10 minutes of ultrasound exposure (55 W/cm2), 
the system was able to maintain the steady state coupling fluid temperature to within ± 1 °C 
of each of the three target temperatures (13 °C, 33 °C, or 46 °C). The introduction of a system 
capable of maintaining the coupling fluid at a set temperature during sonoporation – without 
affecting inertial cavitation activity – is a significant contribution to the field as it removes the 
need for time consuming duty cycles or laborious periodic replacement of the coupling fluid. 
During the control cases (no ultrasound) the temperature control system was used to 
maintain the coupling fluid at the target temperatures for a duration of 10 minutes. 
Temperatures of the receiver chamber fluid and of the donor solution were taken for each 
sonoporation and control protocol to understand the thermal profile of the system. 
 
The temperatures of the receiver chamber were recorded for each sonoporation and 
control protocol (see Fig. 2-20). In the absence of ultrasound during the control cases (Fig. 
2-20a) the receiver fluid temperature decreased to a minimum of 13 °C when the coupling 
fluid temperature was 13 °C, and increased to maximums of 26 °C and 32 °C when the 
coupling fluid temperatures were 33 °C and 46 °C respectively. Therefore, in the absence of 
ultrasound, heat was conducted through the skin during coupling fluid circulation. This heat 
conduction implies that, in an in vivo or clinical transport setup without ultrasound, the 
temperature of the circulating fluid used to heat treat the skin prior to drug application would 
66 
 
affect, not just the SC temperature, but also the temperature of the tissue beneath the SC 
(the dermis and muscle tissue). During sonoporation, the receiver fluid always experienced 
continuous temperature increases (Fig. 2-20b), regardless of coupling fluid temperature. 
From an in vivo or clinical perspective, these temperature increases are important as they 
indicate that, during sonoporation, the underlying tissue can experience temperature 
increases even if the coupling fluid temperature is strictly controlled. The maximum receiver 
temperatures reached during sonoporation were 14 °C, 10 °C, and 7 °C higher than the 
temperatures reached during the control cases (for coupling fluid temperatures of 13 °C, 
33 °C, and 46 °C). The only methodological difference between the control and sonoporation 
protocols was the presence of ultrasound. Therefore, the higher receiver temperatures which 
occurred during the sonoporation protocols must have been caused by absorption of the 
ultrasound energy. The ultrasound waves passed through the skin and were absorbed by the 
receiver fluid which resulted in a temperature increase. Increases in the receiver fluid 
temperature during sonoporation could be controlled in an in vitro setup by using a receiver 
chamber with a water jacket. However, this method of temperature control is not applicable 
to an in vivo or clinical setup. The results of Fig. 2-21 show that, in an in vivo or clinical setup, 
temperature increases in the underlying tissue could instead be mitigated by maintaining a 
low coupling fluid temperature during sonoporation. During sonoporation in the present 
study, the receiver fluid reached maximum temperatures of 27 °C, 36 °C, and 39 °C for 
coupling fluid temperatures of 13 °C, 33 °C, and 46 °C respectively. A lower coupling fluid 
temperature resulted in a smaller increase in the receiver fluid temperature. Therefore, 
future in vivo or clinical studies should consider maintaining a low coupling fluid temperature 
during sonoporation to minimize potentially harmful increases in the temperature of the 
underlying tissue.     
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During the sonoporation and control experiments, the coupling fluid in the donor chamber 
was held at one of three target temperatures (13 °C, 33 °C, or 46 °C) for 10 minutes. Following 
this 10 minute period, the donor chamber was emptied of coupling fluid and a 0.5 mL volume 
of 0.1 % w/v calcein in a phosphate buffer solution was applied to the skin surface with a 
pipette. The temperatures of the permeant solution were recorded for each protocol for 15 
minutes after it was applied to the skin (Fig. 2-21). The temperature of the permeant was at 
~17 °C before it was pipetted into the donor chamber.  
 
Following the control protocol in which the coupling fluid was maintained at the lowest 
target temperature (13 °C), the calcein-buffer solution temperature decreased to 15 °C (Fig. 
2-21a). This temperature decrease occurred because heat was conducted from the calcein-
buffer to the donor chamber walls which had been cooled to 13 °C by the coupling fluid. Note 
that the donor chamber wall temperature was measured using an infrared thermometer 
(Cason CA380). Following the control protocol in which the coupling fluid was maintained 
above room temperature at 33 °C, the calcein-buffer solution increased to 22 °C (Fig. 2-21a). 
This temperature increase was due to heat conduction from both the donor chamber walls, 
which had been heated to 33 °C, and from the receiver chamber fluid, which had been heated 
to 26 °C. Heat conduction from the donor chamber walls and receiver fluid was also 
responsible for the increase in permeant temperature, to 26 °C (Fig. 2-21a), following the 
control protocol at 46 °C.  
 
Following ultrasound application at all target temperatures, the permeant solution always 
experienced an initial increase in temperature (Fig. 2-21b). The initial permeant solution 
temperatures following ultrasound application always reached temperatures that were 3-8 °C 
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above those following the control protocols. For example, the maximum permeant 
temperature following the 33 °C control protocol was 22 °C, while the maximum temperature 
following the 33 °C sonoporation protocol was 28 °C. Following both the 33 °C control and 
33 °C sonoporation protocols, heat was conducted from the donor chamber walls to the 
0.5 mL of permeant solution. However, due to absorption, the receiver chamber fluid 
temperature was 10 °C higher following the 33 °C sonoporation protocol than it was following 
the 33 °C control protocol. Therefore, more thermal energy was stored in the system 
following sonoporation. This additional thermal energy passed from the receiver solution to 
the permeant via conduction through the skin. This is why the permeant solution had a higher 
temperature following the 33 °C sonoporation protocol than it did following the 33 °C control 
protocol. The same is true for the 13 °C and 46 °C cases.  
 
Foil pitting experiments were conducted at coupling fluid temperatures of 10 °C and 40 °C. 
For an intensity of 55 W/cm2, an increase in coupling fluid temperature corresponded to a 
50 % decrease in the number of pits (p<0.05). It is reasonable to conclude from these data 
that, in the skin sonoporation experiments in this study, the skin was exposed to less inertial 
cavitation activity as the coupling fluid temperature was increased. This conclusion agrees 
with the assertion made in the HIFU study by Hockham, et al. (2010) which attributed the 
decrease in inertial cavitation activity to an increase in vapour pressure with increased 
coupling fluid temperature. An explanation is also given in the study by (Bader, et al. 2012): 
the cavitation threshold limits the energy that can be stored within the ultrasound field, which 
limits the maximum rarefactional pressure. The increase in temperature decreases the 
threshold for cavitation which decreases the maximum rarefactional pressure – decreasing 
the inertial cavitation activity which can be achieved for a given intensity. While inertial 
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cavitation activity decreased with increasing coupling fluid temperature, the results of the 
present study show that transdermal transport following sonoporation increased with 
coupling fluid temperature (Fig. 2-19).  
 
The increases in transdermal transport with coupling fluid temperature, following both the 
control and sonoporation protocols (shown Fig. 2-19), were a result of temperature-
dependent changes in the SC lipid structure. The SC lipids are known to undergo multiple 
phase transitions between 10 °C and 50 °C (Akomeah, et al. 2004, Clarys, et al. 1998, Gay, et 
al. 1994, Silva, et al. 2006, Tang, et al. 2002a), and these phase transitions are known to 
increase skin permeability (Gay, et al. 1994). Multiple phase transitions occurred throughout 
the coupling fluid temperature range (13 °C to 46 °C) used for both the control and 
sonoporation protocols. Therefore, these phase transitions provide a logical explanation for 
the increases in transport with temperature shown in Fig. 2-19. Differences in the calcein-
buffer temperature (shown in Fig. 2-21) may also have contributed to the increase in 
transdermal transport with increasing coupling fluid temperature. An increase in the 
temperature of a permeant is known to result in an increase in the diffusivity of that permeant  
(Clarys, et al. 1998). This was demonstrated in the passive diffusion study by Akomeah, et al. 
(2004) which investigated the temperature dependence of methyl paraben transport through 
a cellulose membrane. The transport of methyl paraben through the cellulose membrane, 
measured after four hours of diffusion at a temperature of 23 °C, 30 °C, 37 °C, or 45 °C, 
increased with increasing temperature. The cellulose membrane had a temperature tolerance 
of 60 °C so its permeability was assumed to be constant in the 23 °C to 45 °C temperature 
range. Therefore, the increases in transport through the membrane with increasing 
temperature were due to an increase in the diffusivity of the permeant (methyl paraben). In 
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the present study, the maximum calcein-buffer temperature increased with increasing 
coupling fluid temperature, therefore, the diffusivity of the permeant in the first 15-20 
minutes also increased with increasing coupling fluid temperature. However, this increased 
diffusivity could only affect the receiver chamber concentration measured at the end of the 
first hour of diffusion. Once the sample was taken at the end of the first hour, the coupling 
fluid temperature had already returned to room temperature and been at room temperature 
for 40-45 minutes. The temperature dependence shown in Fig. 2-19 for each subsequent hour 
could not have been influenced by increased diffusivity of the permeant alone. A significant 
dependence on coupling fluid temperature is shown across the full five hours in Fig. 2-19, 
therefore, although permeant diffusivity may have had some affect within the first 15-20 
minutes, the dependence of transport on the coupling fluid temperature at the end of the 
five hours must have been due to a longer lasting effect – skin permeability increase due to 
phase transitions in the SC. 
 
The increase in post-sonoporation transport with increasing coupling fluid temperature 
shown in Fig. 2-19 should be considered by researchers who wish to achieve a high degree of 
post-sonoporation transport in future in vivo or clinical studies. For a given set of ultrasound 
parameters (frequency, intensity, application time, and transducer distance) the post-
sonoporation transport will increase with increasing coupling fluid temperature. Therefore, a 
temperature control system similar to the one introduced in this study could be used to 
maintain an elevated temperature during in vivo or clinical sonoporation so as to increase 
post-sonoporation transport. However, when using an increased coupling fluid temperature 
to increase post-sonoporation transport, researchers must still ensure that the temperatures 
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of the SC and underlying tissue remain at a safe level that will not cause burns or irreversible 
damage to epidermal cells.  
 
The influence of coupling fluid temperature on the post-sonoporation transport has already 
been discussed – the post-sonoporation transport increased with increasing coupling fluid 
temperature (Fig. 2-20). Consider now the influence of coupling fluid temperature on the 
ultrasound enhancement (the ratio of the post-sonoporation to post-control transport at 
each coupling fluid temperature). Researchers have established that inertial cavitation is the 
primary mechanism behind the skin permeability enhancement that occurs during 
sonoporation (Tang, et al. 2002a, Tezel, et al. 2002, Tezel, et al. 2001). From the foil pitting 
experiments it was concluded that the skin was exposed to less inertial cavitation activity at 
higher coupling fluid temperature (Fig. 2-22). From this result, it would be logical to assume 
that increasing the coupling fluid temperature would lead to a decrease in the ultrasound 
enhancement – as this enhancement is caused by inertial cavitation activity which decreased 
with increasing coupling fluid temperature. However, a comparison of the control and 
sonoporation datasets in Fig. 2-19 indicates that the ultrasound enhancement was not 
diminished when the coupling fluid temperature was increased: for each of the five hours 
shown in Fig. 2-19a-e, the post-sonoporation transport datasets were always significantly 
greater (0.026≤p≤0.16) than the post-control transport datasets. Therefore, although the 
number of inertial cavitation collapses impacting the skin decreased by up to 50 % with 
increasing temperature, the cavitation induced permeability increase did not decrease. To 
make up for the lower number of collapses impacting the skin, the permeability increase 
caused by each cavitation collapse must then have increased with increasing coupling fluid 
temperature. In other words, increasing the skin temperature must have decreased the ability 
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of the SC lipids to withstand the disordering which is known to result from cavitation (Alvarez‐
Román, et al. 2003, Lee, et al. 2010, Ueda, et al. 1996). This temperature effect was previously 
postulated in the sonophoresis study by Merino, et al. (2003) which suggested that increasing 
the skin temperature may ‘soften’ the SC lipids for disruption by the ultrasound energy. 
Similarly, in their study on transdermal enhancement by laser-induced stress waves (LISW), 
Makoto, et al. (2002) suggested that an increase in the skin temperature during LISW 
exposure increased the fluidity of the SC lipids, making them more susceptible to disruption 
by the LISW. A similar effect may have occurred in the present study with increased coupling 
fluid temperature disordering the SC lipids thereby making them more susceptible to further 
disordering by inertial cavitation. The brittle-to-ductile phase transition which has been 
shown to occur in the SC between 20 °C and 40 °C (Papir, et al. 1975) could also make the SC 
lipids more susceptible to cavitation-induced disordering. This brittle to ductile transition was 
used in the ballistic particle delivery study by Kendall, et al. (2004) to explain why particle 
penetration depth increased by 2-fold when the ambient temperature was increased from 
20 °C to 40 °C – the lipids were not able to resist the particles as well at higher temperature. 
A similar brittle to ductile change in the SC structure may also have compromised the SC lipids’ 
ability to withstand disordering by the forces induced by inertial cavitation in the present 
study.  
 
The ultrasound enhancements achieved in the present study are comparable to those 
achieved in sonoporation studies in the literature. The mean ultrasound enhancement (the 
ratio of the mean post-sonoporation to mean post-control transport) was 2.3 for the 13 °C 
case (significant at p=0.04). For the 33 °C case the mean enhancement was 4.5 (p=0.04). For 
the 46 °C case the mean enhancement was 3.8 (p=0.13). Direct comparisons with the 
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literature are difficult given the range of intensities, transducers, transducer to skin distances, 
application times, permeants, permeant diffusion times, skin models, skin processing 
protocols, and coupling fluid temperatures used in different studies. However, some 
approximate comparisons are possible and helpful in validating the results of the present 
study. In their low-frequency (20 kHz) sonoporation study, (Herwadkar, et al. 2012) applied 
ultrasound to hairless rat skin for 2 minutes at an intensity of 6.9 W/cm2. The unspecified 
transducer tip was 3 mm from the skin surface during sonoporation. Ketoprofen (an anti-
inflammatory drug) was then applied to the skin surface and left to diffuse for 24 hours. The 
concentration of Ketoprofen in the receiver chamber was then measured with HPLC. Relative 
to a passive control case, the mean enhancement achieved by (Herwadkar, et al. 2012) was 
approximately 3.3 (p=0.05), similar to the enhancements in the present study. In the 
sonoporation study by (Tang, et al. 2002a), 20 kHz ultrasound was applied to full thickness 
porcine skin for 2 hours (10 % duty cycle) at an intensity of 1.6 W/cm2. The unspecified 
transducer tip was 8 mm from the skin surface. Relative to a passive control case, the 
electrical conductivity of the skin was enhanced by 2.5, similar to the enhancements in the 
present study. In the sonoporation study by Mitragotri, et al. (2000a), 20 kHz ultrasound was 
applied to full thickness porcine skin for 15 minutes (10 % duty cycle) at an intensity of 
14 W/cm2. The unspecified transducer tip was 10 mm from the skin surface. Relative to a 
passive control case, the electrical conductivity of the skin was enhanced by 5, again similar 
to the enhancements in the present study.    
 
The present study was motivated by previous skin sonoporation studies that avoided 
excessive ultrasound related temperature rises by using duty cycles and by replacing the 
coupling fluid during US application (Lavon, et al. 2005, Paliwal, et al. 2006, Tang, et al. 2002a, 
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Terahara, et al. 2002a). Duty cycles do not allow for a constant coupling fluid temperature, 
they only slow the rate of heating. In the present setup, when the temperature control system 
was turned off, the coupling fluid temperature increased at a rate of 8.4 °C/min with 
continuous application at 55 W/cm2, 3.5 °C/min with a 50 % duty cycle, and 0.9 °C/min with 
a 10 % duty cycle (Fig. 2-15). The other method that has been used to mitigate temperature 
rises – fluid replacement, also allows for changes in coupling fluid temperature during 
sonoporation. In the studies by Tang, et al. (2002a) and Terahara, et al. (2002a) the coupling 
fluid was at room temperature (~23 °C) at the beginning of sonoporation. The coupling fluid 
was then replaced during sonoporation when it reached approximately 40 °C. The 
temperature-dependent transport increases found in the present study show that even these 
temperature increases of 15-20 °C, reported by Tang, et al. (2002a) and Terahara, et al. 
(2002a), affect skin permeability. Therefore, the skin permeability enhancements that those 
studies reported may have been due to a combination of inertial cavitation and coupling fluid 
temperature increases. Future sonoporation studies should employ a circulation system to 
ensure that the coupling fluid temperature is the same during sonoporation and control 
experiments. This would remove any potential influence of coupling fluid temperature, 
thereby isolating the influence of inertial cavitation.  
 
The temperature control system reported here is capable of maintaining a set steady state 
coupling fluid temperature for much longer than 10 minutes if required. In the present study, 
a 10 minute application time was used as it resulted in significant (0.026≤p≤0.16) permeability 
enhancements, without taking an excessive amount of time to run all 42 individual transport 
experiments. However, even greater permeability enhancement can be achieved by using 
longer application times (Mitragotri, et al. 2000a, Terahara, et al. 2002a). In Appendix B, the 
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mean and median receiver chamber calcein concentration following 30 minutes of 
sonoporation (at constant temperature) were shown to be twice those following 10 minutes 
of sonoporation (significant at p=0.38). The increase in skin permeability enhancement with 
ultrasound application time in Appendix B was due to inertial cavitation activity – the longer 
the skin was exposed to the ultrasound field, the more inertial cavitation events impacted the 
SC. Future, in vitro, in vivo or clinical studies that want to obtain a greater permeability 
increase by using an application time of 30 minutes, 1 hour, or more can do so with the 
present system without any concern for coupling fluid temperature increase. This long 
duration temperature control capability enables far greater ultrasound application times than 
have previously been feasible. Previously, when a duty cycle was used to control thermal 
effects, 30 minutes of ultrasound would have taken up to 5 hours to administer. This duration 
would be impractical in a clinical setting and tedious in a laboratory setting. With the present 
system, long durations of continuous ultrasound application are now possible.  
 
This study focused on coupling fluid temperature control during skin sonoporation. 
However, it is interesting to consider the potential implications of employing such a system 
during sonophoresis, where coupling fluid temperature increases are also common (Alvarez‐
Román, et al. 2003, Merino, et al. 2003, Mitragotri, et al. 1996, Polat, et al. 2012). In 
sonophoresis, the permeant solution also acts as the coupling fluid. Using a coupling fluid 
temperature control system during sonophoresis would not only allow constant ultrasound 
application without the need for duty cycles or fluid replacement, but could also be used to 
maintain a higher diffusion coefficient than that which occurs at room temperature. The 
cooling system was designed so that dissolved permeants could easily be flushed and cleaned 
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from the tubing and heat exchanger. Therefore, the cooling system could easily be employed 
in a sonophoresis study.  
 
The present study also showed that polypropylene can be used for in vitro sonoporation 
experiments. No cavitation damage occurred on any of the donor or receiver chamber 
surfaces. Also, the polypropylene was semi-transparent which made it easy to identify any air 
bubbles in the receiver chamber. Researchers conducting sonoporation (or sonophoresis) 
experiments would find polypropylene cells to be an affordable, easy to customise alternative 
to glass diffusion cells which are expensive and cannot be geometrically customised without 
the help of a glassblower. 
 
 Conclusions 
A modified Franz diffusion cell along with a circulating temperature regulation system 
successfully maintained the coupling fluid temperature at either (13 °C, 33 °C, or 46 °C) during 
the sonoporation of porcine skin at 55 W/cm2. Circulation of the coupling fluid did not affect 
the inertial cavitation activity at the skin aperture. The introduction of a system capable of 
maintaining a constant coupling fluid temperature during continuous sonoporation is a 
significant contribution to the field as it removes the need for replacement of the coupling 
fluid or time consuming duty cycles. In an experimental setting, use of the present 
temperature control system would reduce the time required to run each experiment and the 
labour required by the researcher. In a clinical setting, use of the present temperature control 
system could reduce the required patient contact time 10-fold relative to an application 
protocol that required a 10 % duty cycle to minimise thermal effects. Therefore this system 
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enables far more clinically practical sonoporation protocols than could previously have been 
achieved. Thesis Objective 1 (design and manufacture a system which enables the coupling 
fluid to be set and maintained at a variety of temperatures during skin sonoporation) has 
been fulfilled. 
 
Increasing the coupling fluid temperature led to a decrease in foil pitting. An increase in 
coupling fluid temperature from 10 °C to 40 °C corresponded to a 38 % decrease in the 
number of pits (p<0.05). It is then concluded that, in all of the skin experiments in this study, 
the skin was exposed to less inertial cavitation activity when the coupling fluid temperature 
was higher. This agrees with the assertion made in the HIFU study by Hockham, et al. (2010) 
which attributed a decrease in inertial cavitation activity with increasing coupling fluid 
temperature to an increase in vapour pressure. Thesis Objective 2 (investigate the influence 
of coupling fluid temperature on the inertial cavitation activity that occurs in a low-frequency 
Franz diffusion cell setup) has been fulfilled.  
 
Transdermal transport experiments showed that increasing the temperature at which the 
coupling fluid was maintained during sonoporation increased the post-sonoporation 
transport of calcein. Following 5 hours of diffusion, the median receiver chamber calcein 
concentration after sonoporation at a coupling fluid temperature of 46 °C was 2.3 times the 
concentration achieved after sonoporation at 33 °C, which was 2.2 times the concentration 
achieved after sonoporation at 13 °C. Past studies have used duty cycles and fluid 
replacement to keep the coupling fluid below 37-40 °C during sonoporation. However, this 
study shows that temperature dependent increases in post-sonoporation transport can occur 
above and below 37-40 °C. Thesis Objective 3 (use the coupling fluid temperature control 
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system to investigate the influence of coupling fluid temperature on post-sonoporation 
transport) has been fulfilled.  
 
Two findings from this study have important implications for any future in vivo or clinical 
sonoporation studies that adopt this new method for coupling fluid temperature control. For 
a given set of experimental parameters (intensity, application time etc.), a higher coupling 
fluid temperature during sonoporation results in more post-sonoporation transport. 
However, a lower coupling fluid temperature during sonoporation results in a smaller 
increase in the temperature of the tissue underlying the SC. Given these two findings, future 
in vivo or clinical sonoporation studies that incorporate coupling fluid temperature control 
will need to carefully select their target coupling fluid temperature so as to find a balance 
between transport (which is greatest at high temperature) and safety (which is greatest at 
low temperature).  
 
As a final reinforcement of the present study’s contribution to the field, consider 12 skin 
sonoporation and sonophoresis studies from the literature (Boucaud, et al. 2002, Herwadkar, 
et al. 2012, Lavon, et al. 2005, Le, et al. 2000, Merino, et al. 2003, Mitragotri, et al. 2000a, 
Paliwal, et al. 2006, Sarheed and Abdul Rasool 2011, Smith, et al. 2003, Tang, et al. 2002a, 
Terahara, et al. 2002a, Terahara, et al. 2002b). From the information provided it was 
calculated that a total of 34 hours of ultrasound was applied across these 12 studies. 
However, due to the various duty cycles used, it took 210 hours to administer this 34 hours 
of ultrasound. Even without considering the time that would have been spent replacing 
coupling fluid, it is apparent that use of the temperature control system introduced in the 











Passive cavitation detectors (PCDs) have been effectively employed in high-intensity 
focused ultrasound (HIFU) and cell sonoporation studies to monitor variations in inertial 
cavitation activity during the course of ultrasound application. However, there are few 
published works that use PCDs in the fields of low-frequency skin sonoporation or 
sonophoresis. This is due to the geometric limitations imposed by the glass Franz diffusion 
cells that are commonly used for experimentation. This study uses the enlarged donor 
chamber of Chapter 2 so that a PCD hydrophone can be positioned in the coupling fluid during 
sonoporation. This PCD setup monitored the broadband noise emission as skin was 
sonoporated under four different coupling fluid temperature-intensity combinations. An 
inertial cavitation dose (ICD) value was then calculated for each sonoporation experiment by 
time-averaging the broadband noise emission over the 10 minutes of sonoporation. The 
mean ICD value increased with increasing intensity (as inertial cavitation does) and decreased 
with increasing temperature (as inertial cavitation was shown to do). Following sonoporation, 
a permeant was applied to the skin and left to diffuse passively for 2 hours. The post-
sonoporation transport was then plotted against the ICD to determine whether the PCD 
output could be used, not just to monitor inertial cavitation activity, but as an indicator of the 
post-sonoporation transport. The poor correlation between ICD and post-sonoporation 
transport lead to the conclusion that the coupling fluid temperature must be held constant if 
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ICD is to be used as such an indicator. This is because an increase in coupling fluid temperature 
results in a decrease in ICD yet an increase in post-sonoporation transport. 
 
 Introduction 
Experimental setups that use inertial cavitation often include PCD systems to monitor 
inertial cavitation activity during ultrasound application (Bian, et al. 2017, Bull, et al. 2013, 
Cleveland, et al. 2000, Farny, et al. 2010, Gateau, et al. 2011, Gyöngy and Coussios 2010, 
Hallow, et al. 2006, Helga, et al. 2015, Hockham, et al. 2010, King, et al. 2010, Liu, et al. 1998, 
Salgaonkar, et al. 2009). Inertial cavitation activity can change during the course of ultrasound 
application due to bubble dissolution, the depletion of cavitation nuclei, interactions between 
bubbles, increased vapour pressure caused by heating, and shielding caused by pre-focal 
bubble activity (Hockham, et al. 2010). Monitoring the inertial cavitation activity with a PCD 
allows any changes in the inertial cavitation activity to be detected in real-time. The 
experimental inputs to the ultrasound field can then be adjusted to counteract these changes 
and ensure that the cavitation activity remains at the desired level throughout ultrasound 
application. Furthermore, PCD output is seen as a potential unifying parameter that can 
correlate with permeability increase, meaning that monitoring it during ultrasound 
application can enable real-time feedback about the ultrasound effects that are occurring 
under a diverse range of experimental conditions (Hallow, et al. 2006). 
 
While PCDs have been frequently employed in studies involving the insonation of media 
other than skin (Coussios and Roy 2008, Farny, et al. 2010, Liu, et al. 1998, Yao-Sheng, et al. 
2010), they have rarely been used in low-frequency in vitro skin insonation studies. This is due 
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to the geometric constraints within the traditional Franz diffusion cell which make it difficult 
to fit both a transducer and a hydrophone in the coupling fluid. In the study by Tang, et al. 
(2002a) a hydrophone was fixed to the outer surface of the bottom of a receiver chamber 
with epoxy. This allowed for the PCD data to be recorded during skin insonation but did not 
directly capture the ultrasound field signal within the coupling fluid where important inertial 
cavitation activity is known to occur. Tezel and Mitragotri (2003a) were able to directly 
monitor the ultrasound field in the coupling fluid, but could not take measurements during 
skin insonation as the hydrophone was positioned where the skin sample would usually be 
positioned. Tezel, et al. (2002) placed their hydrophone perpendicular to the transducer in 
their low-frequency skin study, however, they did not specify the distance. Furthermore, they 
performed all of their PCD measurements in a separate chamber due to the geometrical 
constraints of a Franz diffusion cell. An in vitro skin apparatus that allows for a hydrophone 
to be positioned in the coupling fluid during skin sonoporation has not yet been reported. The 
lack of such an apparatus means that there is currently no way to monitor the inertial 
cavitation activity that occurs in the coupling fluid during skin sonoporation. 
 
This study introduces a modified Franz diffusion cell setup that facilitates a PCD 
hydrophone in the coupling fluid during skin sonoporation. This PCD setup monitored the 
broadband noise emission as skin was sonoporated under four different coupling fluid 
temperature-intensity combinations. The dependence of the PCD output on the intensity and 
coupling fluid temperature is quantified to assess the ability of the PCD to respond to changes 
in inertial cavitation activity (brought on by changes in coupling fluid temperature and 
ultrasound intensity). The receiver chamber calcein concentration following sonoporation is 
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then plotted against the PCD output to assess the potential of using the PCD, not just to 
monitor inertial cavitation activity, but also as an indicator of post-sonoporation transport. 
 
 Materials and Methods 
 Modified Vertical Diffusion Cell 
The diffusion cells used in this study were the same as those used in Chapter 2. The donor 
chambers had outer diameters of 65 mm, inner diameters of 61 mm and aperture diameters 
of 9 mm. The receiver chambers had volumes of 3.2 mL and aperture diameters of 9 mm. The 
diffusion cell is shown again in Fig. 3-1. The donor and receiver chambers were turned from 
solid polypropylene rods on a CNC lathe. The receiver chamber sampling arm and donor 
chamber ports were then added by gluing sections of carbon fibre tubing to the 
polypropylene. The donor and receiver chambers were held together with clamps 3-D printed 




Fig. 3-1 Diffusion cell geometry (top) plan view, (middle) front view, and (bottom) 
isometric view 
 
 Coupling Fluid Temperature 
The coupling fluid temperature was maintained at 10 °C or 37 °C during sonoporation. The 
system used to maintain the coupling fluid temperature during sonoporation was the same 
as that used in Chapter 2. Briefly, the coupling fluid was circulated out of one donor chamber 
port, through a heat exchanger, and back into the other donor chamber port. This circulation 
was maintained at a flow rate of 0.14 L/min using a peristaltic pump (6-V Peristaltic Pump, 
Amazon, Seattle, WA, USA). An overview of the temperature control circuit is shown in Fig. 
3-2. The donor chamber, pump and heat exchanger were linked together by silicone tubing 
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(Silicone Tubing Clear Grade Inner Diameter 2.6 mm, Rubbermark Industries, Auckland, New 
Zealand). The heat exchanger consisted of an aluminium block submerged in a water bath 
(FP-50 Refrigerated/Heating Circulator, Julabo GmbH., Selbach, Germany). In this study, 10 °C 
was chosen for the lower temperature because anything colder has been shown to result in 
discomfort after extended exposure (Dunne, et al. 2013). The high coupling fluid temperature 
was set to 37 °C because it has been reported that exposure to temperatures over 40 °C can 
cause significant discomfort and irreversible damge to epidermal cells (Lindeque, et al. 2013, 
Moritz and Henriques 1947). The coupling fluid temperature was measured throughout 
sonoporation using a type K thermocouple (Jaycar Electronics Pty Ltd., Auckland, New 
Zealand). The positioning of the thermocouple in the coupling fluid is qualitatively depicted 
in Fig. 3-3.  
 
 Ultrasound 
A VC 505 ultrasonic processor (Sonics and Materials Inc., Connecticut, USA), fitted with a 
13 mm replaceable tip, was used to generate a 20 kHz ultrasound field. The tip of the 
transducer was 3 mm from the surface of the skin during sonoporation. Following the 
manufacturer’s instructions, compressed air was circulated through the ultrasonic processor 
to keep it cool during ultrasound application. Two intensities were used in this study: 
8.9 W/cm2 and 36 W/cm2 (spatial average, temporal average). These intensities were 
determined using a common calorimetric approach (Merino, et al. 2003, Mitragotri, et al. 
2000a, Mitragotri, et al. 2000b, Morimoto, et al. 2005, Mutoh, et al. 2003, Terahara, et al. 







Fig. 3-2 System schematic. The dashed lines represent the signal inputs and outputs to and 




Fig. 3-3 Cross-section of the diffusion cell showing the positioning of the hydrophone, 
thermocouple, and transducer. The distance between the tip of the hydrophone and the 




 Porcine Skin 
The in vitro skin samples used in this study were harvested from porcine ears. The ears were 
collected from an abatoir (Ashburton Meat Processors Ltd, Ashburton, New Zealand) 
immediately after slaughter. The ears were not exposed to detergent or scalded at the 
abatoir. In the laboratory, the ears were cleaned with cold water to remove the blood and 
soil. The top layer of the skin was then removed with a dermatome (Dermatome 50 mm, 
Nouvag AG, Goldach, Switzerland), which was set to a thickness of 1 mm. The pieces of 
dermatomed skin were individually wrapped in parafilm (PARAFILM, Sigma-Aldrich, St. Loius, 
MO, USA) and placed in airtight plastic containers. These containers were stored in a -20 °C 
freezer until use. The total time from slaughter to freezer was approximately 3.5 hours. All of 
the skin samples used in this study were stored in the freezer no longer than one week.  
 
 Chemicals 
The permeant solution used for the transport experiments was made by dissolving calcein 
(Calcein C0875, Sigma-Alfrich, St. Louis, MO, USA) in phosphate buffered saline (Gibco PBS, 
Thermo Fisher Scientific, Waltham, MA, USA) at a concentration of 0.1 % w/v (1 g/L). This 
solution was stored at room temperature. Deionised water was taken from a Labwater 
L991008 Deioniser (Suez Ltd, Thame, UK). 
 
  Hydrophone Alignment and Passive Cavitation Detection 
One of the objectives for this study was to assess the ability of a PCD hydrophone to monitor 
the inertial cavitation activity occurring in a Franz diffusion cell during sonoporation. A 
hydrophone (2.0 mm Needle Hydrophone, Precision Acoustics Ltd., Dorchester, Dorset, UK) 
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was positioned in the coupling fluid during each of the sonoporation experiments described 
in Section 3.3.7. The manufacturer coated the hydrophone tip with a thin layer of silicone to 
protect the sensitive piezoelectric element from cavitation damage (Fig. 3-4). At the 
transducer driving frequency (20 kHz), the hydrophone had a sensitivity 
of -236.4 dBre1V/μPa. This sensitivity was measured by Neptune Sonar Ltd (East Yorkshire, 
UK). Note that the full list of calibrated sensitivity values, measured by Neptune Sonar, for 
frequencies between 5 kHz and 1000 kHz are shown in Appendix C.  
   
 
Fig. 3-4 Image of the needle hydrophone showing the silicone coating, 2 mm diameter 
piezoelectric element and submersible preamplifier 
 
The hydrophone was held in place by an aluminium sleeve. The mounting point of the 
sleeve was fixed relative to the diffusion cell and transducer. The complete schematics of the 
support structure for the transducer, hydrophone, and diffusion cell are presented in 
Appendix A. In the present study, the hydrophone tip was ~7 mm from the skin aperture 
during sonoporation. When in the “sonoporation position” (Fig. 3-5a), the hydrophone was 
able to record the pressure variations within the coupling fluid (a cross-section of Fig. 3-5a is 
shown in Fig. 3-3). Removal of the diffusion cell from the position shown in Fig. 3-5a was 
necessary as each experimental repetition was performed with a different diffusion cell. To 
enable a diffusion cell to be removed from the setup and replaced by the next one, the 
transducer was moved upwards on the clamp stand which held it in place and the hydrophone 
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sleeve was rotated out of the donor chamber (Fig. 3-5b). The diffusion cell could then be 
removed from its holder (Fig. 3-5c-d). To prepare for the next experimental repetition, 
another diffusion cell was inserted into the holder and the hydrophone sleeve was rotated 
back into the “sonoporation position”. The transducer was then lowered back down the 
clamp stand so that the setup again resembled Fig. 3-5a. This rotating alignment system 
ensured a consistent hydrophone position during sonoporation. An isometric view of the 3D 
printed ABS diffusion cell holder is shown in Fig. 3-6. An image of the transducer, hydrophone, 




Fig. 3-5 Schematic of the disassembly process which began with the components in their 
sonoporation position (a). The transducer (green) was then removed allowing the 
hydrophone/thermocouple holder (aqua) to be rotated out of the donor chamber on its pivot 
mounting (b). The diffusion cell could then be removed from its holder (c and d). The 
diffusion cell for the succeeding experimental repetition was positioned by following this 





Fig. 3-6 Isometric view of the 3D printed ABS diffusion cell holder (a) with the cell in place 
and (b) without the cell 
 
 




Outside of skin applications, studies involving a PCD have positioned the hydrophone so 
that it is confocal with the transducer (Choi, et al. 2014, Farny, et al. 2010, Helga, et al. 2015, 
Heymans, et al. 2017, Hockham, et al. 2010, Liu, et al. 1998). Due to the small distance 
between the transducer and the skin (3 mm) in the present study, it was not possible to 
position the hydrophone confocally. Instead, the hydrophone was focussed towards the gap 
between the transducer tip and the donor chamber (Fig. 3-3). The distance between the tip 
of the hydrophone and the bottom edge of the transducer was 5 mm. This positioning was as 
close to confocal as possible in the present setup. Increasing the transducer to skin distance 
from 3 mm to 5 mm would have enabled a perfectly confocal setup  (with both the transducer 
and hydrophone aligned with the radial centre of the skin surface), as in the earlier PCD study 
reported in Appendix A. However, experiments reported in Appendix B showed that the 
median receiver chamber calcein concentration following 10 minutes of sonoporation at 
3 mm was four times that following sonoporation at 5 mm (significant at p=0.3). Therefore, 
in the present study, perfect confocal alignment was sacrificed for an increase in skin 
permeability enhancement. Note that an increase in skin permeability enhancement with 
decreasing transducer distance was also found in the sonoporation studies by Herwadkar, et 
al. (2012) and Terahara, et al. (2002a), and is due to the greater number of inertial cavitation 
events which occur closer to the transducer tip, as shown with foil pitting experiments in 
Appendix B (Fig. B-14) and in the study by Terahara, et al. (2002a). 
 
The voltage signal recorded by the hydrophone during sonoporation was passed through a 
pre-amplifier (HP Series Submersible Preamplifier, Precision Acoustics Ltd., Dorchester, 
Dorset, UK) and a DC coupler (DC Coupler, Precision Acoustics Ltd., Dorchester, Dorset, UK). 
The voltage signal was then read by an oscilloscope (TDS 2014B, Tektronix, Beaverton, OR, 
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USA) and transferred to a PC running SignalExpress (NI LabVIEW SignalExpress, National 
Instruments, Texas, USA) via a USB cable. The oscilloscope collected 2500 data points at a 
sampling rate of 1 MHz and then transferred these to the PC. The oscilloscope then collected 
another 2500 data points after a delay of around 1 to 2 s. This continued for the 10 minutes 
of sonoporation. Each set of 2500 data points was filtered using a digital infinite impulse 
response bandpass filter. The infinite impulse response bandpass filter was produced using 
MATLAB’s ‘designfilt’ function (MATLAB, MathWorks, Natick, MA, USA). Six different 
passbands were used (2.5-7.5 kHz, 22.5-27.5 kHz, 29-31 kHz, 34-35 kHz, 70-90 kHz, and 
92.5-97.5 kHz) to highlight the importance of PCD passband selection. Similarly, three 
different filter orders (4, 10, and 20) were used to highlight the importance of that parameter. 
Once each set of the 2500 data points had been filtered, the RMS value was calculated for the 
2.5 ms time period associated with those data points. This RMS value then represented one 
noise amplitude data point. The inertial cavitation dose (ICD) was calculated by numerically 
integrating the noise amplitude over the 10 minutes of ultrasound application in each 
experiment. The ICD had units of V-s as in the cell sonoporation studies by Chen, et al. (2003) 










 Transdermal Transport Experiments 
One of the objectives of this study was to investigate whether a PCD can be used to monitor 
inertial cavitation activity during skin sonoporation. This study was also used to assess the 
potential of using PCD output to predict post-sonoporation transport. To assess this potential, 
the post-sonoporation transport had to be plotted against the ICD to see whether any 
correlation was apparent. To quantify the post-sonoporation transport, a calcein-buffer 
solution was applied to the skin immediately following sonoporation and left to passively 
diffuse for 2 hours. Seven repetitions of this transport experiment were conducted for each 
of the four coupling fluid temperature-intensity combinations (10 °C & 8.9 W/cm2, 10 °C & 
36 W/cm2, 37 °C & 8.9 W/cm2, and 37 °C & 36 W/cm2).  
 
Each transport experiment began with filling a receiver chamber with PBS. A skin sample 
was then taken from the freezer and visually checked for any holes or areas of non-uniform 
thickness through which the calcein solution could easily diffuse. Any samples that displayed 
such imperfections were disposed of. Once an appropriate skin sample was selected, it was 
clamped between the filled receiver chamber and the donor chamber. The silicone tubing was 
attached to the donor ports to complete the coupling fluid temperature control circuit. The 
diffusion cell was mounted into place and the transducer was positioned over the skin 
aperture. The thermocouple and PCD hydrophone were then positioned in the donor 
chamber. The donor chamber was filled with room temperature (19 °C ± 1 °C) deionised 
water and left to sit for 3 minutes to thaw the skin. After 3 minutes the circulation pump was 
turned on so that temperature control could begin. The water bath temperature required to 




Table 3-1 Water bath temperatures required to maintain each coupling fluid temperature 
for the control and sonoporation protocols 
Protocol Control Sonoporation (8.9 W/cm2) Sonoporation (36 W/cm2) 
Target temperature ( °C) 10 37 10 37 10 37 
Water bath temperature ( °C) 9 40 7 36 3 33 
 
The coupling fluid was circulated for 10 minutes with ultrasound (the 8.9 W/cm2 and 
36 W/cm2 sonoporation protocols) or without ultrasound (the control protocols). Note that 
the 37 °C control protocol is a positive control as opposed to a true negative control as some 
temperature effect may be expected. However, for the sake of simplicity, the term ‘control’ 
is used for both the 10 °C and 37 °C protocols that do not involve ultrasound. The water bath 
temperatures required to achieve the coupling fluid target temperatures (10 °C or 37 °C) 
during the control experiments are also shown in Table 3-1. 
 
During the 10 minutes of fluid circulation, the coupling fluid temperature was constantly 
monitored with the thermocouple to ensure it remained at the desired target temperature. 
At the end of the 10 minutes, the donor chamber was emptied and the diffusion cell was 
moved to a holding rack. A 0.5 mL volume of the calcein solution was applied to the donor 
side of the skin. The calcein solution was then left to diffuse at room temperature 
(19 °C ± 1 °C) for 2 hours. After 2 hours a 1 mL sample was taken from the receiver chamber 
with a pipette (Calibra Digital 832 Macro Pipette, Socorex, Ecublens, Switzerland). Note that 
each diffusion cell was washed with a surfactant cleaner (Jif, Unilever, France) in between 




 Concentration Measurements 
Following the two hours of diffusion, the receiver chamber calcein concentration was 
measured with a spectrofluorometer (Fluorolog-3, Horiba Ltd., Kyoto, Japan). The excitation 
wavelength was 488 nm. The emission wavelength was 513 nm. The software package 
FluorEssence (FluorEssence V3.5, Horiba Ltd., Kyoto, Japan) was used to control the 
spectrofluorometer and to record its output. The emission intensity values read by the 
spectrofluorometer (at 513 nm) were converted to calcein concentrations using the 
calibration curve described in Section B.3.1.  
 
  Detection of Sudden Changes in Inertial Cavitation Activity 
A PCD can be a helpful tool to detect sudden, potentially unwanted changes in inertial 
cavitation activity in an ultrasound setup (Hockham, et al. 2010). The broadband noise 
emission in the present setup was monitored during 10 minutes of skin sonoporation (at an 
intensity of either 8.9 W/cm2 or 36 W/cm2). During sonoporation, the coupling fluid was 
maintained at (19 °C ± 1 °C). At the beginning of the 10 minute period, the coupling fluid was 
deionised water. A sudden suppression of inertial cavitation activity was then produced by 
adding carbonated water to the coupling fluid during sonoporation. The broadband noise 
emission was analysed to determine whether it decreased at the time the carbonated water 
was added (which would indicate that the PCD detected the sudden change). 
 
The degree to which carbonated water supresses inertial cavitation activity was 
demonstrated with foil pitting experiments. This suppression is thought to be due to the large 
quantity of gas in the fluid. This gas significantly lowers the cavitation threshold. Such a 
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decrease in the cavitation threshold lowers the ultrasound energy that can be stored in the 
system (Bader, et al. 2012) – resulting in a decrease in the peak rarefactional pressure. This 
decrease in the peak rarefactional pressure causes a decrease in the inertial cavitation activity 
(Helga, et al. 2015). Previous studies have used castor oil to supress inertial cavitation 
(Robertson and Becker 2018, Tang, et al. 2002a). However, castor oil was not used in the 
present study as it would have been difficult to flush out of the silicone tubing through which 
the coupling fluid circulated. Ultrasound was applied to a piece of aluminium foil (at an 
intensity of 8.9 W/cm2 for 15 s) with deionised water as the coupling fluid and again with 
carbonated water as the coupling fluid. Digital images were then taken of the two pieces of 
foil to depict the influence of carbonation on pitting. The aluminium foil (Homebrand, 
Manukau, New Zealand) was 0.016 mm thick. 
 
The length of time that a piece of foil is submerged in water prior to ultrasound application 
can affect the prevalence of air bubbles (nucleation sites) on the surface of the foil. Prior to 
each ultrasound application, the foil was submerged in the coupling fluid while the circulation 
system brought the coupling fluid to the specified temperature. The time required to achieve 
this temperature was consistent across each foil pitting dataset. Therefore, the effect of the 






 Coupling Fluid Temperature 
This study employed the temperature control system described in Chapter 2 to set and 
maintain the coupling fluid at 10 °C or 37 °C during 10 minutes of continuous ultrasound 
application. Temperature profiles are shown in Fig. 3-8 for the 8.9 W/cm2 sonoporation, and 
36 W/cm2 sonoporation protocols. The temperature control system successfully maintained 
the coupling fluid temperature at the desired value throughout the experiment.  
 
Fig. 3-8 Coupling fluid temperature profiles for the control (C), sonoporation (S) at 
8.9 W/cm2, and sonoporation at 36 W/cm2 protocols at the target temperatures of 10 °C and 
37 °C 
 
 Passive Cavitation Detection 
One of the motivations of this study was to assess the ability of a PCD to monitor the inertial 
cavitation activity occurring in a Franz diffusion cell during sonoporation. A hydrophone, 
positioned in the coupling fluid of a modified Franz diffusion cell, recorded data during 
sonoporation. Four different combinations of coupling fluid temperature and ultrasound 
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intensity were used: 10 °C & 8.9 W/cm2, 10 °C & 36 W/cm2, 37 °C & 8.9 W/cm2, and 37 °C & 
36 W/cm2. Seven experimental repetitions were run for each of these protocols. Examples of 
frequency transforms for each of the four sonoporation protocols are shown in Fig. 3-9. 
Examples of power spectra for each of the four sonoporation protocols are shown in Fig. 3-10. 
The driving frequency (20 kHz) is clearly represented in both Fig. 3-9 and Fig. 3-10, as are the 
higher harmonics, ultraharmonics, and subharmonics, to varying degrees. These figures are 
included to demonstrate that the 20 kHz sound field that was created by the transducer was 
monitored by the PCD hydrophone throughout the duration of ultrasound application (such 
monitoring was previously impossible with a standard glass Franz diffusion cell setup).   
 
 
Fig. 3-9 Example frequency transforms  for (a) 10 °C and 8.9 W/cm2, (b) 37 °C and 




Fig. 3-10 Example power spectra for (a) 10 °C and 8.9 W/cm2, (b) 37 °C and 8.9 W/cm2, (c) 
10 °C and 36 W/cm2, and (d) 37 °C and 36 W/cm2 
 
Inertial cavitation activity is represented in the frequency spectrum by broadband noise 
which occurs between the subharmonic, harmonic, and ultraharmonic peaks (Yao-Sheng, et 
al. 2010). The hydrophone data was filtered to isolate this noise. This was achieved with a 
digital bandpass filter (described in Section 3.3.6). A filter order of 20 was chosen as it 
facilitated a complete isolation of the passband from any surrounding harmonics. The 
importance of filter order in this isolation can be shown with data from the present study. 
The magnitude responses for filters orders of 4, 10, and 20 are shown in Fig. 3-11 with the 
passband set to 22.5-27.5 kHz. When a filter order of 4 was used, the filter was unable to 
remove the harmonics at both 20 kHz and 40 kHz – the frequency spectra of the filtered signal 
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still showed distinct peaks at these frequencies (Fig. 3-12a). Similarly, a filter order of 10 was 
unable to entirely remove the 1st harmonic at 20 kHz from the frequency spectra of the 
filtered signal (Fig. 3-12b). Therefore, a filter order of 20 was used for this study as it facilitated 





Fig. 3-11 Filter magnitude responses for the 22.5-27.5 kHz band for filter orders of (a) 4, (b) 




Fig. 3-12 Example frequency spectra after filtering with a passband of 22.5-27.5 kHz and 






Using a filter order of 20, the filtered signal from six different passbands was assessed to 
demonstrate the importance of passband selection. Examples of filtered noise data captured 
during sonoporation, for one of these bands (22.5 kHz-27.5 kHz), is shown in Fig. 3-13 for each 
of the four sonoporation protocols. Due to the variability in the broadband noise emission, 
moving averages are provided in Fig. 3-13 to aid interpretation of the data. The relative 
standard deviation in these datasets is between 16 % and 19 %. This degree of time-
dependent variability in the broadband noise emission is similar to the variability in the highly 
cited PCD study by Hockham, et al. (2010). 
 
 
Fig. 3-13 Broadband noise as a function of time for coupling fluid temperature and 
intensities of (a) 10 °C and 8.9 W/cm2, (b) 37 °C and 8.9 W/cm2, (c) 10 °C and 36 W/cm2, and 
(d) 37 °C and 36 W/cm2. A moving average of the noise is also shown to aid interpretation of 
the data.  
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The choice of filter passband affects the response of a PCD to changes in inertial cavitation 
activity. There are no established protocols for selecting filter bandwidths or cut-off 
frequencies when using PCDs, except that no harmonic (n·f, n=1,2,3,4,5), subharmonic (f/2) 
or ultraharmonic (n·f/2, n=3,5,7,9) frequencies should be included as these are considered 
indicative of stable cavitation (Yao-Sheng, et al. 2010). Inertial cavitation activity is known to 
increase with increasing ultrasound intensity (Mitragotri, et al. 2000a, Tang, et al. 2002a, 
Terahara, et al. 2002a) and foil pitting experiments presented in Fig. 2-22 and Fig. A-13 
showed that inertial cavitation activity at the skin aperture decreases with increasing coupling 
fluid temperature. The PCD hydrophone data collected in the present study was filtered with 
six different passbands to identify a passband in which the PCD output increased with 
increasing intensity and decreased with increasing coupling fluid temperature (as this would 
mean that that passband was responding to inertial cavitation activity). Two of these bands 
(29-31 kHz and 70-90 kHz) did include harmonics or ultraharmonics, while the other four (2.5-
7.5 kHz, 22.5-27.5 kHz, 34-35 kHz, and 92.5-97.5 kHz) did not.  
 
Cell sonoporation studies, such as those conducted by Chen, et al. (2003) and Hallow, et al. 
(2006), have shown that it is the ICD (as opposed to the magnitude of broadband noise 
emission at any instant) that best represents the effective inertial cavitation activity over the 
duration of ultrasound application. Each noise vs. time dataset was integrated over the 
duration of ultrasound application to obtain an ICD value. These ICD values are shown in Fig. 
3-14 for the six different frequency bands. Boxplots were used in Fig. 3-14 to represent the 
variability in each dataset. The crosses within each box denote the mean values, while the 
horizontal lines within each box denote the median values. The horizontal lines at the top and 
bottom of each box represent the upper and lower quartiles, while the whiskers represent 
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the maximum and minimum values. Any data point that exceeded the upper quartile value 
by more than 1.5 times the interquartile range is shown as an outlier (represented by the “+” 
symbol). These outlier values were still considered in the calculation of the mean and median.  
 
The influence of ultrasound intensity on the mean ICD value was dependent on the 
passband. The mean ICD value calculated using the 2.5-7.5 kHz passband increased with 
increasing intensity, regardless of coupling fluid temperature (Fig. 3-14a). The same was true 
for the ICD values calculated using the 22.5-27.5 kHz, 34-35 kHz, and 92.5-97.5 kHz 
passbands. However, ICD values calculated using the 29-31 kHz and 70-90 kHz passbands did 
not always increase with increasing intensity. The influence of the coupling fluid temperature 
on the mean ICD value was also dependent on the passband. The mean ICD values calculated 
using the 2.5-7.5 kHz passband increased with increasing coupling fluid temperature (Fig. 
3-14a), regardless of the ultrasound intensity. The mean ICD values calculated with the five 
other passbands all decreased with increasing temperature, regardless of the ultrasound 




Fig. 3-14 Inertial cavitation dose as a function of temperature and intensity for frequency 
bands of (a) 2.5-7.5 kHz, (b) 22.5-27.5 kHz, (c) 29-31 kHz, (d) 34-35 kHz, (e) 70-90 kHz, and 
(f) 92.5-97.5 kHz (n=7). The influences of intensity and coupling fluid temperature on the ICD 
values were dependent on the passband used. The variability in the ICD datasets was also 





 Transdermal Transport 
Following the 10 minutes of sonoporation during which the PCD data was collected, a 
calcein-buffer solution was applied to the donor side of the skin. This solution was left to 
diffuse for 2 hours at room temperature. After 2 hours, samples were taken from the receiver 
chambers. The concentration of calcein in these samples was quantified using a 
spectrofluorometer.  
 
Regardless of the intensity, the mean receiver calcein concentration was higher following 
sonoporation at 37 °C than it was following sonoporation at 10 °C (the same increase in 
transport with coupling fluid temperature occurred following the control protocol). Due to 
the variability, it is important to consider the p-values along with the mean values when 
comparing these datasets (shown as a function of temperature in Fig. 3-15). The mean 
receiver concentration following the control protocol at 37 °C was 4.4 times that following 
the control protocol at 10 °C (significant at p=0.05). The mean receiver concentration 
following the 8.9 W/cm2 sonoporation protocol at 37 °C was 1.7 times that following the 
8.9 W/cm2 sonoporation protocol at 10 °C (p=0.32). Similarly, the mean receiver 
concentration following the 36 W/cm2 sonoporation protocol at 37 °C was 1.7 times that 





Fig. 3-15 Receiver chamber calcein concentration as a function of coupling fluid 
temperature following (a) control (b) sonoporation at 8.9 W/cm2, and (c) sonoporation at 
36 W/cm2.The crosses within the boxes represent the mean values (n=7). 
 
 Transport-PCD Correlation 
Beyond investigating whether a PCD can be used to monitor inertial cavitation activity 
during skin sonoporation, this study was also used to assess the potential of using PCD output 
to predict post-sonoporation transport. In their cell sonoporation study, Hallow, et al. (2006) 
found a strong  correlation between ICD and cell permeability increase (the permeability 
increased with increasing ICD). This correlation lead them to suggest that PCD output could 
be used to provide real-time feedback about the bioeffects in ultrasound-mediated drug 




If PCD output were to be used as an indicator of the cavitation-induced skin permeability 
increase, there would need to be a clear correlation between ICD and post-sonoporation 
transport. If such a correlation could be established, then the equation describing that 
correlation could enable the likely skin permeability increase to be calculated from the real-
time PCD output. In a clinical setting, this kind of real-time feedback system could be used to 
adjust ultrasound intensity and/or application time, during sonoporation, to ensure that the 
ICD falls within a desired range. Ensuring that the ICD falls within a predetermined range of 
values would increase the likelihood that the permeability enhancement falls within a desired 
range. Therefore, this feedback system could be a valuable tool for increasing the consistency 
and predictability of treatment, especially as inertial cavitation activity is dependent on target 
rigidity (Kodama and Tomita 2000), and skin rigidity changes from person to person (Agache, 
et al. 1980, Owen, et al. 2016, Wolff, et al. 2011). 
 
The first step to establishing a PCD based, real-time transport prediction system is to 
establish a correlation between ICD and the post-sonoporation transport. The correlation 
between the ICD output and the post-sonoporation transport was assessed in the present 
study by plotting the mean receiver calcein concentration against the mean ICD for the 22.5-
27.5 kHz frequency band (Fig. 3-16). No correlation is apparent in Fig. 3-16 (the mean 
concentration did not always increase with increasing ICD). When the temperature of the 
coupling fluid was increased, at either intensity, the mean ICD decreased while the mean 





Fig. 3-16 Inertial cavitation dose and receiver chamber concentration for sonoporation at 
(○) 10 °C and (X) 37 °C. The vertical error bars represent the standard deviation in the 
concentration datasets while the horizontal error bars represent the standard deviation in 
the ICD datasets.  
 
 Foil Pitting 
Foil pitting experiments were used to show that inertial cavitation activity at the skin 
aperture is supressed when carbonated water is used as the coupling fluid. Ultrasound was 
applied to aluminium foil for 15 s at an intensity of 8.9 W/cm2. The coupling fluid was either 
carbonated water at room temperature (19 °C ± 1 °C) or deionised water at room 
temperature. When inertial cavitation was supressed, no pitting was visible on the aluminium 
foil after ultrasound application (Fig. 3-17a). After ultrasound application with deionised 






Fig. 3-17 Pitting of aluminium foil following sonoporation with (a) carbonated water and 
(b) deionised water as the coupling fluid. The transducer was positioned 3 mm from the 
surface of the foil and operated at an intensity of 8.9 W/cm2 for 15 s. 
 
 Detection of Sudden Changes in Cavitation During Sonoporation  
Inertial cavitation activity was supressed during skin sonoporation by adding carbonated 
water to the coupling fluid. The response of the PCD at the time the carbonated water was 
added was then analysed to assess the ability of the PCD to detect sudden changes in 
cavitation activity during sonoporation. Skin was sonoporated for 10 minutes at an intensity 
of 8.9 W/cm2 or 36 W/cm2. During sonoporation, the coupling fluid was maintained at 
(19 °C ± 1 °C) using the circulation system. The coupling fluid initially consisted entirely of 
deionised water. After 200 s of sonoporation at 8.9 W/cm2, 20 mL of room temperature 
carbonated water was added to the donor chamber, displacing an equal amount of deionised 
water. The addition of this carbonated water resulted in a sudden reduction in the broadband 
noise emission (22.5-27.5 kHz) from a moving average value of approximately 1.7 mV to a 
value of approximately 0.7 mV (Fig. 3-18a). After a further 150 s of sonoporation, deionised 
water was slowly poured back into the donor chamber, displacing most of the carbonated 
water that had been added. This caused the moving average of the broadband noise to 
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increase from approximately 0.6 mV to approximately 1.2 mV within 50 s. After 300 s of 
sonoporation at 36 W/cm2 carbonated water was added to the donor chamber. The addition 
of the carbonated water again resulted in a sudden reduction in broadband noise emission, 
this time from a moving average value of approximately 6 mV to a value of approximately 
2 mV. Over the next 150 s the moving average then increased to approximately 4 mV as the 
ultrasound degassed the coupling fluid. More carbonated water was then added to the 
coupling fluid resulting in another sudden decrease in the moving average (to a value of 
approximately 0.5 mV). From these results it can be concluded that the output of the PCD 
always changed significantly at the same time that carbonated water was added or removed 






Fig. 3-18 Broadband noise emission (22.5-27.5 kHz) as a function of time with ultrasound 
intensities of (a) 8.9 W/cm2 and (b) 36 W/cm2. In (a) carbonated water was poured into the 
donor chamber at 200 s and deionised water was poured in at 350 s. In (b) carbonated water 
was poured into the donor chamber at 300 s and 450 s. 
 
 Discussion 
A modified Franz diffusion cell setup allowed a PCD hydrophone to be positioned in the 
coupling fluid during sonoporation. The hydrophone signal was filtered to isolate the 
broadband noise which is indicative of inertial cavitation activity (Yao-Sheng, et al. 2010). The 
broadband noise was then time-integrated to obtain a single ICD value for each sonoporation 
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experiment. These ICD values were plotted as a function of the intensity (8.9 W/cm2 or 
36 W/cm2) and of the coupling fluid temperature (10 °C or 37 °C) (Fig. 3-14).  
 
One of the objectives of this study was to assess the ability of the PCD to monitor the inertial 
cavitation activity occurring in a Franz diffusion cell during sonoporation. When a passband 
of 22.5-27.5 kHz was used, the ICD increased with increasing ultrasound intensity and 
decreased with increasing coupling fluid temperature (Fig. 3-14b). Inertial cavitation activity 
is known to increase with increasing ultrasound intensity (Mitragotri, et al. 2000a, Tang, et al. 
2002a, Terahara, et al. 2002a) and foil pitting experiments presented in Fig. 2-22 and Fig. A-13 
lead to the conclusion that inertial cavitation activity at the skin aperture decreases with 
increasing coupling fluid temperature. Therefore, when a passband of 22.5-27.5 kHz was 
used, there was good agreement between the PCD output and the inertial cavitation activity. 
Even though the hydrophone was not perfectly confocal, this agreement supports the 
conclusion that a PCD hydrophone positioned in the coupling fluid can monitor inertial 
cavitation activity during skin sonoporation. This is the first key finding of this study and an 
important contribution to the field. Such a PCD system would be of great benefit in a clinical 
sonoporation setup as it would enable any changes in inertial cavitation activity to be 
detected and counteracted in real-time.  
 
The ICD values produced using the 34-35 kHz and 92.5-97.5 kHz bands also increased with 
increasing intensity and decreased with increasing coupling fluid temperature (Fig. 3-14d and 
Fig. 3-14f). However, relative to the 22.5-27.5 kHz passband, using either of these bands 
would result in a PCD which was less sensitive to changes in inertial cavitation activity. Here 
the “sensitivity” of the PCD system is defined as the magnitude of the change in ICD value 
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when an experimental input is changed. The greater the sensitivity, the more effective a PCD 
is at responding to changes in inertial cavitation activity. The 34-35 kHz band was less 
sensitive to intensity than the 22.5-27.5 kHz band. When the intensity was increased from 
8.9 W/cm2 to 36 W/cm2 (at a coupling fluid target temperature of 37 °C) the mean ICD value 
for the 34-35 kHz band experienced a 1.7-fold increase, compared to a 3.7-fold increase for 
the 22.5-27.5 kHz band. The relatively low sensitivity to changes in inertial cavitation activity 
with intensity makes the 34-35 kHz band less appropriate than the 22.5-27.5 kHz band. The 
92.5-97.5 kHz band was a less appropriate option than the 22.5-27.5 kHz band for the same 
reason. Another reason for not using the 92.5-97.5 kHz band was that it resulted in more 
variable ICD values in comparison to the 22.5-27.5 kHz band. When the intensity was 
8.9 W/cm2 and the coupling fluid temperature was 37 °C, the relative standard deviation in 
the ICD value for the 92.5-97.5 kHz band was 0.3, compared to 0.1 for the 22.5-27.5 kHz band. 
The differences in sensitivity and variability produced with the 22.5-27.5 kHz, 34-35 kHz, and, 
92.5-97.5 kHz bands highlight the importance of passband selection to the usefulness of a 
PCD.  
 
The importance of passband selection is further illustrated by the undesirable response of 
the PCD when passbands containing harmonics and/or ultraharmonics are used. The 29-
31 kHz band contained the ultraharmonic at 30 kHz. The mean ICD values calculated for this 
band decreased with increasing intensity at coupling fluid temperatures of both 10 °C and 
37 °C. The 70-90 kHz passband contained the 4th harmonic at 80 kHz as well as the 
ultraharmonics at 70 kHz and 90 kHz. Using this band resulted in a decrease in the mean ICD 
with increasing intensity at a coupling fluid temperature of 37 °C (Fig. 3-14f). Inertial 
cavitation activity is known to increase with increasing ultrasound intensity. Therefore, the 
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decreases in ICD with intensity found using the 29-31 kHz and 70-90 kHz passbands reinforce 
the notion that PCD passbands should always exclude harmonics, subharmonics, and 
ultraharmonics (Yao-Sheng, et al. 2010). The 2.5-7.5 kHz frequency band could not be used to 
effectively monitor inertial cavitation activity in the present setup as its magnitude increased 
with increasing coupling fluid temperature (Fig. 3-14a). Even though this band did not include 
the subharmonic at 10 kHz, it may still have been influenced by the emissions from stable 
cavitation which occur at and near this frequency (Bull, et al. 2013), especially the f/4 
subharmonic at 5 kHz (Fig. 3-9).    
 
Along with investigating whether a PCD can be used to monitor inertial cavitation activity 
during skin sonoporation, this study was also used to assess the potential of using PCD output 
as an indicator of the cavitation-induced skin permeability increase, and therefore, as a 
predictor of post-sonoporation transport. Previously, researchers have relied on 
measurements of skin conductivity or mass transport to quantify the effect of sonoporation. 
Neither of these measurements are clinically applicable: a clinical conductivity measurement 
would require the placement of an electrode under the patient’s skin, while a clinical mass 
transport measurement would require a sample of bodily fluid to be taken some time after 
ultrasound treatment. The input Intensity could be used to as a predictor, however, a 
predetermined intensity value cannot account for time-dependent or target dependent 
changes in inertial cavitation activity – PCD output can. If PCD output were to be used as an 
indicator of the cavitation-induced skin permeability increase, there would need to be a clear 
correlation between ICD and post-sonoporation transport. If such a correlation could be 
established, then the equation describing that correlation could enable the likely skin 
permeability increase to be predicted from the real-time PCD output. In a clinical setting, this 
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kind of real-time feedback system could be used to adjust ultrasound intensity and/or 
application time, during sonoporation, to ensure that the ICD falls within a desired range. 
Ensuring that the ICD falls within a predetermined range of values would increase the 
likelihood that the permeability enhancement falls within a desired range – which would 
make skin sonoporation a more predictable and consistent delivery method.  
 
To assess the correlation between PCD output and post-sonoporation transport in the 
present study, the receiver chamber calcein concentration following sonoporation was 
plotted along with the ICD (22.5-27.5 kHz). This is shown in Fig. 3-16. No correlation between 
mean post-sonoporation transport and mean ICD is apparent in Fig. 3-16. An increase in mean 
ICD from 1.0 V-s to 1.7 V-s corresponded with a decrease in mean receiver concentration from 
0.016 mg/L to 0.0092 mg/L. An increase in ICD from 1.7 V-s to 3.8 V-s resulted in an increase 
in mean transport from 0.0092 mg/L to 0.024 mg/L. A further increase in ICD to 5.1 V-s 
resulted in a decrease in mean transport from 0.024 mg/L to 0.014 mg/L. Therefore, in the 
present study, any prediction of post-sonoporation transport based on the ICD value alone 
would be inaccurate. One of the reasons for the poor correlation in Fig. 3-16 is that post-
sonoporation transport is dependent on both inertial cavitation activity and coupling fluid 
temperature. Post-sonoporation transport increases with increasing coupling fluid 
temperature (as shown in Fig. 3-15 and Fig. 2-19), while ICD decreases with increasing 
coupling fluid temperature (Fig. 3-14b), due to the decrease in inertial cavitation activity 
(shown by the foil pitting data in Fig. 2-22 and Fig. A-12). Therefore, any future studies that 
attempt to use PCD output as an indicator of post-sonoporation transport must maintain a 
constant coupling fluid temperature during sonoporation. If the coupling fluid temperature is 
allowed to increase, then the resulting decrease in ICD could be misinterpreted as an 
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indication of decreased post-sonoporation transport. The need to maintain a constant 
coupling fluid temperature when attempting to use ICD as an indicator of post-sonoporation 
transport is the second key finding of this study.  
 
An important potential application for passive cavitation detection in a clinical skin 
sonoporation system would be to detect sudden changes in inertial cavitation activity. Such a 
change could be brought on by a variety of unpredicted system malfunctions (for example, 
failure of the transducer, or degassing or leakage of the coupling fluid). In the present study, 
inertial cavitation activity was supressed during skin sonoporation by adding carbonated 
water to the coupling fluid. The response of the PCD at the time the carbonated water was 
added was then analysed to assess the ability of the PCD to detect sudden changes in the 
inertial cavitation activity during sonoporation. During sonoporation at intensities of both 
8.9 W/cm2 and 36 W/cm2, the broadband noise emission decreased significantly at the times 
carbonated water was added (Fig. 3-18). Due to these significant decreases in broadband 
noise emission, which occurred at the times the inertial cavitation was suppressed, it can be 
concluded that, at both intensities, the PCD detected the sudden changes in inertial cavitation 
activity. Therefore, in a clinical setting, a PCD could be used as a single, real-time tool to detect 
sudden reductions in inertial cavitation activity that could arise from a variety of system 
malfunctions. The results of these carbonated water experiments further reinforce the 
previous conclusion that, even if not perfectly confocal, a PCD hydrophone positioned in the 
coupling fluid can monitor inertial cavitation activity during skin sonoporation.  
 
The variability in the ICD values in the present study were significantly lower than those in 
Appendix A (which reports an earlier attempt to incorporate a PCD in a diffusion cell). The 
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lower variability shows that the hydrophone position used in the present study (7 mm from 
the skin aperture) resulted in superior PCD performance relative to that used in Appendix A 
(20 mm from the skin aperture). Also, the harmonic and ultraharmonic peaks in the frequency 
spectra of the present study are more pronounced than those in Appendix A – another 
indicator that the closer hydrophone position in the present study resulted in a superior PCD 
performance. This should be noted by any future in vitro, in vivo, or clinical skin sonoporation 
studies which attempt to use a PCD to monitor inertial cavitation activity – the hydrophone 
should be as close to the skin aperture as possible. 
 
From the transport data in the present study (Fig. 3-15a) it can be concluded that pre-
treating skin with warm circulating coupling fluid (without ultrasound), prior to drug 
application can increase the resulting transdermal transport. The mean receiver chamber 
calcein concentration following the control protocol at 37 °C was 4.4 times (p=0.05) that 
following the control protocol at 10 °C (Fig. 3-15a). A similar trend was shown in Chapter 2 
(Fig. 2-19f): the mean receiver chamber calcein concentration following the control protocol 
at 33 °C was 1.8 times (p=0.6) that following the control protocol at 13 °C. Although not 
directly related to the purposes of this thesis, these temperature dependent increases are 
interesting as they show that briefly exposing excised skin to fluid above room temperature, 
but below the damaging 40 °C level, can increase permeability, relative to exposure at a low 
temperature (10-13 °C). In vitro studies that investigate the effects of temperature on 
transdermal transport usually apply heat treatment concurrent with drug application 
(Akomeah, et al. 2004, Clarys, et al. 1998, Ogiso, et al. 1998, Ohara, et al. 1995). The author is 
not aware of any studies that have investigated the effects of heat pre-treatment on the 
subsequent transdermal transport. Therefore, the temperature-dependent differences in 
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transport following the control protocols in this study, and Chapter 2, appear to be novel 
results. This finding has an important implication for clinical uses of passive transport systems 
as it indicates that the skin temperature prior to drug application can influence the 
subsequent passive diffusion. Skin temperature during passive diffusion has already been 
shown to increase drug transport. For example, in the study by Vanakoski, et al. (1996), 
human subjects were fitted with nicotine patches before entering a heated sauna bath. While 
in the sauna bath, the blood nicotine concentrations were measured at 15 minute intervals. 
The blood nicotine levels of the subjects in the sauna bath were significantly higher (p<0.01) 
during the time in the sauna than a control group who were not exposed to elevated 
temperatures. Similarly, Frölich, et al. (2001) reported a clinical case in which a patient fitted 
with a Fentanyl transdermal system experienced an overdose due to the simultaneous 
application of an upper-body warming blanket. Increases in skin temperature during passive 
diffusion have been shown to increase transdermal transport in numerous other studies too 
(Ashburn, et al. 2003, Newshan 1998, Prodduturi, et al. 2010, Shahzad, et al. 2015, Shomaker, 
et al. 2000, Tominaga and Tojo 2010). The specific conclusion from this study however, is that 
a higher skin temperature prior to the topical application of a permeant may increase the 
subsequent transport, even if the skin is not at an elevated temperature during diffusion. 
From a clinical perspective, this may mean that a patient who has been exposed to hot 
ambient conditions prior to permeant application will experience more transdermal transport 
than they would if their skin temperature was low prior to permeant application, even if their 
skin temperature is the same during diffusion in both cases. Further investigation is required 
if the full implications of pre-application skin temperature to the performance of passive 





A custom sonoporation setup was designed and manufactured. This setup enabled a PCD 
hydrophone to be positioned in the coupling fluid of a Franz diffusion cell during 
sonoporation. Thesis objective 4 (design and manufacture a skin sonoporation setup that 
enables a PCD hydrophone to be positioned in the coupling fluid during sonoporation) has 
been fulfilled. Measurements of broadband noise emission with the novel setup showed that, 
even if not perfectly confocal, a PCD hydrophone positioned in the coupling fluid can be used 
to monitor the inertial cavitation activity which occurs during sonoporation in a Franz 
diffusion cell. The broadband noise emission was shown to increase with increasing intensity 
(as inertial cavitation does) and decrease with increasing coupling fluid temperature (as 
inertial cavitation was shown to do). The performance of the PCD in the present study was 
strongly dependent on the choice of passband and filter order. The introduction of a custom 
diffusion cell setup that facilitates a PCD capable of monitoring inertial cavitation activity 
during sonoporation is a significant contribution to the field. Thesis objective 5 (assess the 
ability of the PCD setup to monitor inertial cavitation activity during skin sonoporation) has 
been fulfilled.  
 
The PCD was also shown to respond to sudden changes in inertial cavitation activity in the 
coupling fluid (brought on by the addition of carbonated water). The timely response of the 
broadband noise emission magnitude to these changes in inertial cavitation activity means 
that it could be an effective tool in a clinical setting. Any sudden, time-dependent changes in 
the inertial cavitation during sonoporation (from transducer malfunction, or coupling fluid 
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degassing or leakage, for example) could be immediately identified by the PCD system so that 
the problem could be addressed.   
 
A second attempt was made to correlate the ICD values with the post-sonoporation 
transport (the first attempt is reported in Appendix A). This correlation was difficult given the 
variability in the transdermal transport datasets. However, the attempt at this correlation still 
lead to an important finding that will be of use to future studies – the coupling fluid 
temperature must be held constant if ICD is to be used to predict post-sonoporation 
transport. Otherwise a decrease in broadband noise emission, resulting from an increase in 
coupling fluid temperature that actually increases skin permeability, could be misinterpreted 
as an indicator of decreased post-sonoporation transport. This is another reason why future 
sonoporation studies should incorporate some version of the circulating temperature control 
system introduced in this thesis.  
 
From the post-control transdermal transport data of the present study (as well as that from 
Chapter 2), it is reasonable to conclude that the skin temperature prior to the topical 
application of a permeant affects the passive transdermal transport. A higher pre-treatment 
temperature was shown to result in greater transdermal transport, even in the clinically 
relevant range of 10 °C to 37 °C. This could have important clinical implications for passive 
transdermal systems, however, further investigation is required if the full implications of pre-










Prior to the work in Chapters 2 and 3, research was conducted to investigate the influence 
of acoustic reflection on inertial cavitation activity during low-frequency ultrasound exposure 
in a Franz diffusion cell. That investigation (which is described in this chapter) provided the 
initial idea of incorporating coupling fluid temperature control and a PCD into a Franz diffusion 
cell (which then became the key focuses of this thesis).  
 
Two versions of a modified Franz diffusion cell setup were employed in this study. One 
version had acoustic conditions that were similar to a standard Franz diffusion cell surrounded 
by air, while the second was designed to greatly reduce the acoustic reflection by submerging 
the transmissive diffusion cell in a water bath. The temperature of the coupling fluid in both 
setups was controlled using a novel thermoelectric cooling system (an earlier version of the 
cooling system used in Chapters 2 and 3). At an ultrasound intensity of 13.6 W/cm2 the mean 
and median inertial cavitation dose when the acoustic reflections were suppressed were 
found to be 16 % and 13 % lower than when reflections were not suppressed (significant at 
p=0.07). From the differences in ICD it can be concluded that the acoustic reflections, which 
occur in a low-frequency skin sonoporation setup, influence the inertial cavitation activity 
that occurs at the skin aperture. Therefore, for a given set input parameters, the same inertial 
cavitation activity that was obtained in vitro is not guaranteed in an in vivo or clinical scenario, 




In vitro experimental studies that investigate the effects of ultrasound on skin permeability 
employ Franz diffusion cells (Merino, et al. 2003, Mitragotri, et al. 2000a, Smith, et al. 2003, 
Terahara, et al. 2002a, Tezel, et al. 2001). These studies have considered the influences of 
parameters such as frequency (Tezel, et al. 2002), exposure time (Terahara, et al. 2002a), duty 
cycle (Herwadkar, et al. 2012), acoustic intensity (Tezel, et al. 2001), and the distance from 
the transducer to the skin (Terahara, et al. 2002a). However, little attention has been paid to 
the potential influence of acoustic reflection in skin sonoporation studies. This was noted by 
Smith (2007), who stressed the importance of reporting the echoic conditions of the 
transdermal insonation apparatus. 
 
Previous studies of the insonation of cells in cell culture plates have shown that acoustic 
reflection from the walls of the cell culture plates may strongly influence the inertial cavitation 
activity. For example, Kinoshita and Hynynen (2007) found that sonoporation could be 
doubled by facilitating the presence of a standing wave. Similarly, Jelenc, et al. (2012) showed 
that by suppressing the acoustic reflection using an acoustically absorbent lining, the 
maximum reflected pressure (at the cell suspension) was reduced by 81 %. This motivates the 
question that is central to the present study: at ultrasound intensities relevant to skin 
sonoporation, do the acoustic reflections that occur within a Franz diffusion cell significantly 
influence the ICD?  
 
While, to the author’s knowledge, there are no published studies that explicitly investigate 
the influence of reflection in in vitro skin sonoporation setups, some researchers have 
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employed experimental methods intended to suppress these reflections. For example, in their 
high-frequency in vivo study on transdermal transport through rat skin, Park, et al. (2012)  
avoided “strong reflection” by positioning their thermocouple outside of the direct beam of 
their transducer. Mitragotri, et al. (1995b) inserted a 1 mm thick Teflon sheet opposite the 
transducer in a high-frequency horizontal diffusion cell setup in an attempt to reduce multiple 
ultrasound reflections. In their HIFU, in vitro study on transdermal transport through pig skin, 
Helga, et al. (2015) inserted a polyurethane absorber opposite the transducer to avoid 
reflections of the HIFU beam.  
 
The presence of inertial cavitation has previously been shown to be observable with a PCD 
(Farny, et al. 2010, Hallow, et al. 2006, Helga, et al. 2015, Liu, et al. 1998). In a PCD setup, a 
hydrophone, placed directly into the coupling fluid and confocally aligned with the ultrasound 
beam, measures the ultrasound pressure fluctuations that are radiated by the cavitation 
bubbles during ultrasound application. The voltage vs. time data that this hydrophone records 
during ultrasound application is then filtered to isolate the broadband noise. The RMS value 
of the broadband noise is indicative of the magnitude of the inertial cavitation within the 
ultrasound field (Hallow, et al. 2006).  
 
This study introduces a standard diameter Franz diffusion cell in which the transducer and 
the hydrophone were able to be simultaneously positioned in the coupling fluid. This allowed 
the ICD to be calculated from data taken directly from the actual donor cell during insonation. 
The diffusion cell setup also employed temperature control to mitigate the coupling fluid 
temperature increases brought on by continuous ultrasound application. This setup is used 
to investigate whether the acoustic reflections that occur within a Franz diffusion cell 
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significantly influence the ICD, and therefore, inertial cavitation activity at an intensity 
relevant to skin sonoporation. 
 
 Materials and Methods 
 Modified Franz Diffusion Cell 
The modified Franz diffusion cell consisted of a donor chamber that was fixed to a receiver 
chamber with a specially designed acoustically transmissive clamp. The donor chamber had 
an inner diameter of 15 mm, an outer diameter of 19 mm and an aperture diameter of 9 mm 
– dimensions similar to a standard glass Franz diffusion cell (Zorec, et al. 2013). The total 
volume of the donor chamber was 6.7 mL. The receiver chamber also had a 9 mm aperture, 
and a volume of 3.2 mL. The donor, receiver, and clamp geometries are presented in Fig. 4-1. 
Dimensions of the donor chamber are shown in Fig. 4-2.  
 
The donor chamber was 3D printed from VeroClear (VeroClear-RGD810, Stratasys Ltd, 
Minnesota, USA). The receiver chamber was turned from a solid polypropylene rod 
(Polystone, Dotmar EPP Pty Ltd, Christchurch, New Zealand) on a CNC lathe (Top-Turn CNC 
406, Jashico Machine Manufacture Co. LTD, Taichung, Taiwan). A piece of carbon fibre tubing 
with an inner diameter of 3.5 mm (Carbon Fibre Tube Pultruded, MAKERshop, Auckland, New 
Zealand) was glued to the polypropylene receiver with Loctite 401 to form the sampling arm. 
To enable coupling fluid circulation and temperature control, two pieces of carbon fibre 
tubing with inner diameters of 2 mm were glued to the donor chamber to form ports (Carbon 
Fibre Tube Pultruded, MAKERshop, Auckland, New Zealand). The clamp was 3D printed from 




Fig. 4-1 Modified diffusion cell geometry (top) plan view, (middle) front view and (bottom) 
isometric view 
 
Fig. 4-2 Dimensions of the 3D printed VeroClear donor chamber. Dimensions of the 
receiver chamber are shown in Chapter 2. 
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A 16 mm diameter, 0.6 mm thick piece of polypropylene was inserted between the donor 
and receiver chambers. This acted as a skin phantom. Phantoms are often used in ultrasound 
studies as they remove the effects of physiological variations between different tissue 
samples (Helga, et al. 2015, Khokhlova, et al. 2006, Liao, et al. 2016, Maxwell, et al. 2010, 
Rifai, et al. 2010, Zell, et al. 2007). Like skin, polypropylene has a similar acoustic impedance 
to water. Therefore, the phantom provided the solid surface necessary for a-symmetrical 
bubble collapse without diminishing the intensity of the ultrasound waves that were 
transmitted through to the receiver fluid. The surface roughness of a material has been shown 
to influence the cavitation activity that arises when that material is insonated (Nour, et al. 
2007). Therefore, the inertial cavitation activity that arises from the insonation of 
polypropylene may be different from that which arises from the insonation of skin under the 
same ultrasound conditions. However, the focus of this study was to assess the influence of 
the diffusion cell’s acoustic conditions on the ICD. Therefore, the phantom was used as it 
provided a consistent target surface condition for inertial cavitation activity. Two polystyrene 
gaskets (Permagear Inc, Pennsylvania, USA) were placed between the donor and receiver 
chambers on each side of the phantom to prevent leakage.  
 
 Coupling Fluid Temperature Measurement and Control 
The temperature of the coupling fluid was measured with a thermocouple (Wire Type K 
Thermocouple, Jaycar Electronics Pty Ltd, Auckland, New Zealand). The relative position of 
the thermocouple can be seen in Fig. 4-3. The readings from the thermocouple were passed 
to a NI-9211 DAQ module (National Instruments Ltd., Texas, USA) then on to a PC for 
processing in LabVIEW (National Instruments Ltd., Texas, USA). The thermocouple sampling 




Fig. 4-3 Cross section of the diffusion cell revealing the positioning of the transducer, 
thermocouple and hydrophone 
 
A constant coupling fluid temperature was maintained by circulating the fluid out of the 
donor chamber, through a custom built temperature controller and back into the donor 
chamber at a flow rate of 0.14 L/min. This circuit is depicted in Fig. 4-4. A peristaltic pump 
(6 V Peristaltic Pump, Amazon, Washington, USA) was used to achieve this flow rate. The 
components in the cooling circuit were linked by 2.6 mm inner diameter silicone tubing 
(Silicone Tubing Clear Grade, Rubbermark Industries Ltd., Auckland, New Zealand). This tubing 
could be easily removed from the donor chamber ports to allow for replacement of fluid 





Fig. 4-4 System schematic. The solid lines represent the coupling fluid circuit. The dashed 
lines represent the signal inputs and outputs to and from the instruments in the coupling 
fluid. 
 
The temperature controller consisted of six 12 V thermoelectric Peltier plates (Peltier 60 W, 
TecParts NZ Ltd., Tauranga, New Zealand) arranged around a block of aluminium (Fig. 4-5). 
The coupling fluid was cooled as it passed through a series of connected holes drilled in the 
aluminium block. The cooling rate was controlled by the power supply to the Peltier plates. 
The hot sides of the Peltier plates were connected to water cooled fins (Fig. 4-6). These fins 
were constructed from square cross-sectioned aluminium tubing that had a side length of 
40 mm, a thickness of 3 mm, and an overall length of 300 mm. A thermally conductive paste 
(Heatsink Compound, Jaycar Electronics Pty Ltd, Auckland, New Zealand) was applied to both 
sides of each Peltier plate to ensure effective heat transfer. The coupling fluid temperature 
was maintained at 15 °C ± 1 °C. Researchers who intend to employ this temperature control 
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system in future studies should note that the Peltier plates can be sufficiently air-cooled 
(allowing a more compact setup) if the ultrasound intensity is below a certain threshold.    
 
Fig. 4-5 Schematic of heat exchanger block. Sections of silicone tubing diverted the 
coupling fluid from one hole in the aluminium block to the next. Three Peltier plates were 
attached to each side of this block.  
 
Fig. 4-6 Schematic of the temperature controller showing (a) the assembled components 
and (b) an exploded view of the components. The hot side of the Peltier plates are shown in 
red while the cold sides are shown in blue. Cool water was pumped through the hollow fins. 
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 Ultrasound Field Generation 
A 20 kHz ultrasound field was generated using an ultrasonic processor (VC 505, Sonics and 
Materials Inc., Connecticut, USA) with a 13 mm diameter replaceable tip. All of the 
experiments in this study used continuous ultrasound (a 100 % duty cycle). Following the 
manufacturer’s instruction, compressed air was circulated through the ultrasonic processor 
to keep it cool during ultrasound application. Terahara, et al. (2002a) showed that the 
effectiveness of low-frequency skin sonoporation increases with decreasing distance 
between the transducer face and the target region. A distance of 5 mm was used for the 
experiments in the present study as this was the smallest distance that still allowed for the 
hydrophone to be confocal with the transducer. 
 









   (3.1) 
 
where D  is the diameter of the active face of the transducer (13mm) and   is the 
wavelength (73 mm), calculated with the speed of sound in water (at 15 °C) of 1466 m/s. For 
these parameters, the value of L  was calculated to be 0.58 mm. Therefore, at the distance 
of 5 mm, the skin phantom was well outside the near-field, which is common practice in low-




 Determination of Ultrasound Intensity 
The ultrasound intensity was determined using the calorimetric method (Merino, et al. 
2003, Mitragotri, et al. 2000a, Mitragotri, et al. 2000b, Morimoto, et al. 2005, Mutoh, et al. 
2003, Terahara, et al. 2002a). An intensity of 13.7 W/cm2, which was achieved with a tip 
displacement setting of 20 % on the VC 505 ultrasonic processor, was used for all experiments 
in this study. This was a spatial average, temporal average intensity as in the study by 
(Mitragotri, et al. 2000a). This intensity level was chosen as both Terahara, et al. (2002a) and 
Mitragotri, et al. (2000a) achieved considerable skin conductivity increases with intensities 
between 5 and 15 W/m2 when using the same diameter transducer tip that was used in this 
study. 
 
 Foil Pitting Experiments 
Foil pitting experiments were used to investigate the influence of coupling fluid circulation 
on the inertial cavitation activity at the skin aperture in the present setup. Seven pieces of 
0.016 mm thick aluminium foil (Homebrand, Manukau, New Zealand) were exposed to 
ultrasound (at an intensity of 13.7 W/cm2) for 5 s with or without coupling fluid circulation. 
The number of pits in each of the 14 pieces of foil were then counted to quantify the influence 
of circulation. In these experiments, the coupling fluid in the donor chamber was deionized 
water at 15 °C ± 1 °C. This temperature was achieved using the circulation system.  
 
The length of time that a piece of foil is submerged in water prior to ultrasound application 
can affect the prevalence of air bubbles (nucleation sites) on the surface of the foil. Prior to 
each ultrasound application, the foil was submerged in the coupling fluid while the circulation 
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system brought the coupling fluid to the specified temperature. The time required to achieve 
this temperature was consistent across each foil pitting dataset. Therefore, the effect of the 
submergence, on the prevalence of nucleation sites on the foil surface, was also consistent. 
 
When counting the foil pits, any circular indent was counted as one pit. Two partially 
overlapping circular indents were counted as two pits. The duration of ultrasound exposure 
was short enough to avoid complete perforation of the foil, which would have made it 
impossible to quantify the number of individual pits.  
 
 Passive Cavitation Detector Alignment 
The acoustic measurements were taken with a 2 mm needle hydrophone (2.0 mm Needle 
Hydrophone, Precision Acoustics Ltd, Dorchester, Dorset, UK), which had a sensitivity 
of -236.4 dBre1V/μPa at the transducer driving frequency of 20 kHz. Note that the full list of 
calibrated sensitivity values, measured by Neptune Sonar Ltd (East Yorkshire, UK), for 
frequencies between 5 kHz and 1000 kHz are shown in Appendix C.  The manufacturer coated 
the tip of this hydrophone in silicone to reduce the potential of cavitation damage. A depiction 
of the relative position of the hydrophone in the diffusion cell is presented in Fig. 4-3. The 
hydrophone was pointed directly at the centre of the skin phantom so that it was confocal 
with the transducer. The tip of the hydrophone was 20 mm from the centre of the skin 
phantom further ensuring that the hydrophone tip was not damaged by cavitation. Note that 
the hydrophone was held in its fixed position using an aluminium sleeve (Fig. 4-7) that was 
fixed in place relative to the diffusion cell. In this way the hydrophone could be easily inserted 
and removed between experiments. Before each experiment, the hydrophone alignment was 
checked (with the transducer in place) by ensuring that a mark on the centre of the skin 
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phantom was visible when looking through the centre of the empty sleeve. Note that the 
support structure for the hydrophone, transducer, and diffusion cell used in this study was 
similar to that depicted in Section A.2.7.   
 
 
Fig. 4-7 Cross section of the hydrophone sleeve revealing the direction of hydrophone 
movement during removal and re-insertion. 
 
The voltage signal measured by the hydrophone was recorded with an oscilloscope (TDS 
2014B, Tektronix, Beaverton, OR, USA) connected via USB to a PC running SignalExpress (NI 
LabVIEW SignalExpress, National Instruments, Texas, USA). The oscilloscope collected 2500 
data points at a sampling rate of 1 MHz and then transferred these to the PC. The oscilloscope 
then collected another 2500 data points after a delay of around 1 to 2 s. This continued for 
the 10 minute duration of insonation.  
 
 Determination of Inertial Cavitation Dose Using Broadband Noise Emission 
Each set of 2500 data points was filtered so that the broadband noise (indicative of inertial 
cavitation) could be isolated from the harmonic and sub-harmonic peaks in the frequency 
spectrum. A digital bandpass filter isolated a band of noise between 92.5 and 97.5 kHz. When 
choosing the frequency range of this band, three factors were considered: that no harmonics 
or sub-harmonics should be included in the chosen filter band, as these are influenced by non-
inertial cavitation (Yao-Sheng, et al. 2010); that the frequency band should be low enough to 
allow for a minimum of 10 data points per period to be sampled by the oscilloscope (to ensure 
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that the hydrophone signal was accurately represented); and that the variability in the 
broadband noise emission during ultrasound application should be as low as possible as no 
significant time-dependent variations are expected under the strictly controlled experimental 
conditions. 
 
The infinite impulse response bandpass filter was produced using MATLAB’s ‘designfilt’ 
function (MATLAB, MathWorks, Natick, MA, USA). A filter order of 20 was used as this was 
found to be the minimum order capable of providing the necessary reduction of the 5th 
harmonic at 100 kHz and the ultraharmonic at 90 kHz.  
 
Once each set of the 2500 data points had been filtered, the RMS value was calculated for 
the 2.5 ms time period associated with those data points. This RMS value then represented 
one noise amplitude data point. The ICD was calculated by numerically integrating the noise 
amplitude over the 10 minutes of ultrasound application in each experiment. Therefore, the 
ICD had units of V-s as in the cell sonoporation studies by Chen, et al. (2003) and Hallow, et 
al. (2006). This numerical integration was evaluated using the MATLAB ‘trapz’ function.  
 
 Acoustic Reflection Experiments 
Two sets of experiments were devised to investigate the influence of acoustic reflections 
on ICD. In one set of experiments, the diffusion cell was surrounded by air to replicate the 
echoic conditions within a traditional Franz diffusion cell. In the second set of experiments, 
acoustic reflection was greatly reduced by submerging the acoustically transmissive diffusion 
cell in a water bath so that the water line was 5 mm below the top of the donor chamber (Fig. 
4-8). The water bath was 794 mm long, 396 mm wide, and 362 mm high. The walls of the 
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water bath were made from 12 mm thick acrylic sheets. To further reduce reflection, the 
interior walls of one half of the water bath (the half containing the diffusion cell) were lined 
with acoustically absorbent panels (SA-J35, Hangzhou Applied Acoustic Institute, Hangzhou, 
Zhejiang, China). These panels have been shown to decrease low-frequency ultrasound 
reflection by 20 dB (Jelenc, et al. 2012). The panels were 300 mm wide, 300 mm long, and had 
a thickness that varied from 10 mm to 35 mm due to their wedged front surface. The unlined 
half of the water bath was used for the coupling fluid temperature control system. 
 
 
Fig. 4-8 Section view of the diffusion cell in the water bath, which was lined with 
acoustically absorbent SA-J35pads.The overall height of the diffusion cell is shown along with 
the waterline, which was 5 mm below the top of the donor chamber. 
 
The proportion of ultrasound that was reflected ( R ) at the interface of the diffusion cell 

















where Z1 is the acoustic impedance of the material that the acoustic wave is propagating from 
(the coupling fluid) and Z2 is the acoustic impedance of the material the acoustic wave is 
propagating into (the surrounding medium). Given the acoustic impedance values for 
polypropylene (2.4 MRayl), water (1.5 MRayl), and air (400 Rayl), the R values are calculated 
as 0.99 for the setup surrounded by air and 0.05 for the setup submerged in water (note that 
the acoustic impedance of the 3D printed VeroClear donor chamber was approximated to be 
equal to that of polypropylene). These values indicate that the proportion of ultrasound that 
was reflected back into the coupling fluid was approximately 20 times greater for the cell 
surrounded by air. 
 
Seven repetitions of the experiments were conducted for each of the two setups (n=7). Each 
experiment consisted of 10 minutes of ultrasound exposure. This application time was chosen 
to reflect those of published low-frequency skin sonoporation studies (Sarheed and Abdul 
Rasool 2011, Terahara, et al. 2002a, Tezel, et al. 2001). The coupling fluid (deionised water) 
was replaced between each experimental repetition. Deionised water was taken from a 
Labwater L991008 Deioniser (Suez Ltd, Thame, UK). The same phantom was used in each 
experimental repetition as no cavitation damage was observed on its surface.  
 
 Results 
 Coupling Fluid Temperature 
Under certain conditions, the application of ultrasound in a diffusion cell has been shown 
to result in an increase in coupling fluid temperature due to absorption (Ahmadi, et al. 2012, 
141 
 
O’Brien Jr 2007): the fluid medium absorbs a portion of the ultrasound energy, converting it 
into heat. A constant coupling fluid temperature was maintained by circulating the fluid 
through a thermoelectric cooling device during the application of ultrasound at an intensity 
of 13.7 W/cm2. The effectiveness of the cooling device was apparent when the coupling fluid 
temperature without circulation was compared to the coupling fluid temperature with 
circulation over 10 minutes of insonation (Fig. 4-9). In the absence of temperature control, 
the coupling fluid temperature increased to 50 °C within 110 s. With circulation, the 
temperature was able to be maintained at 15 °C ± 1 °C. 
 
 
Fig. 4-9 Transient behaviour of the coupling fluid temperature with and without coupling 
fluid circulation during ultrasound application at an intensity of 13.7 W/cm2. 
 
 Foil Pitting Experiments 
Foil pitting experiments were used to investigate the influence of coupling fluid circulation 
on the inertial cavitation activity at the skin aperture in the present setup. Seven pieces of 
aluminium foil were exposed to ultrasound (at an intensity of 13.7 W/cm2 and a transducer 
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distance of 5 mm) for 5 s with and without coupling fluid circulation. The coupling fluid 
temperature was 15 °C ± 1 °C. Without coupling fluid circulation, the mean number of pits 
after ultrasound application was 13 and the median was 12 (Fig. 4-10). With coupling fluid 
circulation, the mean number of pits was 12 and the median was 11. Therefore, circulation 
caused a 4 % decrease in the mean number of pits (p=0.9) and an 8 % increase in the median. 
Given the p-value, the difference between the two datasets is negligible.  
 
 
Fig. 4-10 The influence of coupling fluid circulation on the pitting of aluminium foil. 
Ultrasound was applied for 5 s at an intensity 13.7 W/cm2. The transducer to skin distance 
was 5 mm. The crosses within the boxes represent the mean values (n=7). 
 
 Passive Cavitation Detection 
The amplitude of the broadband noise has been reported to be an effective indicator of the 
presence of inertial cavitation in insonation setups (Farny, et al. 2010, Hallow, et al. 2006, 
Helga, et al. 2015, Liu, et al. 1998). To demonstrate the relationship between inertial 
cavitation and broadband noise in the current setup, the standard configuration (with air as 
the surrounding medium) was used to capture the PCD frequency spectra under three 
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different insonation conditions. First, the frequency spectrum in the absence of any applied 
ultrasound (0 W/cm2) was captured to quantify the noise floor (Fig. 4-11a). The noise floor in 
the frequency band of interest (92.5 to 97.5 kHz) had a magnitude of around -250 dB (relative 
to 1V). Next, two frequency spectra resulting from insonation at 13.7 W/m2 were captured. 
For one of these, the coupling fluid was deionised water, while for the other, the coupling 
fluid was castor oil. Castor oil has a similar acoustic impedance to water (1.4 MRayl for castor 
oil and 1.54 MRayl for water) but a much higher viscosity (0.65 Pa s for castor oil and 
0.00089 Pa s for water) (Polat, et al. 2011b). Therefore castor oil subdues inertial cavitation 
activity (Tang, et al. 2002a) without removing the harmonic and sub-harmonic peaks in the 
frequency spectrum. With this in mind, frequency spectra corresponding to insonation 
without inertial cavitation suppression and insonation with inertial cavitation suppression are 
presented in Fig. 4-11b and Fig. 4-11c respectively. When inertial cavitation was not 
suppressed, the broadband noise emission magnitude in the frequency band of interest was 
around -160 dB, far greater than the noise floor of -250 dB. When inertial cavitation was 
suppressed using castor oil as the coupling fluid, the broadband noise emission magnitude 
was approximately -220 dB. Although this magnitude is still somewhat higher than the noise 
floor, it is significantly lower than the deionised water case. It is then reasonable to conclude 
that broadband noise emission, within this frequency range, did represent the inertial 





Fig. 4-11 Passive cavitation detector frequency spectra in (a) the absence of ultrasound, (b) 
the presence of ultrasound with deionised water as the coupling fluid and (c) the presence of 
ultrasound with castor oil as the coupling fluid. 
 
The 92.5-97.5 kHz passband was used for the PCD in this study as it resulted in relatively 
consistent broadband noise emission over the 10 minutes of ultrasound application. 
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Examples of broadband noise emission are shown in Fig. 4-12 for passbands of 2.5-7.5 kHz, 
22.5-27.5 kHz, 32.5-37.5 kHz, and 92.5-97.5 kHz. There is no reason to suspect that the 
inertial cavitation activity varied dramatically during the 10 minutes of ultrasound application 
under the strictly controlled experimental conditions. Therefore, the temporal variations 
which sometimes occured in the 2.5-7.5 kHz, 22.5-27.5 kHz, 32.5-37.5 kHz passbands made 
those passbands inappropriate for use in the present study. These temporal variations were 
likely a result of fluctuations in nearby harmonic, subharmonic, or ultraharmonic peaks.  
 
 
Fig. 4-12 Examples of broadband noise data for four different frequency bands (a) 2.5-
7.5 kHz, (b) 22.5-27.5 kHz, (c) 32.5-37.5 kHz, and (d)92.5-97.5 kHz. The solid line is a moving 
average intended to aid interpretation of the data. The moving average value was calculated 




Both temperature and broadband noise emission (92.5-97.5 kHz) were monitored over 10 
minutes of ultrasound application in a diffusion cell surrounded by air and in a diffusion cell 
submerged in water. The broadband noise data for one of the seven repetitions that was 
collected when the cell was surrounded by air is presented in Fig. 4-13a. The broadband noise 
data for one of the seven repetitions that was collected when the cell was submerged in water 
is presented in Fig. 4-13b.  Transient temperature data is not shown here, but the coupling 
fluid temperature was always maintained at 15 °C ± 1 °C. 
 
 
Fig. 4-13 Examples of the broadband noise data captured over 10 min of continuous 
ultrasound application at an intensity of 13.7 W/cm2 with the coupling fluid maintained at 
15 1 °C in (a) a diffusion cell surrounded by air and (b) a diffusion cell submerged in water. 
The dashed lines at the very bottom depict the baseline noise level. 
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In the study by Bull, et al. (2013), a simple method was used to determine whether 
broadband noise emission exceeded a threshold level representative of statistically significant 
inertial cavitation activity. The ‘100 % occurrence threshold’ methodology dictates that all 
filtered broadband noise readings must be above a minimum baseline level in order for the 
inertial cavitation threshold to be surpassed. This baseline noise level, BLN , was determined 
from the relation,  
 
 4BLN      (3.3) 
 
where   is the mean value of the noise floor and   is the standard deviation of the noise 
floor. The baseline noise level for the present setup is depicted by the dashed lines at the 
bottom of Fig. 4-13a and Fig. 4-13b. All of the broadband noise emission data in Fig. 4-13a 
and Fig. 4-13b was well above this threshold. Therefore, the level of the broadband noise 
observed during each of the seven repetitions in each of the two diffusion cells was due to 
inertial cavitation activity as opposed to other potential sources of noise such as 
electromagnetic interference. 
 
 The Influence of Acoustic Reflection 
The broadband noise emission data was converted to an ICD value for each of the seven 
repetitions conducted in each of the two diffusion cell setups. Fig. 4-14 displays boxplots of 
the ICD data. The central horizontal line in each of the boxes represents the median value, 
the cross represents the mean value, the top and bottom horizontal line of each box 
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represents the upper and lower quartiles, and the whiskers represent the maximum and 
minimum values in each set. 
 
 
Fig. 4-14 Inertial cavitation dose calculated for the diffusion cell setup surrounded by air 
and the diffusion cell setup submerged in water (n 7). Ultrasound was applied at an 
intensity of 13.7 W/cm2 continuously for 10 min. The coupling fluid was maintained at 
151 °C. 
 
There was a difference between the median and mean dose values for the two setups. 
When the surrounding medium was air, the median and mean values were 1590 mV-s and 
1709 mV-s respectively. When the surrounding medium was water, the median and mean 
values were 1385 mV-s and 1433 mV-s respectively. Therefore, the suppression of acoustic 
reflection resulted in a 13 % decrease in the median ICD and a 16 % decrease in the mean ICD 
(significant at p=0.07). 
 
There was also a difference in the degree of variability for the two cases. When the 
surrounding medium was air, the standard deviation was 255 mV-s. When the surrounding 
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medium was water, the standard deviation was 149 mV-s. This difference in variability was 
anticipated because an increase in the mean ICD has been reported to result in an increase in 
standard deviation (Chen, et al. 2003). Note that three other temporally stable frequency 
bands investigated (62.5-67.5 kHz, 72.5-77.5 kHz, and 82.5-87.5 kHz) also showed decreases 
in mean ICD, between 8 % and 18 % (0.05<p<0.26) with the suppression of reflection.  
 
 Discussion  
At an ultrasound intensity of 13.6 W/cm2, the ICD was influenced by the acoustic reflections 
in the diffusion cell setup. It can then be concluded that the inertial cavitation which occurs 
in a sonoporation setup is influenced by the echoic conditions of that setup. Therefore, 
differences in echoic conditions should be considered when translating the results of in vitro 
studies (conducted in highly reflective Franz diffusion cells) to in vivo or clinical setups that 
have vastly different degrees of acoustic reflection. For a given set of experimental 
parameters, the same inertial cavitation activity that which was obtained in vitro is not 
guaranteed in an in vivo or clinical scenario, due to the differences in acoustic reflection within 
the setups. However, it is unclear from the results in Fig. 4-14 whether the acoustic reflections 
within a diffusion cell would influence the transport results of an in vitro skin sonoporation 
study by a statistically significant amount, especially considering the relatively small 
difference in mean ICD and the high degree of variability in most sonoporation studies 
(Mitragotri, et al. 2000a, Schoellhammer, et al. 2012, Terahara, et al. 2002a, Tezel, et al. 
2001), as in Fig. 2-18, Fig. 3-15, Fig. A-22, and Fig. B-10 of this thesis. Future in vitro studies 
that want to supresses reflection, as was attempted in the studies which inserted a thin 
polymer absorber at the bottom of the receiver chamber (Alvarez‐Román, et al. 2003, Merino, 
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et al. 2003, Mitragotri, et al. 1995b), should use the setup introduced in the present study. 
The acoustically transmissive polymer components allow the vast majority of the ultrasound 
energy (~95 %) to pass through the diffusion cell into the acoustically lined water bath. Using 
the present setup would ensure that the ultrasound field was far closer to an in vivo or clinical 
case than that achieved with any glass setup.   
 
The present study was in part motivated by the results of cell sonoporation studies which 
found that acoustic reflections can have a strong influence on inertial cavitation activity. An 
experiment was conducted to investigate whether acoustic reflections in experimental 
conditions associated with skin sonoporation would also influence inertial cavitation. The 
influence of acoustic reflections found in the present study was minor in comparison to that 
found in a study which investigated the influence of acoustic reflections in a cell sonoporation 
setup. Kinoshita and Hynynen (2007) found that cell sonoporation was halved when acoustic 
reflections were suppressed. One explanation for the much smaller influence of reflection in 
the present study compared to the cell sonoporation study may be related to the different 
setup geometries used in the experiments. The setup geometry affects the intensity of the 
reflected ultrasound waves in the target region, due to the distance that the reflected waves 
must travel before returning to the target region from the point of reflection. The target 
region in the setup of Kinoshita and Hynynen (2007) was the cell culture plate, while the target 
region in the present setup was the coupling fluid near the surface of the phantom. The main 
acoustically reflective interface in the cell culture plate was the top of the cell culture plate 
(which was within the target region), whereas the main acoustically reflective interface in the 
Franz diffusion cell was the bottom of the receiver chamber which was outside the target 
region (by approximately 40 mm in this case). As the reflected wave fronts had to travel a 
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shorter distance in the study by Kinoshita and Hynynen (2007) than they did in the present 
study, they caused a greater amount of acoustic interference, and therefore, lead to a greater 
increase in the peak rarefactional pressure in the target region.  
 
The PCD passband that was used in Chapter 3 (22.5-27.5 kHz) was found to be inappropriate 
for the setup in the present study. The broadband noise emission found with the 22.5-
27.5 kHz passband sometimes varied significantly during the 10 minutes of ultrasound 
application (Fig. 4-12c). Similar temporal variations were found in the broadband noise 
emission using passbands of 2.5-7.5 kHz and 32.5-37.5 kHz. The passband that displayed the 
least amount of temporal variation was 92.5-97.5 kHz, which is why it was used for the 
present study. The differences in temporal variations in broadband noise emission for 
different passbands again lead to the conclusion that, instead of just arbitrarily selecting a 
passband, care should be taken to select a PCD passband that is appropriate for a specific 
ultrasound setup (a point previously discussed in Section 3.5). The importance of tailoring the 
PCD passband to the setup highlights an advantage of using a digital filter instead of the 
analog filtering setups that are often used in PCD systems (Farny, et al. 2010, Helga, et al. 
2015, Hockham, et al. 2010, Tang, et al. 2002a, Tezel, et al. 2002). In the present study, the 
voltage data from the hydrophone was saved before filtering. This enabled the broadband 
noise emission from a number of passbands to be analysed, from one set of voltage data, so 
that the most appropriate band for this specific setup could be selected. 
 
In the present setup, the pitting of aluminium foil was negligibly affected by circulation of 
the coupling fluid. From this result it concluded that the inertial cavitation at the skin aperture 
was unaffected by circulation. This finding is beneficial for any researcher who wishes to use 
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a small diameter Franz diffusion cell with temperature control (as opposed to the large 
diameter setups used in Chapters 2 and 3, and Appendices A and B). If the present small 
diameter setup were to be used to control coupling fluid temperature during sonoporation, 
the circulation would not affect the inertial cavitation activity which impacted the skin.     
 
The present study contains the first known use of the 3D printed material VeroClear in a 
sonoporation or sonophoresis setup. No cavitation damage was observed on any of the 
VeroClear donor chamber’s surfaces at the end of this study (which involved more than 
2.5 hours of ultrasound application at an intensity shown to cause significant pitting in 
aluminium foil). The ability of this translucent material to withstand inertial cavitation damage 
demonstrates that it can be used as an alternative to glass in future studies. The rapid 
manufacturing process also enables more complex custom geometries than are possible with 
glass. The high cost of the material was the only reason it was not used in place of 
Polypropylene in the experiments reported in Chapters 2, 3, Appendix A, and Appendix B. 
 
 Conclusions 
A modified Franz diffusion cell setup with variable echoic properties was developed. The 
reflectivity of one version of this setup was approximately 20 times greater than that of a 
second version that supressed reflection. Thesis objective 6 (design and manufacture a Franz 
diffusion cell setup with variable echoic properties) has been fulfilled.  
 
A PCD hydrophone was positioned confocally with the transducer during ultrasound 
application. A coupling fluid circulation and cooling system enabled the continuous 
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application of ultrasound (at an intensity relevant to skin sonoporation) for a period of 10 
minutes without any notable increase in the temperature of the coupling fluid. The confocal 
hydrophone position allowed for PCD data to be captured during the application of 
ultrasound. This enabled ICD to be employed as a means for quantifying inertial cavitation 
behaviour. This setup was used to investigate the effect of acoustic reflection on the ICD 
during low-frequency insonation at an intensity applicable to skin sonoporation (13.6 W/cm2). 
When acoustic reflection was suppressed, the median and mean ICD were 13 % and 16 % 
lower respectively than when the reflection was not supressed (significant at p=0.07). These 
results show that, at an intensity of 13.6 W/cm2, a frequency of 20 kHz, and a transducer 
distance of 5 mm, the acoustic reflections within a low-frequency Franz diffusion cell skin 
sonoporation setup can influence inertial cavitation during ultrasound application. Therefore, 
differences in echoic conditions should be considered when translating the results of in vitro 
studies (conducted in highly reflective Franz diffusion cells) to in vivo or clinical setups that 
have vastly different echoic properties. For a given set input parameters, the same inertial 
cavitation activity that was obtained in vitro is not guaranteed in an in vivo or clinical scenario, 
due to differences in echoic conditions. Thesis objective 7 (investigate the influence of 
acoustic reflection on inertial cavitation activity during ultrasound application in a Franz 
diffusion cell) has been fulfilled.  
 
The present study represents an initial inquiry into the influence of acoustic reflections in 
skin sonoporation setups. While the intensity and frequency used in this study are applicable 
to skin sonoporation (Mitragotri, et al. 2000a, Terahara, et al. 2002a), further investigation of 
the influence of acoustic reflections in Franz diffusion cells should consider a range of 
frequencies, intensities and target materials if a complete understanding of the underlying 
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physics is to be obtained. The novel transmissive (low reflection) diffusion cell setup 
introduced in this study provides an important basis for the methodologies and setups 
required for these further investigations, and is therefore in itself an important contribution 












This section contains a summation of the conclusions from Chapters 2, 3, and 4 as they 
pertain to thesis objectives 1-7.  
 
1) Design and manufacture a system which enables the coupling fluid to be set and 
maintained at a variety of temperatures during skin sonoporation. 
 
In Chapter 2.4.1, a modified Franz diffusion cell along with a circulating temperature 
regulation system successfully maintained the coupling fluid temperature at either (13 °C, 
33 °C, or 46 °C) during the sonoporation of porcine skin. Foil pitting experiments showed that 
this temperature regulation system had a negligible effect on the inertial cavitation at the skin 
aperture. Thesis objective 1 has been fulfilled. The ability to maintain a constant coupling 
fluid temperature during sonoporation removes the need for time consuming duty cycles or 
tedious periodic replacement of the coupling fluid. Therefore, the coupling fluid temperature 
control system used in this study represents a significant contribution to the field. In an 
experimental setting, use of the present temperature control system would reduce the time 
required to run each experiment and the labour required by the researcher. In a clinical 
setting, use of the present temperature control system could reduce the required patient 
contact time 10-fold relative to an application protocol that required a 10 % duty cycle to 
minimise thermal effects. Therefore this system enables far more clinically practical 
sonoporation protocols than could have previously been achieved.  This system could easily 
be adopted by other skin sonoporation or sonophoresis researchers.   
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2) Investigate the influence of coupling fluid temperature on the inertial cavitation 
activity that occurs in a low-frequency Franz diffusion cell setup. 
 
In foil pitting experiments, reported in Chapter 2.3.10, increasing the coupling fluid 
temperature decreased the number of pits. For an intensity of 55 W/cm2 and a transducer 
distance of 3 mm, an increase in coupling fluid temperature from 10 °C to 40 °C corresponded 
to a 50 % decrease in the number of pits (p<0.05) after 1 s of ultrasound application. For an 
intensity of  13 W/cm2 and a transducer distance of 3 mm, an increase in coupling fluid 
temperature from 10 °C to 40 °C corresponded to a 38 % decrease in the number of pits 
(p<0.05). Additional foil pitting experiments (shown in Fig. A-13) were conducted with an 
ultrasound intensity of 34 W/cm2 and a transducer distance of 5 mm. An increase in coupling 
fluid temperature from 10 °C to 25 °C resulted in a 57 % decrease in the mean number of pits 
(p<0.05), while an increase from 25 °C to 40 °C resulted in a further 65 % decrease (p<0.05) 
after 5 s of ultrasound application. From these decreases in pitting it can be concluded that 
increasing the coupling fluid temperature results in a decrease in the inertial cavitation 
activity that impacts the skin in a Franz diffusion cell. This agrees with the assertion made in 
the HIFU study by Hockham, et al. (2010) which attributed decreasing inertial cavitation 
activity to an increase in vapour pressure with increasing coupling fluid temperature. Thesis 
objective 2 has been fulfilled.  
 





Transdermal transport experiments, reported in Chapter 2.4.2, showed that increasing the 
temperature at which the coupling fluid was maintained during sonoporation increased the 
post-sonoporation transport of calcein. Following 5 hours of diffusion, the median receiver 
chamber calcein concentration after sonoporation at a coupling fluid temperature of 46 °C 
was 2.3 times the concentration achieved after sonoporation at 33 °C (p=0.07), which was 2.2 
times the concentration achieved after sonoporation at 13 °C (p=0.7). Past studies have used 
duty cycles and fluid replacement to keep the coupling fluid below 37-40 °C during 
sonoporation. However, the results of this study show that temperature dependent increases 
in post-sonoporation transport can occur above and below 37-40 °C.  
 
In the transdermal transport experiments in Chapter 3.4.3 the post-sonoporation transport 
also increased with increasing coupling fluid temperature, in the range of 10 °C to 37 °C. This 
reinforces the transport-temperature relationship found in Chapter 2.4.2. Thesis objective 3 
has been fulfilled. 
 
Two findings from objective 3 have important implications for any future in vivo or clinical 
sonoporation studies that adopt the circulating coupling fluid temperature control method. 
For a given set of experimental parameters (intensity, application time etc.), a higher coupling 
fluid temperature during sonoporation results in more post-sonoporation transport. 
However, a lower coupling fluid temperature during sonoporation results in a smaller 
increase in the temperature of the tissue underlying the SC. Given these two findings, future 
in vivo or clinical sonoporation studies that incorporate coupling fluid temperature control 
will need to carefully select their target coupling fluid temperature so as to find a balance 
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between transport (which is greatest at high temperature) and safety (which is greatest at 
low temperature).  
 
4) Design and manufacture a skin sonoporation setup that enables a PCD hydrophone to 
be positioned in the coupling fluid during sonoporation. 
 
A modified Franz diffusion cell setup was designed and manufactured. This setup enabled 
a PCD hydrophone to be positioned in the coupling fluid in a repeatable manner during 
sonoporation. The custom hydrophone and diffusion cell support structures allowed for the 
easy removal and reinsertion of multiple diffusion cells. Thesis objective 4 has been fulfilled.  
 
5) Assess the ability of the PCD setup from 4) to monitor inertial cavitation activity during 
skin sonoporation. Also assess the potential for using the PCD output as a real-time 
indicator of the post-sonoporation transport. 
 
From measurements of broadband noise emission (Chapter 3.4.2) it can be concluded that, 
even if not perfectly confocal, a PCD hydrophone positioned in the coupling fluid can be used 
to monitor the inertial cavitation activity which occurs during sonoporation in a Franz 
diffusion cell. The broadband noise emission was shown to increase with increasing intensity 
(as inertial cavitation does) and decrease with increasing coupling fluid temperature and 
carbonation (as inertial cavitation was shown to do). The introduction of a diffusion cell setup 
that facilitates a PCD capable of monitoring inertial cavitation activity during sonoporation is 




Two attempts were made to correlate PCD output with the post-sonoporation transport (in 
Chapter 3.4.4 and in the earlier study reported in Appendix A.3.3). This correlation was 
difficult given the variability in the transdermal transport datasets. However, the attempts at 
this correlation still lead to an important finding – that the coupling fluid temperature must 
be held constant if ICD is to be used as an indicator of post-sonoporation transport. Otherwise 
a decrease in broadband noise emission, resulting from an increase in coupling fluid 
temperature that actually increases skin permeability, could be misinterpreted as an indicator 
of decreased post-sonoporation transport. Thesis objective 5 has been fulfilled. 
 
6) Design and manufacture a Franz diffusion cell setup with variable echoic properties. 
 
A modified Franz diffusion cell setup with variable echoic properties was developed. This 
diffusion cell consisted of a custom made VeroClear donor chamber which was clamped to a 
polypropylene receiver chamber using an acoustically transmissive clamp. The acoustically 
transmissive support structure for this setup allowed it to be submerged in a water tank which 
was lined with acoustically absorbent panels. The reflectivity of the setup when the 
surrounding medium was air was approximately 20 times greater than when it was 
submerged in water. Like the modified diffusion cells used in Chapters 2 and 3, this setup 








7) Use the setup from 6) to conduct a preliminary investigation into the influence of 
acoustic reflection during ultrasound application in a Franz diffusion cell. 
 
The incorporation of a PCD enabled the ICD to be employed as a means for quantifying 
inertial cavitation behaviour. The reflection setup was used to investigate the effect of 
acoustic reflection on the ICD during low-frequency insonation at an intensity applicable to 
skin sonoporation (13.6 W/cm2). When acoustic reflection was suppressed, the median and 
mean ICD were 13 % and 16 % lower respectively than when the reflection was not supressed 
(significant at p=0.07). It can be concluded from these results that the acoustic reflections 
within a low-frequency Franz diffusion cell influence inertial cavitation activity at the skin 
aperture during ultrasound application. Therefore, differences in echoic conditions should be 
considered when translating the results of in vitro studies (conducted in highly reflective Franz 
diffusion cells) to in vivo or clinical setups that have vastly different echoic properties. For a 
given set of experimental parameters, the same inertial cavitation activity that was obtained 





This thesis contains the first known uses of polypropylene, 3D printed VeroClear, and 3D 
printed ABS components in skin sonoporation or sonophoresis setups. After numerous hours 
of exposure to 20 kHz ultrasound at a variety of intensities, neither the polypropylene or 
VeroClear donor chambers showed any signs of cavitation damage. The ability of these semi-
transparent materials to withstand cavitation damage means that they could be used in place 
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of glass in future sonoporation studies. Relative to glass, both 3D printed VeroClear and 
polypropylene allow for customisation and built for purpose components. The ability to make 
custom diffusion cell setups was important for this thesis as every experiment required 
functionality that cannot be had from standard glass diffusion cells. The polypropylene 
components used in this thesis were also very affordable relative to the expensive off the 






 Future Work 
 
 
It would be beneficial to employ a coupling fluid temperature control system during 
sonophoresis. In sonophoresis, the permeant solution also acts as the coupling fluid. 
Therefore, using a coupling fluid temperature control system during sonophoresis would not 
only allow constant ultrasound application without the need for duty cycles or fluid 
replacement, but could also be used to maintain a higher permeant diffusion coefficient than 
that which occurs at room temperature. The coupling fluid would simply need to be 
maintained in the safe but elevated range of 30-35 °C. The temperature control system 
reported in this thesis was designed so that dissolved permeants could easily be flushed and 
cleaned from the tubing and heat exchanger. Therefore, the system could easily be employed 
in a sonophoresis study. 
 
The temperature control system developed for this thesis is capable of maintaining a variety 
of coupling fluid temperatures during sonoporation at a wide range of ultrasound intensities. 
However, it required a laboratory water cooler. Although water coolers like this are common 
in most research facilities, they are heavy. If coupling fluid cooling was to be incorporated into 
a clinical sonoporation or sonophoresis device, it would be helpful to use a more portable 
setup that didn’t require such a large and heavy piece of equipment. A worthwhile future 
project could involve the development of a lightweight, portable coupling fluid temperature 





It would also be helpful to incorporate a feedback loop into the temperature control system 
so that the user does not have to manually set the water bath temperature (or the 
thermoelectric power supply). Implementing this would require a LabVIEW program which 
had thermocouple temperature as an input and heat exchanger cooling power as an output. 
This feedback would allow the user to change the transducer tip displacement mid-
experiment without having to manually change the water bath temperature (or the 
thermoelectric power supply) in order to maintain the same coupling fluid temperature. For 
such a feedback system to be helpful, the delay between changing the transducer tip 
displacement and restabilising the desired steady coupling fluid temperature would need to 
be minimal.  
 
A chemical dosimeter could be used to further investigate the influence of coupling fluid 
temperature on inertial cavitation activity in a low-frequency sonoporation setup. 
Terephthalic acid (TA) is a common chemical dosimeter that fluoresces when exposed to 
cavitation (Barnett 1996, McLean and Mortimer 1988, Price and Lenz 1993, Tang, et al. 
2002a). Using a coupling fluid containing TA, skin could be sonoporated at variety of 
temperatures between 10 °C and 37 °C. The fluorescence of the coupling fluid after 
sonoporation could then be measured with a spectrofluorometer. The influence of coupling 
fluid temperature on fluorescence and foil pitting could then be compared. Terephthalic acid 
could also be used to further investigate the influence of acoustic reflection on the inertial 
cavitation activity in a Franz diffusion cell. The influence of acoustic reflection on the 






Appendix A Temperature Control and Passive 
Cavitation Detection During Skin Sonoporation – 




This study was conducted prior to those in Chapters 2 and 3 and presents the first attempt 
to employ a PCD system to monitor inertial cavitation activity during constant temperature 
skin sonoporation in a Franz diffusion cell. Three different ultrasound intensities were 
employed to create three different magnitudes of inertial cavitation activity. The broadband 
noise emission was measured during skin sonoporation at each of these intensities. Following 
sonoporation, a caffeine solution was applied to the skin and left to diffuse for 20 hours. The 
correlation between the post-sonoporation receiver chamber caffeine concentration and ICD 
was then assessed. The correlation was poor which means that the PCD output could not be 
used as an effective real-time indicator of post-sonoporation caffeine transport in the present 
setup. However, from this preliminary study it was hypothesised that moving the hydrophone 
closer to the skin aperture would result in a more accurate PCD. Therefore, the hydrophone 
to aperture distance was decreased by 13 mm for the PCD study in Chapter 3 (and the 
performance of the PCD was improved significantly). The heat exchanger used in this study 
was insufficient at high intensity but provided a good basis for the improved system used 
later. Two key findings were made in this study using foil pitting experiments with a 
transducer distance of 5 mm: circulation of the coupling fluid causes only a small difference 
in the inertial cavitation activity that impacts the skin, while increasing the coupling fluid 
temperature results in a significant decrease in the activity that impacts the skin. This was the 
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first known study in which skin permeability (quantified by measuring caffeine transport with 
HPLC) was increased with ultrasound while the coupling fluid was circulated and cooled, a 
significant contribution to the field. The time saved by not needing to use duty cycles or fluid 
replacement meant that a full 10 repetitions could be run for each of the transport datasets 
– more than most previous studies have found it feasible to run.  
 
A.2 Materials and Methods 
A.2.1 Modified Diffusion Cell 
The diffusion cells used in this study were the same as those used in Chapters 2 and 3. The 
donor chambers had outer diameters of 65 mm, inner diameters of 61 mm and aperture 
diameters of 61 mm. The receiver chambers had volumes of 3.2 mL and aperture diameters 
of 9 mm. The diffusion cell is shown again in Fig. A-1. The donor and receiver chambers were 
turned from solid polypropylene rods on a CNC lathe. The receiver chamber sampling arm 
and donor chamber ports were then added by gluing sections of carbon fibre tubing to the 
polypropylene. The donor and receiver chambers were held together with clamps 3-D printed 
from acrylonitrile butadiene styrene (ABS).  
 
A.2.2 Chemicals 
Caffeine (ReagentPlus) was purchased from Sigma-Aldrich (St Louis, MO, USA). Phosphate 
buffered saline (PBS) (pH 7.4) was purchased from Thermofisher (Waltham, MA, USA). The 
caffeine solution was prepared by dissolving the caffeine powder in room temperature PBS 
at a concentration of 0.5 % w/v (5 g/L), as in the study by Sarheed and Abdul Rasool (2011). 
Deionised water was taken from a Labwater L991008 Deioniser (Suez Ltd, Thame, UK). 
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A.2.3 Porcine Skin  
Porcine ears were obtained from Ashburton Meat Processors Ltd (Ashburton, New Zealand) 
immediately after slaughter. The ears were cleaned with cold tap water to remove the blood 
and soil. The top 1 mm of the skin was removed from each ear using a dermatome 
(Dermatome 50 mm, Nouvag AG, Goldach, Switzerland). The dermatomed pieces of skin were 
flash frozen in liquid nitrogen using the technique described by Han and Das (2013) then 
immediately transferred to a -20 °C freezer for storage. Prior to each set of experiments, the 
skin was removed from the freezer and thawed in a container of deionized water at room 
temperature. Each piece of skin was then visually assessed for uniform thickness and integrity 





Fig. A-1 Diffusion cell (top) plan view, (middle) front view, and (bottom) isometric view 
  
A.2.4 Ultrasound Generation and Intensity 
A low-frequency (20 kHz) ultrasound field was generated using a VC 505 ultrasound 
processor (Sonics and Materials Inc., Connecticut, USA). This unit was operated with a 13 mm 
diameter replaceable tip. An application time of 10 minutes was used for all of the skin 
sonoporation experiments in this study. The transducer face was positioned 5 mm from the 
surface of the skin as this was the smallest distance that allowed for a confocal hydrophone 
(shown in Fig. A-3). The ultrasound intensities (23.8 W/cm2, 34.2 W/cm2, and 39.4 W/cm2) 
were determined with the commonly used calorimetric method (Merino, et al. 2003, 
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Mitragotri, et al. 2000a, Mitragotri, et al. 2000b, Morimoto, et al. 2005, Mutoh, et al. 2003, 
Terahara, et al. 2002a). This method is described in (Robertson and Becker 2018). Following 
the manufacturer’s instruction, compressed air was circulated through the ultrasonic 
processor to keep it cool during ultrasound application. 
 
A.2.5 Ultrasound Pressure Measurement 
Throughout this thesis, the ultrasound field strength is reported as an intensity, measured 
with calorimetry. Alternatively, the field strength can also be reported as a pressure 
(Mitragotri, et al. 1996, Park, et al. 2007, Smith, et al. 2003, Tezel, et al. 2001, Zorec, et al. 
2015). To measure pressure, a hydrophone was positioned a set distance from the ultrasound 
transducer and pointed directly at the transducer face. Both the transducer and hydrophone 
were situated in a water bath. The water bath was 794 mm long, 396 mm wide, and 362 mm 
high. The walls of the water bath were made from 12 mm thick acrylic sheets. The interior 
walls of the water bath were lined with acoustically absorbent panels (SA-J35, Hangzhou 
Applied Acoustic Institute, Hangzhou, Zhejiang, China). These panels have been shown to 
decrease low-frequency ultrasound reflection by 20 dB (Jelenc, et al. 2012). The RMS voltage 
signal from the hydrophone was then converted to a pressure using a sensitivity provided by 
the manufacturer. The pressure measurement technique is effective when no cavitation is 
present in the ultrasound field. However, when cavitation is present, the ultrasound energy 
moves to a broader spectrum, away from the driving frequency which is being measured (Liu, 
et al. 1998). This leads to an inaccurate pressure measurement. To demonstrate this 
inaccuracy, the hydrophone output was measured for a range of tip displacements used 
throughout this thesis. The needle hydrophone was positioned 40 mm from the transducer 
(Fig. A-2). This distance was necessary to prevent cavitation damage to the sensitive 
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hydrophone tip. The hydrophone voltage signal was measured for 2.5 ms. An RMS voltage 
was then calculated over this 2.5 ms. Ten RMS values were measured for transducer 
displacements of 20 %, 30 %, 40 %, 50 %, and 60 %. These RMS voltages were converted to 
RMS pressure values.  
 
Fig. A-2 Cross-section of the ultrasound pressure measurement setup in a water bath lined 
with acoustically absorbent SA-J35 panels. The dotted line depicts the water line. The 
hydrophone and transducer were concentrically aligned. Their active tips were separated by 
40 mm. The acrylic tank walls are not shown. 
 
A.2.6 Temperature Measurement and Control 
The temperature of the coupling fluid was measured with a thermocouple (Wire Type K 
thermocouple, Jaycar Electronics Pty Ltd, Auckland, New Zealand). The thermocouple was not 
positioned within the beam of the transducer, where it would have best represented the 
temperature of the coupling fluid near the skin surface, as this would have partially obscured 
the skin surface, and resulted in cavitation damage to the thermocouple tip. Instead the 
thermocouple was positioned outside of the transducer beam (Fig. A-3). The difference in the 
temperatures recorded in these two positions was found to be less than 1.5 °C during 
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sonoporation at 39.4 W/cm2. The readings from the thermocouple were passed (Fig. A-4) to 
a NI-9211 DAQ module (National Instruments Ltd., Texas, USA) then on to a PC for processing 
in LabVIEW (National Instruments Ltd., Texas, USA). The thermocouple sampling frequency 
was 1 Hz. The accuracy and precision of the thermocouple was checked against a calibrated 
thermometer (3040 Precision Thermometer with Immersion Probe, Prema Semiconductor, 
Mainz, Germany). Three beakers were filled with water at either 16 °C, 29 °C, or 43 °C (as 
measured by the thermometer). Three measurements of these temperatures were then 
taken with the thermometer in quick succession. The thermocouple temperature reading 
differed from the thermometer reading by a maximum of 1 °C over this temperature range. 
Note that this process was repeated, with the same result, for two other thermocouples that 
were used for experiments in other parts of this thesis. 
 
Continuous application of ultrasound at the intensities used in this study results in significant 
increases in coupling fluid temperature. A circulating, thermoelectric system, described in 
Section 4.3.2, was used to mitigate this temperature increase during skin sonoporation. 
Between experimental repetitions, the silicon tubing was removed from the donor chamber 





Fig. A-3 Cross section of the diffusion cell showing the positioning of the transducer, 
hydrophone, and thermocouple. 
 
 
Fig. A-4 System schematic. The solid lines represent the coupling fluid circuit. The dashed 
lines represent the signal inputs and outputs to and from the instruments in the coupling 
fluid. 
 
A.2.7 Passive Cavitation Detection 
The PCD hydrophone was positioned in the coupling fluid so that it was confocal with the 
ultrasound transducer (Fig. A-3). This needle hydrophone (2.0 mm Needle Hydrophone, 
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Precision Acoustics Ltd, Dorchester, Dorset, UK) had a sensitivity of -236.4 dBre1V/μPa at the 
transducer driving frequency. Note that the full list of calibrated sensitivity values, measured 
by Neptune Sonar Ltd (East Yorkshire, UK), for frequencies between 5 kHz and 1000 kHz are 
shown in Appendix C.  The position of the hydrophone was kept consistent over all of the 
experimental repetitions by using an aluminium sleeve that was fixed relative to the 
transducer and diffusion cell. A support structure for the transducer, diffusion cell, and 
hydrophone was built to make the removal of one diffusion cell and reinsertion of another as 
simple and repeatable as possible. This support structure (shown in Fig. A-5) was constructed 
from aluminium, laser cut acrylic and 3D printed ABS components. The support structure was 
fixed in position on top of the water bath used for the experiments in Chapter 4 (Fig. A-6).  
 
Fig. A-5 Overview of the experimental setup. The transducer is shown in green. The 
Hydrophone is shown in pink. The frame that holds the transducer, hydrophone and diffusion 
cell is supported by the walls of a Perspex tank. The 3D printed frame feet (shown in red) 




Fig. A-6 Image of the entire experimental setup including the tank, diffusion cell support 
assembly, water cooler, DAQ, power supply, ultrasound driver, oscilloscope, and PC 
 
During sonoporation, the components were positioned as in Fig. A-7. Once one 
sonoporation experiment (described in section A.2.8) was completed, the transducer was 
removed from the donor chamber by sliding it up the clamp stand to the position shown in 
Fig. A-8. The hydrophone was then slid upwards out of the aluminium sleeve (note that the 
thermocouple has held by a similar sleeve and was removed in the same way). With these 
components out of the way, the diffusion cell was then slid horizontally out of its holder (Fig. 
A-9). The next diffusion cell was then inserted into the holder so that the transducer and 
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hydrophone could be returned back to their exact sonoporation positions. An isometric view 
of the diffusion cell holder is shown in Fig. A-10. This holder was 3D printed from ABS (ABS 
P430, Stratasys Ltd, Minnesota, USA). 
 
Fig. A-7 Schematic showing the hydrophone, transducer, and diffusion cell in their 
sonoporation positions (front view).  
 
Fig. A-8 Schematic showing the hydrophone, transducer and diffusion cell in their swap 




Fig. A-9 Schematic showing the removal of a diffusion cell from the experimental setup 
(right view).  
 
 




The method used to process the raw hydrophone data was described in Robertson and 
Becker (2018) and Section 4.3.7. Briefly, the voltage signal measured by the hydrophone was 
recorded with an oscilloscope (TDS 2014B, Tektronix, Beaverton, OR, USA) connected via USB 
to a PC running SignalExpress (NI LabVIEW SignalExpress, National Instruments, Texas, USA). 
The voltage data was filtered to isolate the broadband noise emission between 92.5 kHz and 
97.5 kHz. An RMS value of this filtered data was calculated every 1-2 s. All of the RMS values 
were then integrated over the 10 minutes of ultrasound application to calculate a single ICD 
value for each ultrasound application. Therefore, each ICD value represents the 
time-averaged broadband noise emission for a specific sonoporation experiment. 
 
A.2.8 Transdermal Transport Experiments 
Prior to the ultrasound application, a piece of skin was mounted onto each of the ten 
diffusion cells. The receiver fluid consisted of PBS while the donor chamber fluid was 
deionized water. One at a time, each diffusion cell was positioned in the support structure 
along with the transducer, hydrophone and thermocouple. The temperature control system 
was then switched on to lower the coupling fluid (deionized water) to 10 °C. Continuous 
ultrasound was then applied for 10 minutes. During this time, the temperature control system 
was used to keep the coupling fluid temperature as close to 10 °C as possible. Following 
sonoporation of each skin sample, fresh room temperature deionized water was added to the 
donor chamber to keep the skin hydrated while the other skin samples were sonoporated. 
After all ten of the skin samples had been individually sonoporated, the deionized water was 
removed from each of the donor chambers and the caffeine-buffer solution was applied. This 
solution was allowed to diffuse for a period of 20 hours. During this time the donor chambers 
were covered with Parafilm (Bemis, WI, USA) to prevent evaporation of the fluid. This process 
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was repeated for three different ultrasound intensities (23.8, 34.2, and 39.4 W/cm2). In 
addition to these experiments, two control cases were also investigated. For the first control 
case, the ten diffusion cells were set up in the same manner described above, however, no 
ultrasound was applied. The coupling fluid was simply maintained at 10 °C for ten minutes. 
For the second control case, no ultrasound was applied and the coupling fluid was maintained 
at 25 °C for ten minutes. Note that these are positive controls as opposed to true negative 
controls as some temperature effect may be expected. However, the term ‘control’ is used 
for the sake of simplicity. After each 20 hour diffusion period, a 2 mL sample was removed 
from each receiver chamber via the sampling arm.  
 
A.2.9 Chromotography 
The samples taken from the receiver chambers were pipetted into 2 mL chromatography 
vials (THC09150838, Thermo Fisher Scientific, MA, USA). The chromatography vials were then 
mounted into an HPLC system (Ultimate 3000, Thermo Fisher Scientific, MA, USA). The solid 
phase consisted of a Poroshell 120 column (EC-C18, DKSH NZ Ltd, Palmerston North, New 
Zealand). This column was maintained at 40 °C. The mobile phase consisted of 10 % 
acetonitrile in water. The flow rate was 0.8 mL/min. The injection volume was 1 μL. The 
retention time was 3.5 minutes and the reproducibility relative standard deviation was 1 %.  
 
Each receiver fluid sample was injected into the liquid phase before passing through the 
column and into the UV detector. The peak corresponding to caffeine in each chromatogram 
was identified by its UV spectrum. The area under the caffeine peak was representative of 
the caffeine concentration. The software package Chromeleon (Thermo Fisher Scientific, MA, 
USA) was used to operate the HPLC system and to process the chromatic output. A ‘blank’ 
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consisting of Milli-Q water was run in between each caffeine sample to ensure that any 
caffeine residue from the proceeding sample had passed through the HPLC system. The 
caffeine peak areas from the chromatograms were converted to caffeine concentrations 
using a calibration curve. This curve was produced by measuring the peak areas (in triplicate) 
resulting from six different known concentrations of caffeine in PBS. 
 
A.2.10 Physical Dosimeter Experiments 
The pitting of aluminium foil under ultrasound application has previously been used to 
determine the influence of ultrasound parameters on inertial cavitation activity (Mitragotri, 
et al. 2000a). In the present study, the influence of coupling fluid circulation on the inertial 
cavitation activity at the skin aperture was investigated with foil pitting. Ten pieces of 
0.016 mm thick aluminium foil (Homebrand, Manukau, New Zealand) were insonated (at an 
intensity of 34.2 W/cm2) for 5 s with and without coupling fluid circulation. The number of 
pits in each of the 20 pieces of foil were then counted to quantify the influence of circulation. 
In these experiments, the coupling fluid in the donor chamber was deionized water at 
10 °C ± 1 °C. This temperature was achieved using the circulation system.  
 
Aluminium foil was also used to investigate the influence of coupling fluid temperature on 
the inertial cavitation activity at the skin aperture. Ten pieces of aluminium foil were 
insonated for 5 s at coupling fluid temperatures of 10 °C, 25 °C, and 40 °C. The coupling fluid 
circulation system was used to achieve these temperatures but was then switched off so that 




The length of time that a piece of foil is submerged in water prior to ultrasound application 
can affect the prevalence of air bubbles (nucleation sites) on the surface of the foil. Prior to 
each ultrasound application, the foil was submerged in the coupling fluid while the circulation 
system brought the coupling fluid to the specified temperature. The time required to achieve 
this temperature was consistent across each foil pitting dataset. Therefore, the effect of the 
submergence, on the prevalence of nucleation sites on the foil surface, was also consistent. 
 
When counting the foil pits, any circular indent was counted as one pit. Two partially 
overlapping circular indents were counted as two pits. The duration of ultrasound exposure 
was short enough to avoid complete perforation of the foil, which would have made it 
impossible to quantify the number of individual pits.  
 
A.3 Results 
A.3.1 Measuring Ultrasound Pressure 
Hydrophone measurements were conducted to determine the influence of increasing 
transducer tip displacement on the measured pressure in a cavitating ultrasound field. The 
hydrophone was positioned in front of the transducer, which was operated at tip 
displacements of 20 %, 30 %, 40 %, 50 %, and 60 %. The RMS hydrophone voltage was 
converted to an RMS pressure. The mean RMS pressure was highest at a tip displacement of 
20 % (1166 kPa). The mean value then decreased with increasing tip displacement (Fig. A-11). 
The mean RMS value at a tip displacement of 30 % was 1047 kPa, a 10 % decrease (p<0.05). 





Fig. A-11 RMS pressure as a function of transducer tip displacement. The crosses within the 
boxes represent the mean values (n=10). 
 
A.3.2 Foil Pitting 
Foil pitting experiments were used to determine the influence of coupling fluid circulation 
on the inertial cavitation activity at the skin aperture. Ten pieces of aluminium foil were 
exposed to ultrasound (at an intensity of 34.2 W/cm2 and a transducer distance of 5 mm) for 
5 s with and without coupling fluid circulation. The coupling fluid temperature was 
10 °C ± 1 °C. Without coupling fluid circulation, the mean number of pits after ultrasound 
application was 28.8 and the median was 28.5 (Fig. A-12). With coupling fluid circulation, the 
mean number of pits was 25.3 and the median was 27. Therefore, circulation of the coupling 





Fig. A-12 The influence of coupling fluid circulation on the pitting of aluminium foil. 
Ultrasound was applied for 5 s at an intensity 34.2 W/cm2. The transducer to skin distance 
was 5 mm. The crosses within the boxes represent the mean values (n=10). 
 
Foil pitting experiments were also used to investigate the influence of coupling fluid 
temperature on the inertial cavitation activity that occurs at the skin aperture. Ten pieces of 
aluminium foil were exposed to ultrasound for 5 s at coupling fluid temperatures of 10 °C, 
25 °C, and 40 °C. The mean and median number of pits following ultrasound application at 
10 °C were 23.4 and 24.5 respectively. At 25 °C the mean and median were both 10.0. At 40 °C 
the mean and median were both 3.5. Therefore, an increase in coupling fluid temperature 
from 10 °C to 25 °C resulted in a 57 % decrease in the mean number of pits (p<0.05), while an 





Fig. A-13 The influence of coupling fluid temperature on the pitting of aluminium foil. The 
crosses within the boxes represent the mean values (n=10).  
 
A.3.3 Transdermal Transport and Inertial Cavitation Dose 
Skin sonoporation experiments were conducted at three different ultrasound intensities 
(23.8 W/m2, 34.2 W/m2, 39.4 W/m2). Each skin sample was sonoporated continuously for 
10 minutes (control experiments were also conducted in which no ultrasound was applied 
during these 10 minutes). A caffeine-buffer solution was then applied to the SC (donor side) 
of the skin and left to diffuse at room temperature for 20 hours. The concentration of caffeine 
in the receiver chambers at the end of this period was measured using HPLC. Example 
chromatograms for caffeine concentration measurements following control and 
sonoporation experiments are shown in Fig. A-14 and Fig. A-15 respectively. The 
concentration of caffeine in each receiver fluid sample was proportional to the area under 
the peak which occurred at 1.25 minutes in the chromatograms. This peak was identified from 
its UV spectrum which showed a distinct peak at 273 nm (Fig. A-16 and Fig. A-17), known to 
correspond to caffeine (Fernandez, et al. 2000, Franeta, et al. 2002, Rodrigues, et al. 2007, 
Vichare, et al. 2010). The caffeine peak occurred at a time of 1.25 minutes in all of the 
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chromatograms used in this study which means that the liquid HPLC phase passed through 
the solid phase consistently throughout the experiments. This consistency is important to the 
validity of the concentration data as it means that the condition of the HPLC column was not 
degraded throughout the study. Between each HPLC caffeine measurement, a ‘blank’ 
consisting of milli-Q water was run through the column to ensure that all of the caffeine from 
the proceeding measurement was removed. An example chromatogram for one of these 
‘blank’ runs is shown in Fig. A-18. No peaks are apparent in this chromatogram so all of the 
caffeine was removed from the HPLC system between runs. This is further reinforced by 
analysing the UV spectrum of the ‘blank’ around 1.25 minutes (Fig. A-19). No UV peak is 
apparent at 273 nm, which again shows that all of the caffeine was removed from the HPLC 
system between runs. The area of the caffeine peak in each chromatogram was converted to 
a caffeine concentration value using a calibration curve produced for this study (Fig. A-20). 
This curve was produced by measuring the peak areas (in triplicate) resulting from six 
different known concentrations of caffeine in PBS. A linear trendline was applied to the 
calibration curve. This line had an R2 value of 0.99. Using this trendline, the caffeine 
concentration CAFC  (mg/L) could be found with the equation  
 
 17.6(A )CAF CC    (A.1) 
 





Fig. A-14 Example chromatogram for a receiver fluid sample following control at 10 °C 
 
 
Fig. A-15 Example chromatogram for a receiver chamber fluid sample following 





Fig. A-16 UV spectrum for the caffeine peak shown in Fig. A-14 
 





Fig. A-18 Example chromatogram for a Milli-Q water ‘blank’ 
 
 





Fig. A-20 Caffeine HPLC calibration curve with an R2 value of 0.99 (n=3) 
 
The receiver chamber concentrations following the control experiments (at 10 °C and 25 °C) 
are shown in Fig. A-21. Following diffusion for 20 hours, the mean and median receiver 
caffeine concentrations for the control at 10 °C were 31.6 mg/L and 27.6 mg/L respectively. 
For the control at 25 °C, the mean and median receiver caffeine concentrations were 
42.5 mg/L and 34.9 mg/L respectively. Therefore, an increase in coupling fluid temperature 




Fig. A-21 Receiver chamber caffeine concentration after 10 minutes of exposure to 10 °C or 
25 °C deionized water and 20 hours of passive caffeine diffusion (n=10) 
 
Ultrasound was applied to skin samples at three different intensities. Application at 
23.8 W/cm2 resulted in mean and median receiver caffeine concentrations of 45.9 mg/L and 
15.6 mg/L respectively (shown in Fig. A-22). Application at 34.2 W/cm2 resulted in mean and 
median receiver caffeine concentrations of 111.4 mg/L and 95.2 mg/L. Application at 
39.4 W/cm2 resulted in mean and median receiver caffeine concentrations of 116.6 mg/L and 
108.7 mg/L. When these values are compared to those from the two control cases, it is 
apparent that no enhancement was achieved at an intensity of 23.8 W/cm2 while ultrasound 
at 34.2 W/cm2 and 39.4 W/cm2 resulted in mean values that were 3.5 (p<0.05) and 3.7 
(p<0.05) times the mean of the 10 °C control case. Note that these p-values were found using 
a Wilcoxon rank sum test as a Kolmogorov-Smirnov test rejected the null hypothesis that the 
data is normally distributed at the 5 % significance level in all of the data sets shown in Fig. 




Fig. A-22 Receiver chamber concentration after 10 minutes of ultrasound exposure to 
various intensities. The coupling fluid temperature was maintained between 10 °C and 20 °C 
(n=10). 
 
During each ultrasound exposure, a hydrophone positioned in the coupling fluid recorded 
the pressure variations in the ultrasound field. Examples of frequency spectra for the PCD 
data recorded during sonoporation at each of the three intensities are shown in Fig. A-23. The 
driving frequency at 20 kHz is pronounced in each of these spectra, as are various higher 
harmonics and ultraharmonics. The PCD hydrophone data was filtered to isolate the 
broadband noise between 92.5 kHz and 97.5 kHz. Examples of the broadband noise emission 




Fig. A-23 Example frequency spectra from PCD data captured during sonoporation at 




Fig. A-24 Broadband noise (92.5-97.5 kHz) as a function of time for intensities of (a) 
23.8 W/cm2, (b) 34.2 W/cm2, and (c) 39.4 W/cm2. A moving average of the noise is also 
shown to aid interpretation of the data. 
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The broadband noise emission was time-integrated over the 10 minutes of ultrasound 
application to obtain the ICD. The mean and median ICD increased with increasing intensity. 
Sonoporation at 23.8 W/cm2 resulted in a mean ICD of 269 mV-s and a median of 226 mV-s 
(Fig. A-25). The mean value increased to 507 mV-s for an intensity of 34.2 W/cm2. The median 
for this intensity was 328 mV-s. When the ultrasound intensity was 39.4 W/cm2 the mean and 
median ICD values were 547 mV-s and 637 mV-s respectively.  
 
 
Fig. A-25 Inertial cavitation dose as a function of ultrasound intensity (n=10) 
 
If PCD output were to be used as a real-time indicator of the likely post-sonoporation 
transport, there would need to be a clear correlation between ICD and receiver chamber 
caffeine concentration. If such a correlation could be established, then the equation 
describing that correlation could enable the likely post-sonoporation transport to be 
calculated from the real-time PCD output. To better assess the correlation between the 
receiver chamber caffeine concentration and the corresponding ICD values, each receiver 
concentration value from Fig. A-22 was plotted as a function of its ICD value from Fig. A-25. 
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This direct comparison is shown in Fig. A-26. The values from the 23.8 W/cm2 dataset are 
represented by the ‘○’ symbols. The values from the 34.2 W/cm2 dataset are represented by 
the ‘∆’ symbols. The values from the 39.4 W/cm2 dataset are represented by the ‘□’ symbols. 
No correlation is evident in Fig. A-26: the receiver chamber caffeine concentration did not 
increase with increasing ICD.  
 
 
Fig. A-26 Receiver chamber caffeine concentration as a function of ICD 
 
A.3.4 Coupling Fluid Temperature 
The coupling fluid temperature was recorded during each of the sonoporation experiments. 
The temperature control system was supposed to maintain a constant steady state coupling 
fluid temperature of 10 °C ± 1 °C during sonoporation at each intensity. However, due to the 
insufficient power of the thermoelectric temperature controller used for this study, the 
coupling fluid temperature increased above 11 °C during sonoporation at 34.2 W/cm2 and 
39.4 W/cm2 (Fig. A-27). The maximum coupling fluid temperature recorded during each 
sonoporation experiment is shown in Fig. A-28 as a function of ultrasound intensity. During 
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sonoporation at 34.2 W/cm2, the coupling fluid temperature reached a mean maximum of 
13.7 °C. During sonoporation at 39.4 W/cm2, the coupling fluid temperature reached a mean 
maximum of 15.8 °C.  
 
 








The coupling fluid temperature increase without coupling fluid circulation was also 
measured for each of the three sonoporation protocols. At the lowest intensity, the coupling 
fluid temperature still exceeded the 40 °C threshold (above which burns and damage are 
known to occur) within the 10 minutes (Fig. A-29). The maximum temperature was 44 °C. 
During sonoporation at 34.2 W/cm2, the 40 °C threshold was exceeded after 5 min and 40 s. 
The maximum coupling fluid temperature was 55 °C. During sonoporation at 39.4 W/cm2, the 
40 °C threshold was exceeded after 4 min and 47 s. The maximum temperature was 61 °C. 
From this temperature data it is apparent that a time-consuming duty cycle would have been 
required if the circulating temperature control system was not available. 
 
 







This appendix describes an initial attempt to employ both a coupling fluid temperature 
control system and a PCD system during sonoporation. The receiver chamber caffeine 
concentration following 10 minutes of sonoporation at intensities of 23.8 W/cm2, 
34.2 W/cm2, and 39.4 W/cm2 were measured using HPLC. The concentration values were 
determined from the HPLC chromatograms using a calibration curve produced for this study.  
 
The ultrasound intensity values in this thesis were determined using a common calorimetric 
method. To demonstrate why this method is commonly used to quantify the ultrasound field 
strength, an attempt was made to use the alternative, pressure measurement method. The 
transducer was positioned in an acoustically lined water tank. The hydrophone was 
positioned below the transducer so that its tip was parallel with and directly facing the 
transducer tip. The distance between the transducer and hydrophone tips was kept at 40 mm 
to prevent cavitation damaging the sensitive piezoelectric hydrophone tip. The transducer 
was operated at tip displacements from 20 % to 60 %. The pressure value calculated from the 
hydrophone voltage output decreased consistently over this tip displacement range (Fig. 
A-11) – the mean calculated pressure at a tip displacement of 60 % was only 78 % of that at a 
tip displacement of 20 %. This decrease in calculated pressure with increasing tip 
displacement occurred as a result of increasing inertial cavitation activity: cavitation shifts the 
acoustic energy to frequencies other than the 20 kHz transducer frequency (Liu, et al. 1998). 
Increasing the tip displacement increased the inertial cavitation activity between the 
transducer and hydrophone which shifted the acoustic energy further away from the driving 
frequency, decreasing the measured incident pressure. This shift in acoustic energy makes 
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the hydrophone pressure measurement method an ineffective way to quantify the ultrasound 
field strength when cavitation is present.  
 
Foil pitting, a common experimental tool in sonoporation studies, was used to investigate 
the influence of coupling fluid circulation on the inertial cavitation activity that occurs at the 
skin aperture. When the transducer was 5 mm from the aperture, circulation resulted in a 5 % 
decrease in the median number of pits after 5 s of ultrasound application at 34.2 W/cm2 
(significant at p=0.40). From this small difference in pitting it can be concluded that, when the 
transducer distance is 5 mm, coupling fluid circulation has only a small effect on the inertial 
cavitation activity which impacts the skin. This small difference is acceptable and far 
outweighed by the benefits of employing coupling fluid temperature control during 
sonoporation – namely, not needing to use duty cycles or manual fluid replacement. 
 
Foil pitting experiments were also used to investigate the influence of coupling fluid 
temperature on the inertial cavitation activity that occurred at the skin aperture. For a 
transducer distance was 5 mm, an increase in coupling fluid temperature from 10 °C to 25 °C 
resulted in a 57 % decrease in the mean number of pits (p<0.05) after 5 s. An increase from 
25 °C to 40 °C resulted in a further 65 % decrease in the mean number of pits (p<0.05). It is 
then reasonable to conclude that, for the skin sonoporation experiments in this study, the 
skin was exposed to less inertial cavitation activity when the coupling fluid temperature was 
higher.  
 
The influence of coupling fluid temperature on inertial cavitation further reinforces the 
need for a temperature control system that can be used during skin sonoporation. A 
200 
 
thermoelectric coupling fluid temperature control system (Section 4.3.2) was employed in an 
attempt to maintain a steady state temperature of 10 °C ± 1 °C during sonoporation at 
23.8 W/cm2, 34.2 W/cm2, and 39.4 W/cm2. During sonoporation at 23.8 W/cm2, the 
thermoelectric system was able to maintain the temperature within the desired range. 
However, when the intensity was increased to 34.2 W/cm2 and 39.4 W/cm2, the 
thermoelectric system could not provide the necessary cooling power and the temperature 
increased to mean maximum values of 13.7 °C and 15.8 °C after 10 minutes. This insufficient 
temperature control led to the development of the improved cooling system which was used 
for the sonoporation experiments in Chapters 2 and 3, and Appendix B. This improved system 
was described in Section (2.3.5). Relative to the system used in this study, the improved 
system had more cooling power and more consistent cooling power (the Peltier plates used 
in the present study had a tendency to lose power over time).  
 
Without circulation and cooling, the coupling fluid exceeded the safe 40 °C threshold within 
10 minutes, regardless of the intensity (Fig. A-29). So although the thermoelectric system was 
not always able to maintain a constant coupling fluid temperature in the present study, it was 
still a significant improvement over a system without cooling – duty cycles or fluid 
replacement were not required. The time saved by not needing to use duty cycles or fluid 
replacement made it relatively easy to run 10 repetitions for each of the five caffeine 
transport datasets. A shortcoming of some previous in vitro skin sonoporation and 
sonophoresis studies has been the low number of repetitions within each dataset. The study 
by Terahara, et al. (2002a) reports an investigation into the influence of ultrasound pre-
treatment time on the enhancement of mannitol transport. For each of the four pre-
treatments times, only three repetitions were conducted. If that study had not had to use a 
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50 % duty cycle and fluid replacement to keep the temperature below 40 °C, the time saved 
could have been used to run a greater number of repetitions. Similarly, in the sonoporation 
study by Herwadkar, et al. (2012), each transport dataset consisted of only around three 
repetitions. Again, if a 50 % duty cycle had not been used then a greater number of repetitions 
could have been completed in the same amount of time. Likewise, in the sonophoresis study 
by (Mitragotri, et al. 1996), only three repetitions were used to determine the transdermal 
transport of Salicylic acid as a function of application time over five hours. If a coupling fluid 
cooling system had have been used, instead of a 10 % duty cycle and fluid replacement, then 
the length of each experiment could have been reduced and a greater number of repetitions 
could have been completed within the same timeframe. Sonoporation and sonophoresis 
datasets with n≤4 were also reported in several other studies in the literature (Boucaud, et 
al. 2002, Kushner, et al. 2004, Morimoto, et al. 2005, Rangsimawong, et al. 2018, Ueda, et al. 
2009). As mentioned in Chapter 2, future studies should employ one of the temperature 
control systems introduced in this thesis to reduce the time required for each experiment. 
This saved time could then be put to better use by producing more repetitions, which would 
enable more reliable conclusions to be drawn from each dataset.     
 
Due to the higher coupling fluid temperatures reached during sonoporation at 34.2 W/cm2, 
and 39.4 W/cm2 in the present study, control experiments were run at both 10 °C and 25 °C 
to determine the influence of increased coupling fluid temperature on the receiver chamber 
caffeine concentration. An increase from 10 °C to 25 °C resulted in only a 1.3-fold increase in 
the mean receiver concentration (significant at p=0.4). Therefore, it can be assumed that the 
far smaller increases of 3 °C to 6 °C that occurred during sonoporation at 34.2 W/cm2 and 
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39.4 W/cm2 had negligible influences on the post-sonoporation receiver chamber caffeine 
concentration.  
 
Sonoporation at 23.8 W/cm2 had no discernible influence on receiver chamber caffeine 
concentration relative to the control cases. However, when the intensity was increased to 
34.2 W/cm2, the mean receiver chamber caffeine concentration after 20 hours of diffusion 
increased to 3.5 times that of the 10 °C control case (p<0.05). A further increase in intensity 
to 39.4 W/cm2 resulted in a mean receiver concentration that was 3.7 times that of the 10 °C 
control case (p<0.05). These increases in receiver concentration can be attributed to the 
increase in skin permeability enhancement known to occur with increasing sonoporation 
intensity (Terahara, et al. 2002a). This increase in permeability enhancement with increasing 
intensity is caused by an associated increase in inertial cavitation activity (Tang, et al. 2002a), 
the main mechanism behind sonoporation (Tezel, et al. 2002).  
 
The ultrasound-induced increases in transdermal transport achieved in the present study 
are comparable to those of the most similar study in the literature – Sarheed and Abdul Rasool 
(2011). That study also applied continuous ultrasound to porcine skin for 10 minutes, with a 
transducer to skin distance of 5 mm, then allowed a caffeine solution to diffuse for 24 hours 
(similar to the 20 hours in the present study). However, they used a lower intensity 
(3.7 W/cm2), a smaller transducer tip (3 mm), and lacked sufficient coupling fluid temperature 
control. With that setup and those protocols, Sarheed and Abdul Rasool (2011) achieved a 
1.5-fold mean caffeine transport enhancement relative to a passive permeation case. 
Therefore, the results of the present study are comparable. The caffeine transport 
enhancements achieved with intensities of 34.2 W/cm2 and 39.4 W/cm2 in the present study 
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were, respectively, 2.3 and 2.5 times that achieved by Sarheed and Abdul Rasool (2011). 
These greater enhancements are reasonable given the aforementioned positive relationship 
between intensity and post-sonoporation transport.   
 
   In the present study, the inertial cavitation activity was monitored during sonoporation 
with a PCD. A hydrophone, positioned in the coupling fluid, responded to the pressure 
fluctuations that occurred in the ultrasound field. The hydrophone output was filtered to 
isolate the broadband noise (known to be indicative of inertial cavitation activity). The 
broadband noise recorded over the 10 minutes of sonoporation was time integrated to 
produce a single ICD value for each sonoporation experiment. When the ultrasound intensity 
increased, the mean ICD value increased. For sonoporation at 23.8 W/cm2, the mean value 
was 269 mV-s. This increased by 1.9-fold (p=0.089) to 507 mV-s at 34.2 W/cm2. A further 1.1-
fold increase (p=0.10) to 547 mV-s then occurred when the intensity was increased to 
39.4 W/cm2. Note that an outlier occurred in the 34.2 W/cm2 ICD dataset. This outlier had a 
value of 1761 mV-s. This value was considered an outlier as it exceeded the upper quartile by 
more than 1.5 times the interquartile range (a standard outlier criteria when using box plots). 
This value was not represented in Fig. A-25 but was considered in the calculation of the mean 
and median values in the 34.2 W/cm2 dataset. This outlier explains how a p-value of 0.10 
occurred between the 34.2 W/cm2 and 39.4 W/cm2 datasets when the mean value only 
increased 1.1-fold. The increases in ICD with increasing intensity (shown in Fig. A-25) indicate 
that the output of the PCD system was affected by the inertial cavitation activity that occurred 




In the cell sonoporation study by Hallow, et al. (2006), ICD was touted as a potential unifying 
parameter that can be used as a real-time indicator of a desired ultrasound-induced bioeffect. 
If PCD output were to be used as a real-time indicator of the likely post-sonoporation 
transport, there would need to be a clear correlation between ICD and receiver chamber 
caffeine concentration. If such a correlation could be established, then the equation 
describing that correlation could enable the likely post-sonoporation transport to be 
calculated in real-time from the PCD output. The ultrasound intensity or application time 
could then be adjusted during sonoporation to ensure that the required ICD, and therefore, 
post-sonoporation transport were always achieved. In the study by Hallow, et al. (2006), a 
strong correlation was found between the ICD and the desired bioeffect (uptake into viable 
human prostate cancer cells). To better assess the correlation between the post-
sonoporation transport and the corresponding ICD values in the present study, each receiver 
concentration value was plotted as a function of its corresponding ICD value (Fig. A-26). 
Despite the increase in both receiver chamber caffeine concentration and ICD with increasing 
intensity (Fig. A-22 and Fig. A-25), no correlation is apparent in Fig. A-26. There is no clear 
separation between the intensity groups and no apparent correlation within each intensity 
group - the PCD output could not be used as an effective real-time indicator of post-
sonoporation caffeine transport in the present setup.  
 
The poor correlation shown in Fig. A-26 indicates that the PCD system used in this study did 
not represent the effective inertial cavitation events that occurred during skin sonoporation. 
However, this may be misleading. There are several features of the methodology that may 
have contributed to the poor correlation between caffeine transport and ICD. There was a 
significant amount of variability in both the receiver chamber calcein concentration and ICD 
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datasets. The variability in the ICD datasets may be improved by moving the hydrophone 
closer to the skin aperture (as in Chapter 3) and maintaining more strict control of the 
coupling fluid temperature (which was shown to affect inertial cavitation activity in Fig. A-13). 
 
Some variability in the concentration datasets was expected given the variability in other 
transdermal transport studies in the literature (Merino, et al. 2003, Terahara, et al. 2002a, 
Terahara, et al. 2002b). However, this variability could potentially be reduced by using a 
molecule with a larger molecular weight than caffeine. The small size of the caffeine 
molecules (194 g/mol) meant that any physiological variation between skin samples may have 
resulted in large differences in caffeine transport. Using a larger molecule, for example calcein 
(623 g/mol), should reduce the impact of physiological variations as its molecular weight 
means that it cannot diffuse in large quantities without ultrasound enhancement. Using 
calcein may also have the added benefit of increasing the permeability enhancement relative 
to the control case – the transport of larger molecules that diffuse more slowly through the 
skin is enhanced more by ultrasound than the transport of smaller molecules (Mitragotri, et 
al. 1995b). 
 
The long caffeine residence time (20 hours) may also have contributed to the poor 
correlation shown in Fig. A-26. This long residence time resulted in highly hydrated skin 
samples. Skin hydration is known to significantly affect skin permeability (Alonso, et al. 1995, 
Verdier‐Sévrain and Bonté 2007, Wu, et al. 2006, Zhai, et al. 2002). Therefore, reducing the 
residence time should decrease the effects of hydration which may isolate the effects of 





Circulation of the coupling fluid through the donor chamber (at a flow rate of 0.14 L/min) 
resulted in a 5 % decrease in the median number of pits after 5 s when the transducer was 
5 mm from the aperture (significant at p=0.4). This small decrease in pitting is acceptable 
considering the possibility circulation provides for coupling fluid temperature control during 
sonoporation. Foil pitting experiments were also used to investigate the influence of coupling 
fluid temperature on the inertial cavitation activity that occurred at the skin aperture. An 
increase in coupling fluid temperature from 10 °C to 25 °C resulted in a 57 % decrease in the 
mean number of pits (p<0.05), while an increase from 25 °C to 40 °C resulted in a further 65 % 
decrease (p<0.05). It is then concluded that, for the experimental parameters used in this 
study, increasing the coupling fluid temperature results in a decrease in the inertial cavitation 
activity that impacts the skin. 
 
This study included a first attempt at incorporating both coupling fluid temperature control 
and passive cavitation detection during skin sonoporation. The potential of both systems was 
apparent. The temperature control system was able to maintain a constant coupling fluid 
temperature during sonoporation at 23.8 W/cm2, and was able to maintain safe coupling fluid 
temperatures at all three intensities – time consuming duty cycles and fluid replacement were 
not required. The PCD system was able to monitor the broadband noise emission within the 
coupling fluid during skin sonoporation. However, neither system functioned to the required 
standard. The temperature control system was unable to maintain a constant coupling fluid 
temperature at intensities of 34.2 W/cm2 and 39.4 W/cm2. No correlation between the ICD 
and transdermal transport values was identified despite both of these variables increasing 
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with increasing intensity. The poor correlation means that the PCD output could not be used 
as an effective real-time indicator of post-sonoporation caffeine transport in the present 
setup.  
 
The shortcomings of the systems used in this study were important in informing the 
materials and methods used in Chapters 2 and 3. Improvements made to the temperature 
control system following this study resulted in a system capable of maintaining a variety of 
coupling fluid temperatures during sonoporation at 55 W/cm2 (Chapter 2). Researchers 
intending to adopt a circulating temperature controller in their own studies should note the 
difference in performance of the temperature control systems used in Chapter 2 and the 
present study – the water bath heat exchanger used in Chapter 2 is a more powerful and 
consistent option than the thermoelectric heat exchanger used in the present study. Moving 
the hydrophone closer to the skin aperture following the present study resulted in a 
significant reduction in the variability of the ICD values found in Chapter 3. The lower 
variability indicates that, for the large diameter diffusion cell setup, the hydrophone position 
used in Chapter 3 (7 mm from the skin aperture) resulted in superior PCD performance 
relative to that used in the present study (20 mm from the skin aperture). Also, the harmonic 
and ultraharmonic peaks in the frequency spectra of Chapter 3 are more pronounced than 
those in the present study – another indicator that the closer hydrophone position in resulted 
in a superior PCD performance. This should be noted by any future in vitro, in vivo, or clinical 
skin sonoporation studies which attempt to use a PCD to monitor inertial cavitation activity – 
the hydrophone should be as close to the skin aperture as possible. Despite its shortcomings, 
this is the first known study in which transdermal transport was enhanced with sonoporation 








Appendix B The Influence of Transducer Distance and 




Following the caffeine sonoporation study reported in Appendix A, a larger permeant 
molecule was required for the experiments reported in Chapter 2. Preliminary experiments 
were attempted with Testosterone but abandoned due to its poor solubility in water. 
Eventually Calcein was selected as an appropriate permeant. Calcein has a molecular weight 
of 623 g/mol and has been used as a model drug in many transdermal transport studies in the 
literature (Henry, et al. 1998a, Oh, et al. 2008, Prausnitz, et al. 1993, Vanbever and Preat 1999, 
Xie, et al. 2005). This Chapter reports a series of sonoporation experiments with Calcein. 
These experiments were conducted to find a combination of experimental parameters that 
resulted in a significant enhancement in Calcein transport relative to a control case. It can be 
concluded from the results that, in a sonoporation setup with circulating coupling fluid, the 
post-sonoporation transport increases with increasing ultrasound application time and 
decreases with increasing transducer to skin distance. Of the five combinations of 
experimental parameters investigated in this study, that which involved an application time 
of 10 minutes, an intensity of 55 W/cm2 and a transducer to skin distance of 3 mm was 
deemed most appropriate for use in the coupling fluid temperature study (Chapter 2). 
Although the present study did not directly address any of the thesis objectives, it does 
contain the first known example of calcein transport enhancement using continuous 
sonoporation with coupling fluid temperature control. This study also demonstrates the 
circulation system’s ability of to maintain a constant coupling fluid temperature during a long 
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(30 minute), continuous application of ultrasound – another significant contribution to the 
field. 
 
B.2 Materials and Methods 
B.2.1 Modified Diffusion Cell 
Modified diffusion cells were used to conduct the transdermal transport experiments. The 
diffusion cells were the same as those used in Chapters 2, 3, and Appendix A. A description of 
these cells was given in Section 2.3.1. The geometry of the cells was shown in Fig. 2-1.  
 
B.2.2 Chemicals 
The permeant solution that was applied to the skin consisted of calcein (Calcein C0875, 
Sigma-Aldrich, St. Louis, MO, USA) dissolved in phosphate buffered saline (PBS) (Gibco PBS 
pH 7.4, Thermo Fisher Scientific, Waltham, MA, USA) at a concentration of 0.1 % w/v (1 g/L). 
This solution was made and stored at room temperature. Deionised water was taken from a 
Labwater L991008 Deioniser (Suez Ltd, Thame, UK). 
 
B.2.3 Porcine Skin 
The in vitro skin models used in this study consisted of porcine ear skin. The ears were 
obtained from an abattoir (Ashburton Meat Processors Ltd, Ashburton, New Zealand) 
immediately after slaughter. These ears were not scalded or exposed to detergent at the 
abattoir. Upon arrival at the laboratory, the ears were cleaned with cold tap water. The skin 
was then removed from the ears using a dermatome (Dermatome 50 mm, Nouvag AG, 
Goldach, Switzerland) set to a thickness of 1 mm. Following the dermatome process, the 
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pieces of skin were individually wrapped in Parafilm (PARAFILM, Sigma-Aldrich, St. Louis, MO, 
USA), placed in airtight plastic containers, and then transferred to a -20 °C freezer until use.  
 
B.2.4 Ultrasound Generation and Intensity 
A low-frequency (20 kHz) ultrasound field was generated with an ultrasonic processor (VC 
505 Ultrasonic Processor, Sonics and Materials Inc., Newtown, CT, USA). This processor was 
fitted with a 13 mm replaceable tip. Following the manufacturer’s instruction, compressed air 
was circulated through the ultrasonic processor to keep it cool during ultrasound application.  
The intensity of the ultrasound field was determined using the same calorimetric approach 
described in Section 4.3.4. Two intensities were used in this study: a low intensity (13 W/cm2) 
and a high intensity (55 W/cm2). The low intensity was generated with a tip displacement 
setting of 20 %. The high intensity was generated with a tip displacement setting of 60 %. 
 
B.2.5 Coupling Fluid Temperature Measurement and Control 
The temperature measurement and control system was the same as that used in Chapters 
2 and 3. Briefly, a peristaltic pump circulated the coupling fluid out of one donor chamber 
port, through a heat exchanger, and back into the other donor chamber port. The heat 
exchanger consisted of an aluminium block submerged in a water bath (FP-50 
Refrigerated/Heating Circulator, Julabo GmbH., Selbach, Germany). The coupling fluid 
temperature tended towards the temperature of the water bath as it passed through 
channels milled within the aluminium block (shown in Fig. 2-9). This system ensured that the 
steady state coupling fluid temperature was always 12 °C ± 1 °C during sonoporation, as 
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measured by the thermocouple in the coupling fluid. A cross-section of the diffusion cell setup 
is shown again in Fig. B-1. The system schematic is shown again in Fig. B-2. 
 
 






Fig. B-2 System schematic. The solid lines represent the coupling fluid circuit. The dashed 
lines represent the signal inputs to the transducer and the signal outputs from the 
thermocouple. 
 
The location of the thermocouple (qualitatively depicted in Fig. 2-5) was chosen so that it 
was outside of the transducer beam and did not interfere with the ultrasound field near the 
skin. This position (8 mm above the bottom donor chamber wall and 7 mm from the 
transducer) also prevented cavitation damage to the thermocouple tip. Preliminary 
temperature measurements were conducted to assess the influence of the thermocouple 
position on the measured temperature. In these experiments, a second thermocouple was 
positioned directly over the skin (as shown in Fig. B-3). The steady state temperatures 





Fig. B-3 Cross-section of the diffusion cell showing the thermocouple positioned directly 
above the skin surface 
 
B.2.6 Measurement of Receiver Chamber fluid Temperature 
Ultrasound-induced temperature increases are a result of absorption. This absorption can 
occur in both the donor and receiver fluids due to the propagation of the ultrasound field 
throughout the diffusion cell. To measure the heat transfer to the receiver fluid, a hole was 
drilled in the bottom of a spare receiver chamber which was not required for the transport 
experiments. A thermocouple was then inserted through this hole so that its tip was 
positioned 2 mm below the skin surface (Fig. B-4). The hole in the bottom of the receiver 
chamber was then glued to prevent any leakage and to ensure that the thermocouple 






Fig. B-4 Cross-section of the diffusion cell showing the positioning of the thermocouple 
used to measure the receiver fluid temperature. The tip of the thermocouple was 2 mm from 
the bottom surface of the skin.  
 
B.2.7 Transdermal Transport Experiments 
Transdermal transport experiments were conducted to investigate the influence of 
intensity, ultrasound application time, and transducer to skin distance on the transport 
enhancement achieved with sonoporation. These experiments began with filling one of the 
receiver chambers with PBS. A skin sample was then taken from the freezer and visually 
checked for any holes or areas of non-uniform thickness through which the calcein solution 
could easily diffuse. Any samples that displayed such imperfections were disposed of. Once 
an appropriate skin sample was selected, it was clamped between the filled receiver chamber 
and the donor chamber. After ensuring that no air bubbles were present in the receiver 
chamber, the diffusion cell was mounted into the temperature regulation setup, which 
involved attaching the silicone tubing to the donor ports and moving the thermocouple into 
position. Room temperature (19 °C ± 1 °C) deionised water was then added to the donor 
chamber and allowed to sit for three minutes to thaw the skin. Temperature control was then 
initiated by switching on the circulation pump. With the temperature control system running, 
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the coupling fluid was circulated for 10 minutes with or without ultrasound. The temperature 
was constantly monitored with the thermocouple during this time to ensure it remained at 
12 °C ± 1 °C. After 10 minutes of circulation, the coupling fluid was removed from the donor 
chamber and the diffusion cell was moved to a holding rack. A 0.5 mL volume of the calcein 
solution was then applied to the top of the skin so that its entire surface was submerged. This 
solution was then left to diffuse for one hour at room temperature (19 °C ± 1 °C). After 1 hour, 
a 1 mL volume was taken from the receiver chamber. Six different combinations of ultrasound 
parameters were used during the 10 minutes of coupling fluid circulation. These are shown 
in Table B-1. Seven transport experiments were conducted using each combination of 
ultrasound parameters. Note that each cell was washed with a surfactant cleaner (Jif, 
Unilever, France) in between each use to remove the calcein which had a tendency to stick to 
the polypropylene.  
 
Table B-1 Combinations of experimental parameters used.  
Combination a (control) b c d e f 
Ultrasound Intensity (W/cm2) 0 13.3 55.1 55.1 55.1 55.1 
Transducer to skin distance (mm) 5 5 5 5 3 3 
Ultrasound application time (min) 0 10 10 30 10 30 
 
B.2.8 Concentration Measurements and Calibration Curve 
The concentration of calcein in the receiver fluid was measured using a spectrofluorometer 
(Fluorolog-3, Horiba Ltd., Kyoto, Japan). The excitation and emission wavelengths were 
488 nm and 513 nm respectively. These wavelengths are similar to those used in the literature 
(Alvarez‐Román, et al. 2003, El Jastimi and Lafleur 1999, Morimoto, et al. 2005, Mueller, et al. 
2004, Petronilli, et al. 1999). The software package FluorEssence (FluorEssence V3.5, Horiba 
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Ltd., Kyoto, Japan) was used to operate the spectrofluorometer and analyse its output. The 
fluorescence values read by the spectrofluorometer were converted to calcein concentrations 
using a calibration curve. This curve was produced by measuring (in triplicate) the fluorescent 
intensity of nine different known concentrations of calcein in PBS. Each sample was pipetted 
into a 1.2 mL quartz crystal cuvette (Starna Ltd, Essex, UK). This cuvette was cleaned with 
deionised water and Kimwipes (Kimtech, Kimberly-Clarke, Irving, TX, USA) between each 
measurement to ensure that all of the calcein was removed.  
 
B.2.9 Foil Pitting Experiments 
In the present study, aluminium foil was used as a physical dosimeter to investigate the 
influence of transducer to skin distance on the on the inertial cavitation activity at the skin 
aperture with circulating coupling fluid. Ten pieces of 0.016 mm thick aluminium foil 
(Homebrand, Manukau, New Zealand) were insonated (at an intensity of 55 W/cm2) for 2 s 
with the transducer 3 mm, 5 mm, or 7 mm from the skin surface. The number of pits in each 
of the 30 pieces of foil were then counted to quantify the influence of transducer distance. In 
these experiments, the coupling fluid in the donor chamber was deionized water at 
12 °C ± 1 °C. This temperature was achieved using the circulation system. 
 
The length of time that a piece of foil is submerged in water prior to ultrasound application 
can affect the prevalence of air bubbles (nucleation sites) on the surface of the foil. Prior to 
each ultrasound application, the foil was submerged in the coupling fluid while the circulation 
system brought the coupling fluid to the specified temperature. The time required to achieve 
this temperature was consistent across each foil pitting dataset. Therefore, the effect of the 
submergence, on the prevalence of nucleation sites on the foil surface, was also consistent. 
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When counting the foil pits, any circular indent was counted as one pit. Two partially 
overlapping circular indents were counted as two pits. The duration of ultrasound exposure 
was short enough to avoid complete perforation of the foil, which would have made it 
impossible to quantify the number of individual pits.  
 
B.3 Results 
B.3.1 Calcein Calibration 
A calibration curve was produced so that receiver chamber calcein concentration could be 
calculated from the spectrofluorometer output. Examples of spectrofluorometer outputs are 
shown when no calcein was present (Fig. B-5) and when calcein was present (Fig. B-6). The 
emission intensity value at 513 nm was proportional to the concentration of calcein in the 
receiver chamber. A linear trendline was applied to the calibration curve (Fig. B-7). This line 
had an R2 value of 0.99. Using this calibration, the calcein concentration RAWC  could be found 
with the equation 
  
 
10 58.21 10 (I ) 4.04 10RAW SC
       (B.1) 
 
where SI  is the fluorescent intensity emitted by the calcein. The maximum emission intensity 
of the spectrofluorometer was approximately 20 MCPS. Therefore, any samples that 
approached this value (in this Appendix or in Chapters 2 or 3) were diluted with PBS. This 





Fig. B-5 Example fluorometer output with no calcein. The excitation wavelength was 
488 nm. The emission wavelength was 513 nm. 
 
 
Fig. B-6 Example fluorometer output with calcein. The excitation wavelength was 488 nm. 





Fig. B-7 Calcein fluorometry calibration curve with an R2 value of 0.99 (n=3) 
 
B.3.2 Transdermal Transport 
Transdermal transport experiments were conducted to find a combination of experimental 
parameters that resulted in a significant enhancement in Calcein transport relative to a 
control case (without ultrasound). With the steady state coupling fluid temperature at 
12 °C ± 1 °C, skin was sonoporated under a variety of different experimental conditions (Table 
B-1). The calcein-buffer solution was then applied to the skin and left to diffuse at room 
temperature for 1 hour. The fluorescence of the receiver chamber fluid was then measured 
and converted to concentration using the calibration curve (Fig. B-7). 
 
Initially, the transducer to skin distance was set to 5 mm, as it was for the caffeine 
sonoporation experiments in Appendix A. At this distance, skin was sonoporated for 
10 minutes at both 13 W/cm2 and 55 W/cm2. Relative to the control case (with no 
ultrasound), sonoporation at 13 W/cm2 resulted in a 1.8-fold increase in the mean receiver 
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chamber calcein concentration (Fig. B-8). However, the median decreased by 0.7-fold and the 
p-value was 0.8. Sonoporation for 10 minutes at 55 W/cm2 resulted in a 3.8-fold increase in 
the mean receiver concentration (p=0.46) but a 0.7-fold decrease in the median value. Note 
that these p-values were found using a Wilcoxon rank sum test as a Kolmogorov-Smirnov test 
rejected the null hypothesis that the data was normally distributed at the 5 % significance 
level. Skin was also sonoporated for 30 minutes at 55 W/cm2 with a transducer to skin 
distance of 5 mm. Relative to the control case, this protocol resulted in a 6-fold increase in 
the mean receiver concentration (p=0.26) and a 1.1-fold increase in the median (Fig. B-9). 
 
 
Fig. B-8 Receiver chamber calcein concentration as a function of ultrasound intensity. The 
transducer to skin distance was 5 mm. The ultrasound application time was 10 minutes. The 





Fig. B-9 Receiver chamber calcein concentration as a function of ultrasound application 
time. The ultrasound intensity was 55 W/cm2. The transducer to skin distance was 5 mm. 
The post-sonoporation diffusion time was 1 hour (n=7).  
 
With the transducer to skin distance set to 3 mm, skin was sonoporated for 10 or 
30 minutes at an intensity of 55 W/cm2. Relative to the control case, 10 minutes of 
sonoporation resulted in a 3.8-fold increase (p<0.05) in mean receiver chamber 
concentration. The median value increased by 2.8-fold (Fig. B-10). Sonoporation for 
30 minutes resulted in a 7.1-fold increase in the mean receiver concentration (p<0.05) and a 





Fig. B-10 Receiver chamber calcein concentration as a function of ultrasound application 
time. The ultrasound intensity was 55 W/cm2. The transducer to skin distance was 3 mm. 
The post-sonoporation diffusion time was 1 hour (n=7).  
 
B.3.3 Donor Temperature 
This study employed a temperature regulation system to set and maintain the coupling fluid 
at 12 °C ± 1 °C during 10 minutes or 30 minutes of continuous ultrasound application. The 
coupling fluid temperature was measured with a thermocouple that was positioned outside 
of the transducer beam. Preliminary temperature measurements were conducted to 
determine the difference in coupling fluid temperature outside of the transducer beam and 
directly over the skin surface. At steady state, when the transducer was 3 mm from the skin 
surface, the temperature over the skin surface was at most 2 °C higher during sonoporation 
(Fig. B-11). When the transducer was 5 mm from the skin surface, the temperature over the 
skin surface was at most 1 °C higher than the temperature outside of the beam. These small 
differences illustrate that the thermocouple outside of the beam undervalued the 
temperature over the skin surface by 1-2 °C during sonoporation. This undervaluing was too 




Fig. B-11 The influence of thermocouple position on the steady state thermocouple reading 
during sonoporation with a tip displacement of 60 % and a target temperature of 12 °C. The 
dotted line represents the temperature recorded with the thermocouple outside of the 
transducer beam. The dashed and solid lines represent the temperatures recorded with the 
thermocouple directly over the skin when the transducer was 3 mm and 5 mm from the skin. 
 
B.3.4 Receiver Temperature 
The temperature of the receiver fluid was measured during each of the high intensity 
sonoporation protocols to quantify its dependence on the transducer to skin distance. A 
thermocouple, inserted through the bottom of the receiver chamber so that its tip was 2 mm 
below the skin, recorded data for the duration of ultrasound application. When the 
transducer was 5 mm from the skin surface, the receiver temperature after 10 minutes of 
sonoporation was 25 °C (Fig. B-12). When the transducer was 3 mm from the skin surface, the 
temperature after 10 minutes was 30 °C. Therefore, the transducer to skin distance had only 
a minor influence on the receiver chamber temperature during 10 minutes of sonoporation 




Fig. B-12 Receiver chamber temperatures during 10 minutes of sonoporation (55 W/cm2) 
for transducer distances of 3 mm and 5 mm. Coupling fluid temperature is also shown. 
 
When the transducer was 5 mm from the skin surface, the receiver temperature after 
30 minutes of sonoporation was 26 °C (Fig. B-13). When the transducer was 3 mm from the 
skin surface, the temperature after 30 minutes was 31 °C. Therefore, the transducer to skin 
distance had only a minor influence on the receiver chamber temperature during 30 minutes 
of sonoporation at 55 W/cm2. 
 
Fig. B-13 Receiver chamber temperatures during 30 minutes of sonoporation (55 W/cm2) 
for transducer distances of 3 mm and 5 mm. Coupling fluid temperature is also shown. 
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B.3.5 Foil Pitting Experiments 
Foil pitting experiments were used to determine the influence of transducer to skin distance 
on the inertial cavitation activity at the skin aperture. With the coupling fluid circulating, each 
piece of aluminium foil was exposed to ultrasound for 2 s at an intensity of 55 W/cm2. When 
the transducer was 3 mm from the skin aperture, the mean number of pits was 35 (Fig. B-14). 
When the distance was increased to 5 mm, the mean number of pits was 16 – representing a 
56 % decrease (p<0.05). The mean then decreased by a further 93 % when the distance was 
increased to 7 mm.  
 
 
Fig. B-14 Number of pits in aluminium foil as a function of transducer to skin distance. 
Ultrasound was applied for 2 s at an ultrasound of 55 W/cm2 (n=10) 
 
B.4 Discussion 
The purpose of this study was to find a combination of sonoporation parameters that could 
be used to enhance post-sonoporation calcein transport in the coupling fluid temperature 
study (Chapter 2). Of the five combinations of sonoporation parameters investigated 
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(outlined in Table B-1), only two combinations resulted in significant (p<0.05) increases in the 
mean receiver concentration (and therefore skin permeability) relative to the control case. 
The greatest increase was achieved with an application time of 30 minutes, an intensity of 
55 W/cm2 and a transducer to skin distance of 3 mm. A lesser, but still significant, increase 
was achieved with an application time of 10 minutes, an intensity of 55 W/cm2 and a 
transducer to skin distance of 3 mm. A comparison of these two datasets shows that 
increasing the ultrasound application time increased the mean skin permeability 
enhancement by 88 % (significant at p=0.38). This is due to inertial cavitation activity – the 
longer the skin was exposed to the ultrasound field, the more inertial cavitation events 
impacted the SC. An increase in permeability enhancement with increasing ultrasound 
application time was also found in the study by Mitragotri, et al. (2000a). In that study, the 
skin conductivity enhancement achieved with an effective ultrasound time of 6 minutes was 
approximately twice that achieved with an effective time of 3 minutes. Similarly, Terahara, et 
al. (2002a) found that the mannitol permeability enhancement achieved with 6 minutes of 
effective ultrasound pre-treatment time was almost twice that achieved with 1.5 minutes.   
 
Relative to the protocols at 3 mm, the three sonoporation protocols that involved a 
distance of 5 mm all resulted in insignificant increases in the mean receiver calcein 
concentration. Therefore, decreasing the transducer to skin distance (from 5 mm to 3 mm) 
increased the skin permeability enhancement. An increase in skin permeability enhancement 
with decreasing transducer distance was also found in the sonoporation study by Herwadkar, 
et al. (2012). In that study, the transdermal transport of ketoprofen following 2 minutes of 
sonoporation with the transducer 3 mm from the skin was almost 5 times the transport 
following sonoporation at 6 mm. Similarly, Terahara, et al. (2002a) found that the skin 
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conductivity (an established proxy for permeability to mass transport) achieved after 12 
minutes of ultrasound application at 2.5 mm was 4 times that achieved after application at 
10 mm. The increase in ultrasound enhancement that occurs with decreasing transducer to 
skin distance is due to the greater number of inertial cavitation events which occur closer to 
the transducer tip. This was shown with foil pitting experiments in the study by Terahara, et 
al. (2002a) – the number of pits after ultrasound application at 40 mm was only 12 % of that 
after application at 5 mm. Foil pitting experiments showed that an increase in pitting occurs 
with decreasing distance in the present circulating setup too. When the transducer was 3 mm 
from the skin, the mean number of pits after 2 s of ultrasound application (at 55 W/cm2) was 
35. The mean number of pits then decreased as the transducer distance increased (Fig. B-14) 
– the mean at 5 mm was only 44 % of that at 3 mm, while the mean at 7 mm was only 3 % of 
that at 3 mm. From these pitting results it can be concluded that the inertial cavitation activity 
at the skin aperture increases with decreasing transducer distance in the present circulating 
setup. This explains the increased post-sonoporation transport with decreasing transducer 
distance.  
 
An increase in receiver chamber temperature with decreasing transducer distance may also 
have contributed to the increase in post-sonoporation transport with decreasing transducer 
distance. In the study by Akomeah, et al. (2004), the transdermal transport of methyl paraben 
after 4 hours with the diffusion cell in a water bath at 45 °C was shown to be 3.5 times that 
after 4 hours in a water bath at 23 °C. This difference was attributed, in part, to temperature 
induced changes in the lipid structure of the stratum corneum – changes which are known to 
influence the skin’s permeability to mass transfer (Gay, et al. 1994, Potts and Francoeur 1990).  
To quantify the influence of transducer distance on receiver chamber temperature in the 
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present study, a thermocouple was positioned in the receiver fluid, 2 mm below the skin 
surface. Measurements with this thermocouple showed that, regardless of the application 
time, the receiver chamber temperature during sonoporation at 3 mm was a maximum of 
5 °C greater than the receiver temperature during sonoporation at 5 mm. Considering the 
strict control of the fluid on the SC side, a receiver temperature difference of 5 °C would have 
had a near negligible influence on the skin permeability. Therefore, an increase in receiver 
chamber temperature with decreasing transducer distance did not contribute to the increase 
in post-sonoporation transport with decreasing distance. This reinforces the conclusion that 
it was increased inertial cavitation activity impacting the skin that resulted in greater 
transport following sonoporation at 3 mm. 
 
Given the benefits of moving the transducer closer to the skin surface it would be logical to 
reduce the distance to 0.58 mm – the very edge of the far field according to Eq. (3.1). 
However, the minimum transducer to skin distance was limited by the design of the donor 
chamber (shown in Fig. B-1). The thickness of the polypropylene at the base of the donor 
chamber was 2 mm. Therefore, 3 mm was considered to be the minimum transducer to skin 
distance as a 1 mm gap was required between the transducer tip and the donor chamber base 
so that the cooled coupling fluid could flow freely over the skin surface.  
 
Of the five combinations of experimental parameters investigated in this study, that which 
involved an application time of 10 minutes, an intensity of 55 W/cm2 and a transducer to skin 
distance of 3 mm was deemed most appropriate for use in the coupling fluid temperature 
study (Chapter 2). This combination of parameters resulted in a significant transport 
enhancement after only a short ultrasound application. An application time of 30 minutes 
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resulted in a greater skin permeability enhancement, however, as 42 individual transport 
experiments were needed for the study in Chapter 2, this was deemed to be an unnecessarily 
long application time. 
 
Future, in vitro, in vivo or clinical studies that want to obtain a greater permeability increase 
by using an application time of 30 minutes, 1 hour, or more should note that the ability of the 
circulating temperature control system is not time dependent. When an application time of 
30 minutes was used in the present study, the coupling fluid temperature was constant over 
the entire duration (Fig. B-13). Therefore, constant ultrasound application can be used, 
regardless of the application time, without any concern for coupling fluid temperature 
increase. This long duration temperature control capability enables far greater ultrasound 
application times that have previously been feasible. Previously, when a 10 % duty cycle was 
used to control thermal effects, 30 minutes of ultrasound would have taken 5 hours to 
administer. This duration would be impractical in a clinical setting and tedious in a laboratory 
setting. With the present system, a 30 minute or 1 hour application time is now far more 
practical as duty cycles are no longer required.  
 
B.5 Conclusions 
The purpose of this study was to find a combination of sonoporation parameters that could 
be used to enhance post-sonoporation calcein transport in the coupling fluid temperature 
study (Chapter 2). A calibration curve was produced so that the concentration of calcein in 
the receiver fluid could be calculated from the fluorescent intensity measured by the 
spectrofluorometer. The concentration of calcein in the receiver fluid following a control case 
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with no ultrasound was then compared to the concentration following sonoporation with five 
different combinations of experimental parameters. The combination that was deemed most 
appropriate for the coupling fluid temperature study involved an application time of 
10 minutes, an intensity of 55 W/cm2 and a transducer to skin distance of 3 mm. Relative to 
the control case, this combination of parameters resulted in a in a 3.8-fold increase 
(significant at p<0.05) in mean receiver chamber concentration and a 2.8-fold increase in the 
median. Although the present study did not directly address any of the thesis objectives, it 
does contain the first known example of calcein transport enhancement using continuous 
sonoporation with coupling fluid temperature control. The present study also shows that, in 
a sonoporation setup with circulating coupling fluid temperature control, post-sonoporation 
transport decreases with increasing transducer to skin distance and increases with increasing 
ultrasound application time. 
 
Given this positive relationship between application time and transport, future researchers 
and clinicians will find it beneficial to use long application times. Prior to the introduction of 
the circulating temperature control system presented in this thesis, 30 minutes of 
sonoporation would have taken up to 5 hours to administer, due to the need for duty cycles 
to minimise thermal effects. Such a timeframe is tedious in an experimental setting and 
impractical in a clinical setting. With temperature control, duty cycles and fluid replacement 
are no longer required. It is now possible to apply long durations (≥30 minutes) of ultrasound 




Appendix C Hydrophone Calibration Data 
 
 
This appendix contains the complete calibration information for the hydrophone (2.0 mm 
Needle Hydrophone, Precision Acoustics Ltd., Dorchester, Dorset, UK) used in Chapters 3 and 








































This thesis involved the purchase, construction and assembly of an entire laboratory setup 
from scratch; 176 transdermal transport experiments (plus the same amount again to learn 
how); 279 spectrofluorometer measurements (double that for mistakes); 68 HPLC 
measurements (triple that for mistakes); 156 foil pitting experiments (plus another 100 with a 
transducer that didn’t work); approximately 79 million hydrophone data points; 
approximately 25 hours of temperature data (double that for development of temperature 
control); 1 broken water tank which caused a small flood; about 10 2.5 hour round trips to the 
abattoir; approximately 150 pigs’ ears; and at least 3 instances of pigs’ blood squirting into 




A final note to the reader, and to the author as well,  
 
Only now that I have done it, that I have attempted it once, do I finally understand how it must 
be done. There is a cruel irony in this, and a wonderful lesson. 
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